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Abstract of the thesis 
The main aim of this thesis was to assess if early deprivation (ED) and glucocorticoid 
(GC) treatment exert long-term effects on the volume of the brain regions implicated in 
responses to stress, and if it associates with alterations in the distribution and structure of 
astroglia, which are known to support brain plasticity. This study also investigated the 
effects of prenatal dexamethasone (Dex) treatment on selected brain receptors, namely 
the oxytocin and 5-HT1A receptors, as they are implicated in the regulation of responses 
to stress. In addition, in vitro effects of Dex on neural stem cells were studied, in order 
to explore the drug effects on cell proliferation and differentiation, and on glial cell 
markers. 
Unbiased stereological estimation was employed to determine the regional brain volume, 
astroglial morphology and total cell count. Peripheral quantitative computed tomography 
(pQCT) technique was used to quantify total brain volume. Autoradiography technique 
was employed to visualise and analyse oxytocin and 5HT-1A serotonin receptor binding 
using selective radioactive ligands. 
The results of the present study demonstrate that both ED and prenatal Dex exposure 
leads to long-term effects on hippocampal remodelling with volume losses and 
impoverished astroglial morphology in the form of reduced primary process length. The 
observed deterioration in astroglial morphology adds further evidence that astrocytic 
changes contribute to hippocampal volume losses, a phenomenon that deserves more 
research in the context of effects of corticosteroid overload and stress-related 
pathologies.  
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The present results also demonstrate that prenatal Dex induces long-term effects at the 
level of central neuroregulatory processes. Thus significant region- and sex-dependent 
reductions or increases in the oxytocin and 5-HT1A receptor binding were observed. 
The in vitro study has shown that Dex affects both proliferation and differentiation of 
GFAP positive NSCs with no toxic effects as such.  
Overall, both early postnatal or prenatal manipulations that increase levels of stress 
and/or glucocorticoids as the chemical mediators of stress, lead to a long-term 
maladaptive brain remodelling with losses in the hippocampal volume, impoverishment 
of hippocampal astroglial morphology and changes in the properties of central 
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Chapter 1  
 
General Introduction 
This chapter consists of the background information and provides an introduction to the 












1.1.1 The concept 
The very concept of stress evolved in the early twentieth century. Although over the 
decades, stress has been a major subject of research, there is no precise or 
straightforward definition of stress.  
Stress affects the lives of most adults in developed countries in many ways. It is a major 
factor in rising health care costs in the United Kingdom. The Health and Safety 
Executive (HSE) statistics report that about half a million people in the U.K. experience 
work-related stress at a level they believe is making them ill. Furthermore, the overall 
cost of medical care, time lost from work, and workplace accidents come to over £15 
billion per year (HSE report, 2009-10). 
It was in the year 1936 when Hans Selye coined the term “Stress” and described it as a 
“general adaptation syndrome”. He wrote: “Stress  is  the  body’s  nonspecific  response 
 to  a demand placed on it” (Selye, 1936; page 32). In the general adaptation syndrome, 
he described three periodic stages of the stress syndrome occurring under the stressful 
event, the general alarm reaction, resistance and exhaustion (Selye, 1936). This new 
concept provided a basis for researchers to extend their knowledge and its implications. 
Stress is a term most commonly used to describe experiences that are challenging 
emotionally and physiologically. Activation of adaptive responses induced by a 
physical, chemical or psychological factor (known as ‘stressor’) and leading to a 
disruption of body homeostatic processes is stress according to Sapolsky (2003). These 
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adaptive responses constantly attempt to alter the external environment in order to 
reduce the challenge to homeostasis.   
Homeostasis is a concept introduced by Walter Cannon (1926). It is the physiological 
process, which maintains stable and constant internal environments, despite of the 
variations occurring in the external environments. The components of the internal milieu 
like pH, oxygen tension or body temperature are the important factors for the survival of 
an individual and cannot adapt as per external stressor. The mediators such as hormones, 
neurotransmitters, immune system, heart rate, blood pressure participate in the process 
of adaptation by fluctuating their levels (McEwen, 2000).  
The brain is the key organ, which registers any real or perceived stressful situation. It is 
the master regulator of the neuroendocrine, autonomic and immune systems, also 
controls the behavioural and physiological responses that are produced (Figure 1.1). 
Along with the metabolic, cardiovascular and immune systems, the brain is also a target 
of stress. Within the brain, the hypothalamus is essential for autonomic and 
neuroendocrine responses to stressors. The limbic system of the brain, involved in 
memory, anxiety and decision making, is the prime target of stress and stress hormones. 
Stress hormones play a major role in mediating both adaptive and maladaptive 
responses, by interacting with specific aspects of the physiology of each tissue. A 
characteristic behavioural feature of a stress response is the classical “fight-or-flight” 
situation. The normal stress hormone response is crucial to survive in such situations 
instead of inadequate or excessive functioning, which is deleterious for health and 
survival. 





Figure 1.1 Central role of brain in allostasis, behavioural and physiological response 
during the event of stressful situation (Source: McEwen, 1998, page 3) 
The perception of stress is influenced by an individual’s experience, genetics and 
behaviour. In response to stress-inducing factors (stressors) the brain initiates the 
physiologic and behavioural responses, leading to allostasis and adaptation. When the 
stress exists for longer time, allostatic load can accumulate and the overexposure to 
mediators of neural, endocrine, and immune stress can have damaging effects on various 
organ systems, leading to disorders (McEwen, 1998; 2007). 
Stress and an adaptive response to it have protective as well as detrimental effects, due 
to this nature introduction of the term ‘allostasis’ was defined by Sterling and Eyer 
(1988). Allostasis is “the process that keeps the organism alive and functioning, i.e. 
maintaining homeostasis or ‘maintaining stability through change’ and promoting 
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adaptation and coping, at least in the short run” (McEwen, 1998). The mediators, which 
are involved in the allostatic state are tissue mediators – corticotropin releasing hormone 
(CRH), pituitary hormones – adreno-corticotropic hormone (ACTH), glucocorticoids 
(GCs), cytokines, neurotransmitters – γ-aminobutyric acid (GABA) and neuropeptides – 
NPY (McEwen, 2002). 
The consequence of the psychosocial or physiological adaptations is allostatic load. It is 
referred to as the price, which the body pays for being forced by adaptations caused by 
use of allostasis, particularly when the mediators are dys-regulated (not turned off when 
the stress is over or not turned on when they are needed) (McEwen, 1998 and 2007).    
 
1.1.2 The stress response system: Hypothalamo–Pituitary–Adrenal axis 
and Sympathetic–Adrenomedullary system  
As mentioned earlier, the stress response is the body's constant effort to right any 
physical or mental stressor to maintain physiological, mental and emotional harmony or 
homeostasis. The consequence of an individual not able to re-establish homeostasis is a 
disease. These homeostatic processes are maintained via the hypothalamo-pituitary-
adrenal (HPA) axis, which is the primary responder to stress (De Kloet et al, 1999). 
Activation of the hormonal stress pathway (glucocorticosteroids) tends to be associated 
with depression, whereas the activation of the neural stress pathway (adrenaline) is more 
frequently correlated with anxiety (Reilly, 2006).  
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Stress responses in humans and animals lead to various biological and neuro-endocrine 
effects, such as excessive activation of the HPA axis with a release of glucocorticoids 
from the adrenal gland cortex and activation of the autonomic nervous system (ANS), 
but these depend on the level and duration of stress (Fuchs and Flugge, 1998). The 
extent of the stressor applied is determined by the parvocellular neurosecretory cells of 
paraventricular nuclei of the hypothalamus. Immediate release of the corticotropin 
releasing hormone (CRH) occurs into the portal vascular system, which stimulates the 
release of the adreno-corticotropic hormone (ACTH) via the anterior pituitary gland. 
ACTH then enters the blood circulation and stimulates the adrenal cortex to produce and 
release glucocorticoids (cortisol in humans and corticosterone in rats) (Kaufman et al, 
2002; Swaab et al, 2005). At the same time, activation of the sympathetic-
adrenomedullary-system (SAM) occurs as an immediate response to stress. SAM 
stimulates the adrenal medulla to release catecholamines (adrenaline and noradrenaline) 
initiating fight or flight response. GCs can pass through the blood brain barrier while 
adrenaline does not cross the blood brain barrier (Seckfort et al, 2008). 
The HPA axis responsiveness is determined by the ability of the glucocorticoids to 
regulate CRH and ACTH release by binding to two corticosteroid receptors, 
glucocorticoid receptors (GRs) and mineralocorticoid receptors (MRs). GRs are widely 
distributed in the brain and play a major role in stress responsiveness, as even at high 
levels of GCs there are still GRs sites available (De Kloet et al., 1991). MRs are majorly 
found in hippocampus and are less distributed in comparison to GRs. MRs have high 
affinity for GCs and play an important role during the ACTH inhibition (Reul and de 
Kloet, 1985; de Kloet et al., 1991; Young et al., 1998). Once the extent of stressor is 
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decreased, the negative feedback mechanism is activated at various levels of the system 
i.e. from the adrenal gland to the hypothalamus and other brain regions including the 
hippocampus and prefrontal cortex (Figure 1.2) (Lupien et al., 2009). This in turn lead to 
HPA axis shutdown and the system returns to homeostasis or normal stable point.  
GRs in the hippocampus respond to GC release from the adrenal cortex and induce 
negative feedback inhibition of the HPA axis (McEwen, 2001b). Therefore, the 
hippocampus activates a GC-dependent negative feedback regulation of the HPA axis by 
inhibiting CRH and further ACTH release preventing excess glucocorticoid secretion 
(Jongen-Relo et al., 2002). Glucocorticoids play a major role in the HPA axis-mediated 
regulation in stress and stress related disorders within the brain mainly affecting the 
prefrontal cortex and limbic system, which includes the hippocampus and amygdala 
(Fuchs and Flugge., 1998). 
The autonomic nervous system, cytokines, metabolic hormones and neuroendocrine 
systems that are involved in stress response are altered by the HPA axis activity, are also 
involved in the pathophysiological changes that occur in response to chronic stress, from 









Figure 1.2  Hypothalamic Pituitary Adrenal axis system response of brain to the 
stress. 
(Source: Lupien et al., 2009) 
(MRs - mineralocorticoid receptors, GRs - glucocorticoid receptors, CRH – 
corticotropin releasing hormone, AVP – arginine vasopressin and ACTH – adreno-
corticotropic hormone) 
The HPA axis pathway is activated under the stressful situation and is crucial in terms 
of the survival due to its homeostasis activity via a negative feedback mechanism. The 
above figure shows various key processes involved in the event of stress and body’s 
reaction to it.   
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1.1.3 Acute and Chronic stress 
Stress is often linked with negative or adverse life experiences, being perceived as bad 
or damaging. The extent of stressor determines the extent of the vulnerability. Stressors 
can be categorized as short term (acute) or long term (chronic). Experience of stress that 
is of limited duration is known as acute stress which can be ‘good’, and which leaves a 
sense of exhilaration and accomplishment in humans. Whereas experience which is 
prolonged or recurrent, irritating, emotionally draining and physically exhausting or 
dangerous, and beyond control is what Selye called ‘bad stress’ and which leads to 
deleterious effects. In other words, acute stress often leads to adaptive responses, which 
can maintain homeostasis. On the other hand, chronic stress leads to maladaptive 
responses, which are not able to maintain homeostasis leading to a pathopysiological 
cascade and may result in episodes of depression (De Kloet et al., 2005; McEwen, 1998 
and 2007). 
Acute stress is the reaction to an immediate threat, classically known as the fight or 
flight response. The threat can be any situation that is perceived, even subconsciously or 
falsely, as a danger. Common acute stressors include noise, isolation, hunger, infection 
or even remembering a dangerous event. Under most of these circumstances, once the 
acute threat has passed the relaxation response occurs where levels of stress hormones 
return to normal. Frequently, life poses ongoing stressful situations result ing in chronic 
stress. Common chronic stressors include ongoing highly pressured work, long-term 
relationship problems or financial insecurities. These results in the upregulation of the 
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stress hormones, which causes detrimental effects leading to a disease (Joëls, 2006; Joëls 
et al., 2006; McEwen, 1998). 
Preclinical research has shown that acute stress can produce a beneficial effect on 
learning and memory, through the effects of glucocorticoids on the hippocampus and the 
cerebral prefrontal cortex, the key regions that control memory (McEwen, 1998; 2000). 
Acute stress also leads to an increase in the release of the neurotransmitter glutamate in 
the prefrontal cortex which supports working memory (Yuen et al., 2009). Chronic stress 
is linked with damaging effects on the normal brain functioning, which results in deficits 
of hippocampus-mediated learning and memory disruption of cell growth  and 
neurogenesis (Joëls, 2006; McEwen, 2007; Joëls et al., 2006; Pardon and Marsden, 
2008).  
1.1.4 Life cycle model of stress 
The brain is referred to as dynamic and unique due to its feature of adaptive plasticity. 
Compared to other organs, the brain is the slowest to develop. Prenatal stress exposure 
has programming effects on the development of brain regions such as the hippocampus, 
frontal cortex and amygdala. These brain parts belong to the so called limbic system, 
which is involved in the regulation of the hypothalamus-pituitary-adrenal axis (HPA) 
(Levine, 1994).  
Early postnatal stress exposure can have damaging effects on the brain. Postnatal stress 
exposure in the form of early deprivation or maternal separation in childhood causes 
excessive release of glucocorticoids whereas exposure in the form of childhood abuse 
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leads to reduced secretion of glucocorticoids according to the model suggested by 
Lupien et al. (2009). Developing brain regions are susceptible to the effects of stress 
hormones, yet some areas undergo quick recovery during a particular time. The 
hippocampus is the key area related to memory formation and is under development 
stage for an initial two years of age in humans and is most prone to stress effects. While 
the amygdala continues to develop until late 20s. Hence, stress exposure in childhood 
and/or adolescence may cause changes in amygdala volume (Heim and Nemeroff, 1999; 
Lupien et al, 2009). Stress exposure during adolescence may also lead to changes in the 
frontal cortex volume when it is still under development (Teicher et al., 2006). 
Adolescence is the most critical period of development where the probability of stress 
exposure is higher due to protracted glucocorticoid response causing 
potentiation/incubation effects which may extend to adulthood. Most rapid decline in 
brain region commences during adulthood and aging due to proneness to stress 
hormones and which is why the brain is most susceptible to neurodegenerative diseases 
during aging (Barr et al., 2004; Lupien et al, 2009). 
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1.2 Early Life Stress  
1.2.1 The concept and effects on the brain 
The importance of the environment in the regulation of brain, physiology and behaviour 
has long been recognised in the biological, social and medical sciences, which leads to 
an important junction in the study of the causal relationships between physical and social 
environmental factors and neurobiological, physiological and behavioural phenotypes 
(Levine, 1960; Nemeroff, 1998; Pryce and Feldon, 2003). In humans, stressful early life 
experience occurs in the form of child abuse/neglect or parental loss which is a major 
risk factor of depression (Heim and Nemeroff 2001; McEwen, 2000). Studies have 
observed that low maternal care and avoidance of depressed mothers towards their 
children affect the normal neuronal development and HPA axis function resulting into 
neuropsychiatric or neurological disorders later in life (Francis and Meaney, 1999; 
Kaufman et al., 2000; Nicol-Harper et al., 2007).  
In mammals, infancy is the period of life which is characterised by marked 
neuroplasticity and strong mother – infant interactions (Pryce et al, 2002). The normal 
postnatal development of the CNS of an infant depends on the mother – infant 
relationship (Pryce et al, 2005). The mother provides stimuli to rat pups not only 
through feeding but also through contact and warmth (Lehmann and Feldon, 2000). The 
maternal homeostatic regulation in infants is maintained via thermal - metabolic 
regulation which maintains oxygen consumption and heart rate at a normal stable level, 
nutritional regulation which is provided by milk and tactile regulation which maintains 
growth hormone and catecholamines (Pryce et al, 2005).   
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In the year 1962, Schapiro and colleagues conducted one of the earliest studies on 
postnatal effects of the HPA axis in rats during the first two weeks after birth and found 
very low blood levels of corticosterone and no overactivity of HPA axis when exposed 
to mild stressors. Hence, this period was named as stress non-responsive period (SNRP) 
(Schapiro et al., 1962). These studies were based on the measurement of the 
corticosterone levels in the blood. However, later studies by Schoenfeld and colleagues 
and Walker found HPA axis overactivity in rats exposed to ether fumes (Schoenfeld et 
al., 1980) suggesting HPA axis functioning depends on the time and type of stressor 
(Walker et al., 1990). Hence, the stress non-responsive period (SNRP) was renamed as 
stress hypo-responsive period (SHRP). 
Rat pups are said to be in a stress hypo - responsive period (SHRP) during 2-14 
postnatal days (PND) and show characteristic neuroplastic and neuroendocrine patterns 
(Pryce et al, 2002). The SHRP maintenance is dependent on the level of maternal care. 
Inadequate maternal care leads to the stimulation and dysregulation of the HPA axis 
activity because newborn pups have a high density of glucocorticoid receptors in the 
pituitary and activates the negative feedback inhibitory signals during early stages of life 
(Lehmann and Feldon, 2000). Animal models using disrupted maternal care are 
characterised with chronic physiological, neurobiological and behavioural effects in 
their adulthood (Pryce and Feldon, 2003; Pryce et al, 2005). Early life manipulation in 
rodents and primates can model the relationship between early life stress and depression. 
Manipulation in early life reflects  human traits such as neglect like behaviour and 
reduced motility towards reward (Pryce et al, 2005; Rüedi-Bettschen et al, 2005). 
Marked changes in behaviour such as increased anxiety, anhedonia, sleep disturbance, 
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decreased appetite and increases in the ACTH and glucocorticoids responses to a variety 
of stressors are observed in infants that had experienced disruption in maternal care in 
the first 14 postnatal days (PND) (Heim et al, 2004). In addition to this, neurobiological 
studies of early life stress in rats observed marked CNS changes such as an increase in 
CRH activity, decrease in glucocorticoid receptor density in the hippocampus and 
prefrontal cortex (Heim et al, 2004) or reduced astroglial density in the limbic system of 
ED rats (Leventopoulos et al., 2007). Therefore, early life stress results in various 
neurobiological changes such as alterations in the HPA axis system, the SAM system, 
the serotonergic and mesolimbic dopamine pathways (Heim et al, 2004; Leventopoulos 
et al, 2009; Rüedi-Bettschen et al, 2005). It is of prime importance to understand the 
mechanisms, which activate stressful events and which serve as a link between early life 
stress and brain development (Brunson et al, 2001). Studies carried out on early 
deprived rodents reveal multiple changes in various neurocircuits involved in 
neuroendocrine and behavioural responses to stress, which may cause an increased risk 
for depressive disorders in humans (Heim et al, 2004). 
Extrapolating to the human condition, healthy physical and mental development is of 
prime importance during the childhood and adolescence stage for the betterment of 
adulthood life but stress related deficit is common during these phases. A large-scale 
study carried out by Cohen et al (2006b) on early life stress (ELS) (n=1659) found that 
more than one-third of the participants suffered from adverse childhood events mostly 
were divorce (22%), family conflicts (20%) and social abuse (17%). ELS leads to stress 
response system dysfunction and reduced immune function which may have prolonged 
effects continuing into adulthood (Graham et al, 2006).  
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A study reported significant reduction in the anterior cingulate cortex and caudate 
nucleus volume (brain regions involved in emotional and cognitive behaviour apart from 
movement control) in healthy adults who had a previous history of adverse childhood 
events (Cohen et al, 2006a). Another study found significant left hippocampal volume 
reduction in adult women who suffered from childhood sexual abuse (Sapolsky, 2000). 
Teicher et al (2004) reported a 17% decrease in the corpus callosum volume in socially 
abused and neglected children compared to non-exposed group. Studies have found links 
between ELS and cognitive function; with ELS effects on mental functions, information 
processing, memory, intelligence, verbal abilities, low IQ’s (Goethals et al, 2003). ELS 
may play a role in the alterations of white matter pathways in the brain also indicates the 
vulnerability of the brain during these critical periods of development (Seckfort et al, 
2008). 
 
1.2.2 Early life environmental manipulation 
As mentioned earlier, the insights of behavioural and physiological mechanism involved 
in any neurobiological disease are identified using animal models (McEwen, 2007). In 
rodents, early life maternal care is important factor which determines long term 
emotional and stress hormone reactivity and increase in both leads to earlier cognitive 
decline and shorter life span (Francis et al., 1999).    
Strong mother – infant interaction, more licking and grooming, produces offspring 
which is more exploratory of novel environment and less emotionally reactive known as 
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a neophilic animal. This type of strong maternal behaviour leads to decreased levels of 
glucocorticoid response in novel situations. Poor mother – infant interaction, less licking 
and grooming, results in offspring which is less exploratory of novel environment and 
with increased emotional and HPA reactivity, known as a neophobic animal (Meaney et 
al., 1994).  
The neonatal handling involves disruption in maternal care, short term (decreased HPA 
reactivity) and long term (increased HPA reactivity) separation of pups from their 
mothers whereas, enriched environment during the peripubertal period overcomes the 
neurobiological deficits resulted from low maternal care (Levine et al., 1955). 
The influence of the nature and nurture is an important factor for the social well being of 
an individual. The effects of early life manipulation of the infant’s social environment 
can be studied at different time points. The phenotypes that are developed are associated 
with depression like neurobiological changes and behaviour observed in rodents and 
which are reversible with anti-depressant treatment (Pryce et al., 2005; Leventopoulos et 
al., 2007). These depression-like phenotypes  emerge into behavioural, physiological 
and neurobiological test paradigms (Figure 1.3) which can be quantified may provide 









Figure 1.3  Early life manipulation yields animal models of stress and depression. 
(Source: Pryce et al., 2005)  
The above diagram represents various stages, mechanisms and measures involved in the 
development of the animal models of depression and stress.   
 
1.2.3 Types of early life environmental manipulation (postnatal) 
Postnatal manipulations during the early life developmental period result in loss of 
homeostasis which can cause long term changes (Pryce et al, 2005; Sapolsky, 2004). 
Such postnatal manipulations were characterised long ago and have been studied 
experimentally for nearly 50 years. The work in the field is pioneered by Seymour 
Levine and Victor Denenberg (Levine et al, 1955; Denenberg et al., 1963).   
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The postnatal manipulations in rodents and primates which may disrupt the homeostatic 
relationship between mother and infant are achieved mainly by early-handling and early-
deprivation (Pryce et al, 2005).  
1.2.3.1 Early-Handling (EH) 
In EH manipulation mother and infants are exposed daily to human physical contact and 
are exposed for 15 min to a different physical environment. Mother and infants are 
always separated whereas infants are separated from dam either as an intact litter or as 
individual pups (Pryce and Feldon., 2003). EH of rats leads to adult offspring that are 
less anxious and fearful when exposed to environmental challenge (Levine et al., 1955; 
Pryce et al., 2001). EH rats attract increased maternal attention in the form of licking and 
nursing in comparison to non-handled rats (NH) (Liu et al., 1997). Reduced ACTH and 
GC responses are also observed together with enhanced cognitive abilities in adulthood 
(Pryce et al., 2001a, b).  
1.2.3.2 Early-Deprivation (ED) 
In ED rats, mother and infants are exposed daily to human physical contact and 0.5–6 
hours of daily separation of individual infants from littermates and from the mother, in a 
different physical environment during the PND 1-14 is performed (Pryce and Feldon., 
2003). The mother remains in the home cage. The procedure is performed at the ambient 
colony room temperature (Pryce et al., 2005). (Figure 1.5) 
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1.2.3.3 Non-Handling (NH) 
To control for EH and ED, NH rats are used where mother and infants are not exposed 
to human physical contact and exposed to only minimal distal human disturbance, e.g. 
room entry restricted to one person only during the postnatal period of life (Pryce et al., 
2005). Studies have observed that NH rats move less in the open field test and are 
characterised by increased acoustic startle and corticosterone response (Pryce et al., 
2001). In later stages of adult life, NH rats seem to show increased levels of basal 
hypothalamic CRF mRNA and increased CRF in the median eminence (Plotsky and 
Meaney, 1993).     
Early maternal deprivation in rats is a model which replicates the relation between early 
life stress and depression and reflects similar human traits such as neglect like behaviour 
and reduced motivation to obtain the reward (measured by sucrose test) (Pryce et al, 
2005; Rüedi-Bettschen et al, 2005). Early deprived rats develop marked changes in 
behaviour such as increased anxiety, anhedonia, sleep disturbance, decreased appetite 
and also shows three – fold increase in the ACTH and glucocorticoids responses to a 
variety of stressors when experienced separation from mother for 180 min in the first 14 
postnatal days (PND) (Heim et al, 2004). 
Behaviourally, ED rats are more active in the open field with a reduced acoustic startle 
reflex and show enhanced two way active avoidance in comparison to NH rats (Rüedi-
Bettschen et al., 2005). 
An ED procedure established at the Swiss Federal Institute of Technology in Zurich, 
Switzerland consists of isolation of rat pups from both the dam and littermates for 4 
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hours/day on 1-14 postnatal days (PND). The pups are placed in open plastic 
compartments on a thin layer of saw dust, at ambient room temperature during and the 
dark phase of a reversed light-dark cycle. Absorbent paper is placed on the bottom of the 
cage for urine and feces. The cage is placed in an isolation chamber that is illuminated 
with a 4-W bulb. A small video camera placed above the cage which allows for the 
behaviour to be observed and recorded (Figure 1.4). 
 
Figure 1.4 Early deprivation procedure where rat pups are placed in separate 
compartments.     (Source: Pryce et al., 2005) 
Picture representing early deprivation procedure carried out at ETH, Zurich laboratory, 
where rat pups are placed in open plastic compartments on a thin layer of sawdust. 
1.2.4  Early responses to postnatal manipulations  
As mentioned above, the effect of stress depends on the duration and the level of stress, 
which further results in an acute or chronic response depending on stress exposure. The 
neurochemical changes occurring in the phase of postnatal deprivation can lead to 
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detrimental effects causing morphological and functional changes in neurones and 
astroglia (Watanabe et al., 1992; McEwen, 2005). McCormick et al (1998) suggest that 
repeated daily separation of pups from the mother can lead to an increase in stress 
responses which may result in higher GC levels causing disruption of memory and 
learning processes mediated by the hippocampus (McCormick et al, 1998; Zhang et al, 
2002). Levine et al (2001) conclude that isolation of rat pups from their mothers for 
eight hours can cause acute stress and result in increased levels of ACTH and 
glucocorticoids following an increase in HPA axis activity. A study carried out on daily 
maternally deprived rats on 2-14 PND then followed by a single acute 3 hour separation 
have demonstrated a significant increase in the expression of BDNF mRNA in the 
hippocampus and prefrontal cortex (Roceri et al, 2004). Increased serotonin activity and 
GC mRNA expression in the hippocampus is observed in early handled rats (Meaney et 
al., 2000). Maternal separation (6 hours/day – PND 2-14) affecting the early rearing 
environment in male rats showed impairment in the programming of fear conditioning 
and extinction (Stevenson et al., 2009). Slotten et al. (2006) found long-term gender 
dependent effects on the behaviour and HPA axis function in rats exposed to maternal 
separation (PND 3-15, 3 hours/day). These early responses are of prime importance to 
understand the mechanisms which lead to long term effects of early life stress and 
pathophysiology of depression. 
1.2.5 Long-term responses to postnatal manipulations 
Research to date suggests that long term effects of postnatal manipulations cause varied 
changes in the neurobiological and neuroendocrinological systems. These early life 
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alterations result in an overactivity of the HPA axis with increased levels of CRH and 
corticosterone, which may have a detrimental impact on hippocampal neurones 
contributing to the onset and pathophysiology of depression (Nemeroff, 1998; Swaab et 
al, 2005). Hypercortisolaemia (high GC concentrations in blood) (Fuchs and Flugge, 
1998) may lead to glial and neuronal cell death. 
The postnatal manipulations lead to depression-like behavioural phenotypes in rats and 
have long-term outcomes in behavioural and endocrine responses (e.g. Pryce et al, 
2005). These effects can be investigated by using tests to monitor anhedonia and the 
coping ability of animals. ED rats exhibited a significant reduction in the motivation to 
obtain reward in the progressive ratio schedule test compared to NH (Pryce et al, 2005). 
In-house studies have demonstrated that stress hyper-responsive Fischer rats exposed to 
early life deprivation developed into adults with reduced astroglial GFAP-
immunoreactivity in the limbic regions of the brain (Leventopoulos et al, 2007). In 
normal responsive Wistar rats, early deprivation leads to decrease in the 5HT1A receptor 
binding (Leventopoulos et al., 2009). Evidence of this kind suggests that early adverse 
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1.3 Prenatal Stress 
Prenatal period, which lasts from fertilisation to birth, is complex and interesting as the 
stress system of the neonate during this time is dependent, influenced and closely linked 
with the stress system of the mother. It is during this time the central components of the 
HPA axis emerge and begin to function (Challis et al., 2001). In rodents, at gestational 
day 18, the foetal HPA axis responds to maternal stress with elevated ACTH levels 
(Ohkawa et al., 1991). The fetal HPA axis can also be stimulated by the maternal CRH 
originating from the placenta (Weinstock, 2005).  
Excess glucocorticoids during this development phase are detrimental. Foetal 
glucocorticoids produced are mainly of maternal origin. The placenta acts as the 
protective element against foetal exposure to maternal glucocorticoids by high activity 
of enzyme 11β-hydroxysteroid dehydrogenase 2 (11β-HSD2), which converts 
corticosteroids to inactive 11-keto forms. Excessive or long lasting maternal stress leads 
to deficiency of the 11β-HSD2 enzyme further leading to damaging effects on foetal 
development (Figure 1.5) (Seckl and Holmes, 2007). In humans, prenatal stress exposure 
is linked to new born infants with low birth weight further developing neurological 
disorders (Van den Bergh et al., 2005; Schmidt, 2010). 
 




Figure 1.5 - Prenatal stress effects on the foetal HPA axis functioning  
(Source: Charil et al., 2010) 
(PS – prenatal stress, CRH – corticotropin releasing hormone, 11βHSD2 – 
hydroxysteroid dehydrogenase, HPA – hypothalamus pituitary adrenal axis) 
The above pathway details the activation of foetal HPA axis via the maternal CRH and 
cortisol release affecting foetal development.  
 
In comparison to humans, rodent’s prenatal period corresponds to the early prenatal 
period in humans (Figure 1.6).  
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Prenatal stress is related to cognitive, physical behavioural and emotional disorders in 
later life. In humans, it is associated with various psychosocial problems during 
childhood and adulthood development (King and Laplante., 2005; Charil et al., 2010).  
Prenatal stress due to natural calamity is also linked with developing depression and 
schizophrenia in adulthood (Watson et al., 1999; Kinney, 2001). 
Preclinical studies in animals have observed that prenatal stress produces specific 
behavioural changes such as non-directed locomotor activity, anxiety, and decrease in 
memory and learning tasks (Coe et al., 2003; Wu et al., 2007). These cognitive, 
behavioural and psychosocial deficits are possibly caused by maternal stress which 
shows damaging effects on the offspring’s brain (Anderson et al., 1985; Coe et al., 
2003). 
 
Figure 1.6 - Human prenatal period timeline. 
(Source:http://www.ehd.org/dev_article_intro.php) 
Red and blue line indicates different stages and time periods involved during pregnancy 
and early human development. 
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In humans, monkeys and rodents, glucocorticoids play a key role in the development of 
the foetus, which is why its levels are high during pregnancy (Seckl and Holmes, 2007). 
However, in the event of maternal stressful condition GC levels reach abnormally high 
levels which may have potential effect on the foetal growth. Animal studies have found 
alterations in the hippocampal volume and neuronal development in the brain due to 
high corticosteroid exposure during the prenatal period (Uno et al., 1994; Avishai-Eliner 
et al., 2002; Coe et al., 2003).  
In human pregnancy, maternal HPA axis regulates the placental CRH activity which in 
turn influences the foetal hippocampal development (Wadhwa et al., 1998). Prenatal 
stress increases the hypothalamic CRH release in the bloodstream. Suppression of 
hypothalamic CRH takes place while placental CRH is increased by glucocorticoids 
leading to higher foetal plasma CRH levels (Sandman et al., 1999). Activation of CRH 
receptors results in altered foetal HPA axis function which has a negative impact on the 
postnatal development of the new born (Avishai-Eliner et al., 2002).       
1.3.1 Effects of prenatal stress on brain regions  
The key region affected by prenatal stress is the hippocampus which develops primarily 
during the foetal period (Rice and Barone, 2000). Hippocampus is the region where 
neuronal cell proliferation takes place and is actively involved in learning and memory 
function. Early studies carried out on non-human primates suggest hippocampus as the 
prime target of both pre and postnatal stress because corticosteroid administration alters 
normal hippocampal functioning (Uno et al., 1994). Hippocampal volume loss and a 
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decrease in neurogenesis in the dentate gyrus region are observed in primates exposed to 
prenatal stress (Coe et al., 2003).  
Amygdala, a brain region involved in emotional regulation, appears to be also affected 
by prenatal stress. Thus offspring of Sprague Dawley rats exposed to a novel 
environment following saline injection to pregnant dams during gestational days 14 and 
21 have shown reduction in amygdala volume and a decrease in the number of neuronal 
and glial cells (Kraszpulski et al., 2006).  
The other effects of prenatal stress reported in experimental animals are, a decrease in 
the size of the corpus callosum (Coe et al., 2002), morphological changes in neurones 
and glial cells in the cerebral cortex region (Poland et al., 1999), loss of interneuronal 
connectivity and decreased granular cell nuclei volume in the cerebellum (Ulupinar and 
Yucel, 2005) and in hypothalamus differences in the sexually dimorphic nucleus of 
preoptic area size (Anderson et al., 1985).  
1.3.2 Differences and limitation to prenatal stress in animal studies  
Even though the rat lifespan is 3 years, it does not indicate that it lives a miniature 
human lifetime within those 3 years life time (Quinn, 2005). The developmental stages 
such as infancy, weaning, puberty, adulthood, reproductive senescence, post senescence 
are similar in both humans and rats but their timings are different.  The approximation 
may be considered during the periods of development but straight age translation could 
not be reasonable between humans and rodents (Quinn, 2005, Clancy et al., 2001). 
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The central nervous system develops in a time-dependent manner. Duration and time of 
the neurodevelopmental events and the ratio of specific brain regional volume to whole 
brain volume is different in different species (Rilling and Insel, 1998; Charil et al., 
2010). In humans the brain maturity level is different compared to rodents at birth. 
Rodents are born with an immature brain which develops mostly during the postnatal 
period whereas human brain development starts prenatally (Rice and Barone, 2000).    
In case of prenatal stress studies various factors can affect the outcome, which includes 
differences in species with varying gestational periods (in rats 21.5days, monkeys 165 
days and humans 270 days), type of stressor applied, timings of stress administration and 
postnatal assessment, as well as effects of sex, maternal care and epigenetics. 
 
1.4 Genetics and early life experiences 
As mentioned earlier, early life experiences or environment may have an enduring effect 
on the CNS as infant brain rapidly changes during post-natal days. Neurodevelopment of 
infants depends on the maternal care in the form of feeding and warmth. In order to 
understand how the brain is shaped by these experiences, studies have been conducted 
on the neurodevelopment of rodent pups who receive either low or high levels of 
maternal care (Liu et al, 1997). Like human infants, newborn rodent pups, need to be 
fed, kept warm and stimulated in order to grow. This stimulation is provided by licking 
and grooming (LG). However, not all mothers provide the same level of maternal care to 
their offspring. Individuals who receive low levels of LG are found to have fewer 
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glucocorticoid receptors within the hippocampus as well as altered dopamine, serotonin 
and GABA neurochemical pathways in the brain. These neural changes emerge early in 
infancy and are sustained into adulthood with consequences for behaviour across the 




Figure 1.7 - Level of offspring glucocorticoids receptor expression in relation to 
maternal licking and grooming and stress responses. (Source: Champagne et al., 2003) 
(LG – licking and grooming, GR – glucocorticoid receptors) 
The above figure indicates low level of LG results into increased stress response due to 
high GR methylation and high level of LG causes reduced stress response due to high 
GR expression resulting from lower GR methylation.  
 
The stable increase in the activity of ERα gene (estrogen receptor) allows the 
“inheritance” of maternal care. This raises the argument of how changes to a gene's 
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activity can persist long after the experience of maternal care. Levels of gene expression 
are dependent on how accessible the sequence of DNA is to factors which initiate the 
transcription process. These factors can be blocked by a stable and heritable chemical 
modification known as DNA methylation. Once DNA is methylated it is no longer 
available to transcription factors and gene expression; it is thus “silenced”. DNA 
methylation is referred to as “epigenetic” because this modification alters the activity of 
genes without altering the sequence of their DNA (Champagne et al., 2003).  
Studies of maternal behaviour in the rat suggest that mothering is transmitted 
“epigenetically” from mother to daughter through levels of methylation of the ERα gene 
promotor. Studies have also shown that the experience of low levels of maternal care in 
infancy can lead to increased levels of DNA methylation within the promotor region of 
the ERα gene leading to reduced levels of receptors in adulthood. In this way, the quality 
of mother-infant interactions can act as an “on/off” switch to gene expression with 
consequences for neurobiology and behaviour (Champagne et al., 2003). 
While the brain is likely to be particularly sensitive to experiences occurring early in 
development, there is a high degree of plasticity in the brain beyond infancy. Maternal 
and social behaviours can be influenced by the quality of the juvenile environment and 
prolonged exposure to stress is effective at shifting patterns of behaviour across the 
lifespan (Hane et al., 2006). Though it is not yet known how these changes occur, it is 
possible that these environmental experiences turn genes “on” or “off” through 
epigenetic pathways (Champagne et al., 2003). In gaining a better understanding of how 
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the environment can shape gene expression and the brain we may be able to develop 
new strategies for intervention in humans to reverse the effects of early life adversity. 
 
 
Figure 1.8 Resilience and susceptibility to early life stress (Source: Schmidt, 2010) 
The applied stressor during the developmental phase results into either adaptive 
(beneficial) or maladaptive (detrimental) offsprings. 
 
Preclinical research suggests the fact being overlooked is that the majority of the 
individuals are resilient to early life stress. It is the genetic makeup (epigenetic) of the 
individual which decides whether stress exposure during prenatal or postnatal 
development leads to maladapted with high risk factor of disease later in life or well 
adapted with no vulnerabilities (Fig 1.8). Gene-environment interactions play an 
important role in early life stress. Interestingly, individuals with short allele of the 
serotonin transporter gene (5-HTT) possess high chances of depression later in life when 
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they were maltreated during childhood whereas individuals with long allele of 5-HTT 
gene are protected (Capsi et al., 2003). 5-HTT gene depleted mice show susceptibility to 
early life stress (Carola et al., 2008) which supports a role of genetics in depression. 
 
1.5 Depression and its links with early life experiences 
Depression is a common psychiatric disorder which affects one in six people and leads 
to suicide in approximately 10% sufferers. Depression is expected to become the second 
leading cause of disease burden by 2020 (WHO 2007). The brain mechanisms that lead 
to depression have not been fully explained despite years of clinical and preclinical 
studies, although chronic stress is considered to be a risk factor.  
Published research suggests a role of multiple neuro-endocrine, neuro-chemical and 
neuro-anatomical brain changes in major depressive disorder (e.g. Heim et al, 2004). 
Considerable evidence also indicates involvement of neuronal and glial changes in 
certain regions of the brain which are responsible for the modulation of stress and 
emotion (Duman, 2002). Ethical restrictions which limit the clinical studies in 
depressive patients confine the knowledge of neurobiological processes and mechanisms 
involved in depression (Fuchs et al, 2004). To overcome this, rodents and primates have 
been used in experiments designed to investigate the neurobiology of depression and 
depression-like conditions.   
Alterations and modification of neuronal circuits, cell morphology and synaptic 
connections due to external or internal stimuli are known as neuroplasticity. 
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Neuroplasticity is the ability of the brain to adapt functionally to various challenges 
occurring due to external environment (Fuchs and Flugge, 1998; McEwen, 2000).  
Capacity of neural systems, brain pathways, neurons, synapses, and receptors play an 
important role in this process (Fuchs et al, 2004; Zilles, 1992). Neuroplasticity occurring 
in response to environment is of prime importance for brain function in health and 
disease, but it is not always beneficial. Alterations in the structure and function of the 
brain in patients with depressive disorder illustrate deleterious effects of neuroplasticity 
(e.g. Duman, 2002; Fuchs et al, 2004) and they will be addressed below.     
Mechanisms behind neuroplastic changes occuring in the brain which mediate 
depression, leading to return of depressive symptoms in successfully treated patients 
remains unclear. Various neuroimaging studies in patients suffering from depressive 
disorder and preclinical studies in animal models of depression show involvement of 
certain brain areas (involved in memory and emotion) such as hippocampus, amygdala 
and prefrontal cortex, are thought to play a role in developing symptoms of depression 
(Bremner, 2005). 
One of the important regions of the brain affected by depressive disorders is the 
hippocampus. Hippocampus is the part of brain which deals with emotional processing 
(ventral hippocampus) and learning and memory processing (dorsal hippocampus) 
(Fuchs and Flugge, 1998; McEwen, 2000). Both clinical and experimental research 
suggests a role of the hippocampus in major depressive disorder (e.g. McEwen, 2001). 
Structural neuroplasticity in the form of remodeling of dendrites takes place in the CA3 
region of the hippocampus (Duman, 2002). Dendritic remodeling could be the basis of 
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neuroplasticity effects and the reason of a reduction in the hippocampal volume in 
depression (Duman, 2002, 2004; Fuchs et al, 2004). Indeed, neuroimaging studies by 
means of MRI show a reduction in the hippocampal volume in patients suffering from 
long term depression (Coe et al, 2003; Nemeroff, 1998). Reduced volume of right 
hippocampus and left amygdala have been observed in patients suffering from bipolar 
depression (Bremner et al, 2000). 
Stress-induced hippocampal plasticity reported in animal studies as being associated 
with cortisol has given new insights into the relationship between hippocampus, memory 
and cortisol in patients suffering from depressive disorders. Hypercortisolaemia in 
patients with Cushing’s syndrome is linked with a reduction in the hippocampal volume 
similar to depression (Starkman et al, 1992). Enlarged pituitary and adrenal gland, 
increase in the corticotropin-releasing factor (CRF) and non-suppression in the 
dexamethasone suppression test leading to high levels of cortisol in the periphery are 
observed in the depressed patients (Nemeroff et al, 1984 and 1992).       
Hippocampal plasticity is a well-replicated finding in depression. Hippocampal volume 
shrinkage and reduction in the hippocampal neuronal size are the consistent effects of 
stress on hippocampus. Hippocampus holds a key function possessing an inhibitory 
effect on the HPA axis through which CRF release from the hypothalamus could be 
blocked. In depression, hippocampal damage causes loss of negative feedback inhibition 
leading to excessive release of cortisol contributing to hypercortisolaemia and 
detrimental effects to normal brain functioning (Jacobson et al, 1991).   
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The amygdala plays an important role in the emotional memory formation and emotion 
regulation. Studies also suggest its role in pathophysiology of mood disorders (Fuchs et 
al, 2004). MRI studies carried out on female patients with depression showed a 
reduction in amygdala core (Sheline et al, 1998) whilst another study on men and 
women showed a larger total amygdala volume in depressed patients (Bremner et al, 
2000). A post-mortem histopathological study showed a decrease in the number of glial 
cells in the amygdala in major depressive disorder (MDD) patients with no change in 
neuronal numbers (Bowley et al, 2002). Another study with a stereological approach 
carried out on MDD patients showed that a decrease in glial cells in the amygdala 
primarily was due to oligodendrocyte reduction (Hamidi et al, 2004). The reported glial 
changes are likely to be causally linked with the volume reduction in the amygdala. 
Prefrontal cortex (PFC) dysfunction plays an important role in the aetiology of major 
depression and has connections with hippocampus (Nemeroff, 1998). Recent findings 
also suggest that dendritic alterations observed in PFC and hippocampus are due to high 
levels of glucocorticoids, which indicates that these biochemical mediators of stress play 
a role in neuroplasticity (Fuchs et al, 2004). 
 Volumetric brain imaging carried out by Sheline et al. has found a relationship between 
disease chronicity and hippocampal volume loss. Protective effects of antidepressants 
have been observed in patients who were previously untreated for depression showing 
an inverse correlation between the hippocampal volume and the duration of 
antidepressant treatment (Sheline et al, 2003). Hippocampal  volume loss in patients 
with multiple episodes of depression but not new-onset depression was reported 
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(MacQueen et al, 2003). No changes in the hippocampus volume have been observed in 
young depressed patients (Rusch et al, 2001). These studies suggest that duration or 
chronicity of illness plays a key role in determining hippocampal atrophy in depression. 
It is estimated that a 40-50% chance of having depression is genetic, although the 
specific genes have not been identified (Nestler et al, 2002). Genomic and epigenetic 
changes may occur due to maternal care disruption which influences the development of 
the offspring (Weaver et al, 2004). Environmental factors such as parental death, social 
neglect, sexual abuse, or chronic illness which occurs in early life can lead to depression 
in later life (Agid et al, 2000). Early life stress (ELS) is considered to be a risk factor of 
depression (e.g. Agid et al, 2000; Heim and Nemeroff, 2001). In support of the latter is a 
clinical study involving 2000 women revealed that those with a history of sexual abuse 
in childhood developed most of the symptoms of depression and had more attempts of 
suicide than women without any history of childhood sexual abuse (McCauley et al, 
1997). There is consensus that a depressive disorder is the outcome of the ongoing stress 
in conjugation with multiple other psycho-physiological effects (Agid et al, 2000; Heim 
and Nemeroff, 2001).      
 
1.6 Glucocorticoids and its links with early life experiences 
Glucocorticoids, cortisol (in humans) and corticosterone (in rodents) provide one of the 
most powerful endogenous feedback systems, which exert negative regulation that sets 
the basis for stress related activity of the HPA axis (de Kloet et al, 1999; Heim et al, 
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2004). Glucocorticoids (GC) control the excitability of neuronal networks, which 
support the learning and memory processes (de Kloet et al, 1999).  
As mentioned earlier, GCs bind to two different types of receptors type 1-
mineralocorticoid and type 2-glucocorticoid receptors. MRs are found majorly in 
hippocampus whereas GRs are concentrated in the entire brain (Reul and de Kloet, 
1985). These receptors show different affinities towards cortisol and other 
glucocorticoids such as dexamethasone, prednisone. GR shows less affinity for cortisol 
which makes it more critical during stress response when plasma cortisol levels 
increases (Meaney et al, 1988). Glucocorticoid receptors (GRs) are highly expressed in 
various brain regions, such as hippocampus, amygdala and prefrontal cortex (limbic 
system of the brain - involved in the feedback regulation of the HPA axis) (Herman et 
al, 2005). The GRs are found abundant in hippocampus which actively responds to the 
GC release from adrenal glands and stimulates the negative feedback mechanism of 
HPA. As a result, inhibition of CRH and further ACTH release occur via GC-dependent 
negative feedback mechanism of HPA axis (De Kloet et al, 1999; Herman et al, 2005).  
The release of GC is known to cause several morphological and physiological alterations 
in the central nervous system (CNS) (McEwen et al, 1986). High levels of 
glucocorticoids have a detrimental impact on the normal functions of brain, which leads 
to an impairment in the processes of memory and learning along with hippocampal 
dendritic atrophy (Colla et al, 2007; Fuchs and Flugge, 1998). The limbic system is 
highly sensitive to endogenous glucocorticoids during the period of brain development 
(Matthews, 2000).  
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Glucocorticoids regulate the glial fibrillary acidic protein (GFAP) gene expression in 
non-neuronal cells called astroglia; reduced GFAP gene expression correlates with  the 
degree of astroglial responses in the adult brain (Nichols et al, 2005) and shows a 
reduction in the delayed astrocytic maturation in developing brain (Huang et al, 2001). 
The glucocorticoid receptor expression levels in the hippocampus are regulated by early 
life experiences across life span via epigenetic processes (natural variations in maternal 
care influence HPA axis stress reactivity in the offspring via long term changes in tissue-
specific gene expression) which suggests a link between early deprivation (ED) and 
GFAP levels which were examined in a rat model (Weaver et al, 2004; Leventopoulos et 
al., 2007). Research suggests that exposure of neonatal rats to high levels of 
glucocorticoids leads to a reduction in the brain weight (Howard and Benjamin, 1975), 
reduction of dendritic spines and neuronal atrophy (Cotterrell et al, 1972). High level of 
glucocorticoids causes alteration in social behaviour and learning processes (Sousa et al, 
2000). Glucocorticoids released as a response to stress down regulate the brain derived 
neurotrophic factor (BDNF) which is important for neurogenesis and synaptogenesis 
(elements of neuroplasticity) (Russo-Neustadt, 2003). Wistar rats exposed to 
glucocorticoids show a reduction in the dendritic length and density and CA3 apical 
dendritic atrophy in comparison with control rats (Sousa et al, 2000). There is also 
evidence of cell loss and cell atrophy in prefrontal cortex (PFC) which indicates that 
glucocorticoids target PFC which contains high levels of glucocorticoid receptors (Heim 
et al, 2004; Stark et al, 2006). Overall, there is growing consensus that glucocorticoids 
as mediators of stress affect brain plasticity in multiple ways. 
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1.7 Glial cells 
Cells known as glia (Greek for “glue”) were long thought to provide support to nerve 
cells while neurones were considered as the main functional unit of the brain. However, 
more recent research has revealed that glial cells not only play a supportive role but are 
an active participant in brain function which includes brain development, formation and 
function of synapses, immune response and brain homeostasis (Kurosinki and Goetz, 
2002; Garcia-Segura and McCarty, 2004; Jauregui-Huerta et al., 2010).  
1.7.1 Types of glial cells 
Glial cells are mainly divided into two types in the CNS, macroglia and microglia. 
Based on their phenotype and function these two types are further divided into various 
subtypes of cells. Microglia, also known as resting microglia in the normal uninjured 
brain, are very active and versatile cells. They are considered as immune cells of the 
CNS because they are the early detectors of the brain injury and become activated in 
response to damage by altering their morphology and expression pattern. Even in resting 
stage they serve as very active biochemical sensors. Thus, microglial cells play 
important role in prevention from brain damage and support in maintaining brain 
homeostasis. (Kim and de Vellis, 2005; Hanisch and Kettenmann, 2007; Napoli and 
Neumann, 2009). Macroglia include different sub cell types - astroglia, oligodendroglia, 
and ependymal and Schwann cells (in the peripheral nervous system). Astroglial roles 
are discussed below. Oligodendroglia and Schwann cells play a key role in myelination 
of axons in the central and peripheral nervous system, respectively, and ependymal cells 
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play a protective role by lining cavities of CNS and forms wall of the ventricles in brain 
and central canal in the spinal cord. (Jauregui-Huerta et al., 2010). 
1.7.2 Astroglia 
Astroglial cells are the most abundant cells and involved in variety of roles in the brain. 
Astroglial cells include different types of cells - astrocytes, radial glia, Bergmann cells, 
Muller cells, pituicytes and tanycytes.  
Astroglial functions include regulation of synaptogenesis, support of neurogenesis and 
gliogenesis, guidance in neuronal migration, regulation of cerebral microcirculation, 
provision of energy substrates for neurons, regulation of extracellular ion concentrations 
and extracellular pH, modulation of neurotransmitter signalling and recycling, regulation 
of the brain water homeostasis, modulation of synaptic transmission, integration and 
regulation of synaptic networks, neuroplasticity and modulation of neuroendocrine 
functions (Blankenfeld and Kettenmann 1992; Cohen et al 1999; Hirst et al 1998; 
Kimelberg and Katz 1985; Russ et al 1996; Schousboe and Westergaard 1995; Garcia 
Segura and McCarthy, 2004). Astroglia are involved in various important functions such 
as providing neuronal cells with pyruvate, lactate, neurotrophic factors and energy 
storage (Dringen et al., 1993), promote synaptic formation of neuronal cells from stem 
cells (Song et al., 2002) and metabolism of glutathione and reactive oxygen species 
(Wilson, 1997; Sharma et al., 2007). 
Recent studies have suggested an involvement of astroglial cells in the pathology of 
stress and glucocorticoid overproduction. Reductions in the astroglia density and number 
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are linked with the region-specific volume changes which are observed in stress related 
pathologies (Rajkowska and Miguel-Hidalgo, 2007; Czeh et al., 2007). Synthetic 
glucocorticoid – dexamethasone is found to block the astrogliogenesis process observed 
in neural precursor cells (Sabolek et al., 2006). However, these findings do suggest an 
unknown role of astroglial cells in response to stress and glucocorticoids which needs to 
be further researched in order to fully understand the neuroprotective role of glial cells.  
Astroglial plasticity in the form of morphological changes have been reported in 
response to stress. Studies have shown long lasting astroglial reactions and decreased 
dendritic arborisation in response to prenatal stress (Barros et al., 2006) and increase in 
the glial fibrillary acidic protein (GFAP) immunoreactivity in the hippocampal CA1 
region and striatum following repeated immobilization stress (Kwon et al., 2008). 
Reduced GFAP immuno-reactive (ir) cells and cell proliferation decrease was seen in 
the prefrontal cortex and dentate gyrus in rats exposed to chronic social stress (Czeh et 
al., 2007; Fuchs et al., 2004). Similar changes in the GFAP-ir cell have been observed in 
the amygdala, hippocampus and prefrontal cortex of the rats with depressive like 
behaviour (Gosselin et al., 2009).  Hippocampal GFAP –ir reductions have also been 
reported in maternally deprived stress-hyperresponsive Fischer rats (Leventopoulos et 
al., 2007). Reduced GFAP expression due to chronic unpredictable mild stress, which 
was partially rescued by hippocampal brain derived neurotrophic factor (BDNF) 
administration, provides insights into the glial physiology as a therapeutic target in 
depression and other stress-related conditions (Ye et al., 2011). 
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1.7.3 Glial Fibrillary Acidic Protein (GFAP) 
Glial fibrillary acidic protein (GFAP) is the main intermediate filament protein in mature 
astrocytes, in addition to vimentin, nestin and synemin, but also an important component 
of the cytoskeleton in astrocytes during development, aging and in neurodegenerative 
diseases. The intermediate filament network is a key component of the cells 
cytoskeleton, integrity and resilience. There are different isoforms and splice variants of 
GFAP – GFAP α, β, γ, δ and κ, but the differential roles and distribution of these 
isoforms is not yet clear (Andreiuolo et al., 2009; Blechingberg et al., 2007;  Roelofs et 
al., 2005).   
Classically, GFAP is a marker for astrocytes, known to be induced upon brain damage 
or during CNS degeneration, and to be more highly expressed in the aged brain. GFAP 
has become a prototypical marker for immunohistochemical identification of astroglial 
cells (Sonfroniew and Vinters, 2010). Initially, GFAP was identified in the brains of 
patients with multiple sclerosis, in which GFAP was purified from a large multiple 
sclerosis plaque consisting primarily of fibrous astrocytes and demyelinated axons (Eng 
et al., 1971). 
GFAP belongs to the family of intermediate filaments that, along with microtubules and 
microfilaments, make up the cytoskeleton of most eukaryotic cells. Major developments 
in astroglial biology and the discovery of novel intermediate filament functions have 
shown interest in the function of GFAP (Eng et al., 2000). 
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1.7.4 Effect of stress on astroglia 
Effects of long term stress and depression on neurones, mostly in the limbic system and 
prefrontal cortex have been demonstrated by a number of studies (e.g. McEwen, 2001, 
2005). However, there is growing evidence that glia are also implicated in responses to 
stress and depression, and responsible for depression related brain remodeling (Harrison, 
2002). 
A decrease in the hippocampal astrocytic density was observed in male tree shrews, 
which were exposed to social stress and these changes were correlated with the 
hippocampal volume reduction (Czeh et al, 2006). Also an in-house study demonstrates 
an impoverished hippocampal astroglial morphology and reduced hippocampal volume 
in adult Wistar rats that underwent early life deprivation (Opacka-Juffry et al., 2008).  
When it comes to clinical evidence, a post mortem histological analysis of the frontal 
cortex showed a decrease in number of glia in major depressive disorder patients (Cotter 
et al, 2001a, 2002; Rajkowska et al, 1999) and reduced glial density and glia/neuron 
ratio has been observed in amygdala (Bowley et al, 2002; Hamidi et al, 2004). Hamidi et 
al (2004) also showed oligodendrocyte deterioration in the amygdala region of MDD 
patients. Study carried out by Cotter et al (2002) suggested a decrease in glial cell 
density in the prefrontal cortex region of major depressive disorder patient. 
Immunohistochemical studies using glial fibrillary acidic protein (GFAP), a selective 
marker of astroglia, also showed a decrease in GFAP stained cell count in prefrontal 
cortex and hippocampal CA1 and CA2 areas in MDD patients and interestingly no 
parallel changes were observed in hippocampal neurons (Miguel-Hidalgo et al, 2000; 
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Muller et al, 2001). These and other observations have led to the hypothesis that glial 
cell dysfunction may contribute to the pathogenesis of depressive disorders (Cotter et al, 
2001).  
The present study will assess tissue remodeling and astroglial changes in the brain 
regions implicated in the neurobiology / neuropathology of depression and effects of 
early life stress. The regions of interest are hippocampus, amygdala (associated with 
mood and memory of recent events), prefrontal cortex, raphe nucleus (associated with 
serotonin receptors) and nucleus accumbens (responsible for perception of pleasure and 
reward) (Bannerman et al, 2004; McEwen, 2000; Fuchs and Flugge, 1998). 
 
1.8 Glia - Neurone interaction 
Over the past decade, there is increasing evidence that neurones and glia cell interaction 
plays a role in the plastic morphological and functional relationship (Pfrieger and Barres, 
1996). Glia-neurone interactions control various important processes of brain 
development like neurogenesis (Lim & Alvarez-Buylla 1999), myelination (Bhat, 2003), 
synapse formation (Slezak & Pfrieger, 2003; Ullian et al., 2004), neuronal migration 
(Nadarajah & Parnavelas, 2002), proliferation (Gomes et al., 1999), neuroplasticity 
(Azcoitia et al., 2010) and differentiation (Garcia-Abreu et al., 1995). Both glia and 
neurones secrete important soluble factors such as neurotransmitters, hormones and 
growth factors which have been implicated in the nervous system morphogenesis 
(Gomes, 2001).  
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Glia – Neurone interaction is critical for the neuronal survival, both in vitro and in vivo, 
as glia provides trophic and nutritive support (Meyer-Franke et al., 1995; Tsacopoulos 
and Magistretti, 1996). It is also crucial for the maintenance of homeostasis and central 
nervous system (Giaume et al., 2007; Rossi and Volterra, 2009). The glia - neurone 
cross talk includes signalling via ion fluxes, cell adhesion molecules and glutamate 
neurotransmitters (Marchetti, 1997; Fields and Graham, 2002) 
Neurones control the glia-mediated activation of the two major neurotransmitter systems 
- acetylcholine and noradrenaline and deficiency of these neurotransmitter systems are 
linked to Parkinson’s and Alzheimer’s disease suggesting the pivotal role of the glia-
neurone interaction (Camevale et al., 2007). Multiple sclerosis (MS), a disease caused 
by loss of myelin resulting into abnormal conduction of action potential, is considered to 
be due to disruption in the glia-neurone communication which is pivotal for the axonal 
conduction and myelination (Fields and Graham, 2002). Loss of axons and neurones is 
observed in patients suffering from MS (Bjartmar et al., 2001).  
Alterations of the both glia and neurones has been observed in the both preclinical and 
clinical studies suggesting the importance of these two cell types and understanding the 
mechanisms involved in their bidirectional interaction could provide valuable insights in 
further understanding of the neurodegenerative disease which may further yield into 
valuable therapeutic strategy. 
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1.9 Serotonin and its receptors 
Serotonin is known as important brain neurotransmitter which is involved in the 
regulation of human behavior, as well as in the pathophysiology of psychiatric disorders.  
1.9.1 Structure, synthesis and metabolism of serotonin 
Serotonin, chemically known as 5-hydroxytryptamine, is a biogenic monoamine found 
in almost all organisms. Tryptophan, an essential amino acid which we get through diet, 
is a precursor to serotonin. In the neuron, tryptophan is converted into 5-
hydroxytryptophan (5-HTP) via action of enzyme tryptophan hydroxylase (TPH). 5-
HTP in turn is converted into serotonin by aromatic amino acid decarboxylase (AADC). 
Serotonin is then transported into vesicles by the vesicular monoamine transporter 
(VMAT) and stored in the neural endings before being released into the synaptic cleft. 
The serotonin transporter (5-HTT) clears serotonin from the synaptic cleft by 
transporting it back into the nerve terminal. Further, serotonin metabolises into 5-
hydroxyindole acetic acid (5-HIAA) by monoamine oxidase (MAO) enzyme activity. 
1.9.2 Types of serotonergic receptors 
Serotonin receptors, except one, are guanine nucleotide – binding protein (G-protein) 
coupled receptors. The released serotonin effects are mediated by a large number of 
receptors. So far 15 subtypes of serotonin receptors have been characterised (Bockaert et 
al, 2006). The serotonin receptor subtypes are divided into seven classes i.e. 5HT1 – 
5HT7 depending on ligand affinity, molecular structure and intracellular transduction 
mechanism. 5-HT3 receptors are the only subtype which is ligand-gated ion channels 
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which possess different mode of action compared to others (Barnes and Sharp, 1999). 
The 5-HT1A (also located in somatodendritic and postsynaptic site), 5HT-1B and 5HT-
1D (located in nerve terminals) receptors act as autoreceptors and exerts inhibitory 
effects on the serotonergic transmission (Hoyer et al, 2002). 5HT4 receptor has been 
linked with increased motor activity in animals exposed to stress and is observed to be 
altered in animal models of depression (Rymar et al, 2007). 
1.9.3 Role of serotonin and its effects in the brain 
Various physiological and behavioral processes mainly cognition (learning and 
memory), anxiety, feeding, sleep, pain and aggression are mediated through the 
serotonergic system (Whitaker-Azmitia et al., 1996; Lucki, 1998; Hoyer et al., 2002; 
David et al., 2005). The monoamine 5HT is know to be involved in the pathophysiology 
and therapy of depression (Stockmeier, 2003). Alteration in the 5HT neurotransmission 
has been implicated in various neurological disorders such as autism, depression (Lucki, 
1998), Huntington’s disease  (Yohrling IV et al., 2002), Alzheimer’s disease (Schmitt et 
al., 2006), schizophrenia and attention deficit disorder (Azmitia, 1999). Studies have 
shown altered level of 5HT and receptor densities in animal models of early life 
deprivation, stress and anxiety (Drevets et al., 2000, Hoyer et al., 2002) and also in 
patients suffering from depression (Arango et al., 1995). Studies have also confirmed 
altered serotonergic function in the hippocampus of rats underwent social isolation 
(Marsden et al., 2011) in response to stress using both footshock and conditioned 
emotional response (Fulford and Marsden, 1998a; Muchimapura et al., 2002). 
Furthermore, serotonin system has been correlated with addictive personality disorders 
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such as gambling and substance abuse (Campbell-Meiklejohn et al., 2011). An 
experimental study in rats has shown long term learning and memory deficits in 
response to early developmental exposure to drugs of abuse (methamphetamine), which 
are known to disrupt the 5HT system (Williams et al. 2002; 2003; review by Parrott and 
Marsden, 2006).  
However, among the different 5HT receptor subtypes, the 5-HT1A receptors are 
considered to be the most influential (David et al., 2005) and have gained more attention 
in regards to 5HT developmental effects (Patel and Zhou 2005). The important regulatory 
role of the 5HT1A receptors is to mediate the negative feedback and these are known to 
desensitize due to the antidepressant treatment (David et al., 2005). In rodents, 5-HT1A 
binding sites have been identified during the neonatal development stage mostly in the 
neurons and glia in the hippocampus and cortex along with brain stem (Daval et al. 1987; 
Patel and Zhou 2005).   
Increased 5-HT1A receptor binding in the prefrontal cortex of nonviolent suicides 
compared to violent suicides and controls has been reported (Arrango et al., 1995).  The 
5-HT1A autoreceptor function is reduced in rats exposed to high glucocorticoid dose or 
under chronic stress (Fairchild et al., 2003). In another study conducted by Joels and 
colleagues have reported increased 5HT1A receptor sensitivity in the CA1 pyramidal 
cells of hippocampus due to stress acting via glucocorticoid receptors (Hesen and Joels, 
1996). However, in contrast to this finding, adrenalectomy in rats has shown to increase 
5-HT1A binding in cortex (Kuroda et al., 1994). Rats implanted with slow release 
corticosterone pellet (for 7 days) has shown to induce long-term alterations in the 
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cortical 5-HT1A receptor binding along with persistent decrease in whole body and 
adrenal weight (Bush et al., 2003). 
 
1.10 Oxytocin and its receptors 
Oxytocin (OT) is a central nervous system (CNS) neuropeptide consisting of nine amino 
acids. OT is also known as a nonapeptide and was discovered by Sir Henry Dale in the 
year 1906. The name oxytocin was derived from the greek words – ωκνξ and τoκoxξ 
meaning “quick birth” (Dale, 1906). In 1953, OT was the first peptide hormone to be 
sequenced and synthesised by Vincent du Vigneaud, for this work he was awarded the 
Nobel Prize in 1955 (du Vigneaud, 1956). 
OT is mainly produced and synthesised in magnocellular neurons of the hypothalamic 
paraventricular (PVN) and supraoptic nuclei. OT is secreted into the periphery via the 
posterior pituitary where it mediates effects on uterine contractions, milk ejection in 
lactation and cardiovascular control, among others. The central actions of the OT are 
mediated via oxytocin receptors (OTR) which are distributed widely in the CNS. Till 
date only one OTR is identified which is a member of class 1 – G protein coupled 
receptor family (Gimply, 2001). OTR are located in various brain regions which include 
- the ventromedial nucleus of the hypothalamus, the amygdala, the lateral septum, the 
bed nucleus of the stria terminalis, the anterior olfactory nucleus, the preoptic and 
ventral tegmental areas, and the hippocampus (Li et al, 1997). 
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1.10.1 Role of oxytocin and its effects in the brain 
Oxytocin was originally considered as a “maternal hormone” due to its functional role in 
the regulation of reproductive functions and maternal behaviour. However, recently OT 
has been implicated in a various other behaviour and neurochemical processes 
(Neumann, 2008). 
Oxytocin plays important role in respect to social interaction and bonding which is 
essential for the positive health benefits and survival of species as it favours sexual 
behaviour, protection, environment and brain development. However, social isolation 
leads to various behavioural pathologies such as autism and depression characterised by 
neurochemical pathway deficits (Carter et al, 2008; Neumann, 2009). 
OT is a hypophysiotrophic hormone which under physiological condition controls the 
secretion of the adreno-corticotropic hormone in stressful situation. This oxytocin-
induced ACTH secretion is blocked by adrenal glucocorticoid hormone (Gibbs, 1986). 
Hence, oxytocin regulates the HPA axis functioning by reducing ACTH release which in 
contrast is helpful in treating stress-HPA induced pathologies (Boutet et al, 2006). 
The oxytocinergic system is equally developed in both males and females; still it is 
under strong influence by the female steroid hormone – estrogen. Strong connections 
between estrogen and OT lead to sex differences (Yamaguchi et al, 1979; Schumacher et 
al, 1993). Estrogen hormone stimulates synthesis and release of OT and increases the 
OTR in brain regions. A recent study has shown involvement of estrogen β receptor 
mediated oxytocin release (Somponpun and Sladek, 2002) and estrogen α receptor 
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mediated OTR increase in amygdala (Choleris et al, 2003). Interestingly, oxytocin 
autoreceptors have been identified on some of the oxytocinergic neurons due to these 
autoreceptors OT is able to stimulate its own release (Moos et al, 1984; Freund-Mercier 
and Stoeckel, 1995).  
OT administration may induce anxiolytic and sedative effects with high doses. These 
effects are mediated via amygdala which contains high OTR and plays important role in 
social recognition (Uvnas-Moberg et al, 1994; Ferguson et al, 2001). 
The other effects of OT are increase in nociceptive thresholds (Lund et al, 2002), 
decrease in heart rate and blood pressure (Uvnäs-Moberg, 1998), influences secretion of 
insulin and glucagon (Dunning et al, 1984) and induce anti-oxidative effect (Moosmann 
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1.11 Main aims and hypotheses of the thesis 
This doctoral thesis consists of four studies. The first one (Chapter 3) was aimed to 
assess the long-term effects of the early life postnatal deprivation (ED) on the brain 
regional volume and astroglia morphology in two rat strains of different responsiveness 
to stress, Wistar and Lewis, normo- and hypo-responsive, respectively. Based on the 
previous findings, it was hypothesised that ED would lead to a long-term reduction in 
the volume of the hippocampus and impoverishment of astroglial morphology in Wistars 
with no changes in Lewis rats. The second study (Chapter 4) on rats exposed prenatally 
to glucocorticoids (dexamethasone) during E16-E19 hypothesised that in utero 
dexamethasone administration would lead to hippocampal volume loss and 
impairements in GFAP-positive astroglial morphology in adult offspring.  
The third study (Chapter 5) aimed to investigate the long-term effects of prenatal 
dexamethasone administration on the oxytocin and 5-HT1A serotonin receptor binding 
in male and female rats. These receptors were selected for their involvement in the stress 
response, and because of the associations between prenatal stress, exposure to 
glucocorticoids and risk of neuropsychiatric disorders in adult life. The fact that very 
few studies have researched the effects of prenatal manipulations affecting 
glucocorticoid programming motivated the present approach.  
In addition, in the fourth study (Chapter 6), the in vitro effects of dexamethasone on 
neural stem cells were investigated, in order to assess the effects of dexamethasone on 
the cell proliferation and differentiation, and on glial cell markers. This part of thesis 
referred to the mechanisms of stress/glucocorticoid-dependent hippocampal volume 
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loss; it has been known that neural stem cell activity continues in the hippocampus until 





























2.1 Animal models 
  
2.1.1 Early Deprivation  
 
2.1.1.1 Experimental Design and Materials 
The present study was designed as an experiment with between group comparisons. 
Two rat strains of different responsiveness to stress - Wistar and Lewis were 
compared, also treatment effect were compared between the groups: non-handled 
(NH), early handled (EH) and early deprived (ED). It is aimed to estimate the 
volume of the specific brain regions implicated in stress and depression. The brain 
regions considered for analysis were: dorsal hippocampus, basolateral amygdala and 
nucleus accumbens (see Figure 2.6).  
The material, perfused and frozen male rat brains, was offered by Dr Christopher 
Pryce of the Swiss Federal Institute of Technology (ETH) in Zurich. It included 32 
brains, six per group: non-handled control, early handled and early maternally 
deprived (ED), representing Wistar strain and 3 non-handled, 5 early handled and 6 
early deprived representing Lewis strain (exception being Lewis NH where n=1 was 
used for total brain volume analysis).  The choice of rat strains was informed by the 
previous research: the Wistar strain has been found to respond to ED - behavioural 
and receptor changes have been observed (Leventopoulos et al., 2009). The Lewis 
strain seems to show no negative behavioural response to ED (Personal 
communication – Dr Pryce). 
The number of animals (n=6 per group) is based on the previous collaborative studies 
carried out at the Roehampton University and the Swiss Federal Institute of 
Technology (ETH) in Zurich (Leventopoulos et al., 2007 and 2009; Opacka-Juffry et 
al., 2008) and reflects the ethical restrictions that recommend reducing the numbers 




of animals to the necessary minimum. The behavioural assessment was performed at 
the ETH in Zurich (Pryce, personal communication) and post-mortem analyses were 
carried out at the Clinical Laboratory, Department of Life Sciences (previously 
School of Human and Life Sciences) University of Roehampton. 
 
Figure 2.1 - Graphical representation of the early deprivation model experimental 
design employed for brain regional volume and astroglia morphology analysis (as 
used in chapter 3). 
2.1.1.2 Animals and their treatment 
 
Wistar rats (Harlan, NL) were bred and maintained at the animal facility of the Swiss 
Federal Institute of Technology, Schwerzenbach, Switzerland on a reversed light–
dark cycle (off 07:00–19:00 h) at 21
0 
C and 50–60% humidity, with water and food 
available ad libitum. All experiments were carried out in agreement with Swiss 
Cantonal Veterinary Office regulations for animal experimentation. On postnatal day 
1 (PND) each of ten early deprivation (ED) litters, ten early handled (EH) litters and 
ten non-handled (NH, control) litters were culled to four male and four female pups. 




ED pups were isolated from dam and littermates 4 h daily (12:00–16:00 h) on PND 
1–14 at room temperature (21
0
 C) during the dark phase (according to Ruedi-
Bettschen et al., 2005). EH pups were removed from the dam for 1 minute in order to 
control for the human handling component of ED. NH dams and litters were kept 
undisturbed and the colony room was entered for provision of food and water and 
observation of maternal behaviour only. The ED procedure consisted of removal of 
the dam from the home cage, removal of the pups and individual placement on 
sawdust in a PVC separation apparatus comprising single pup compartments of 10 x 
10 x 20 (H) cm, and return of the dam to the home cage during ED. At the end of 
ED, the dam was again removed from the home cage, the pups were returned to it, 
and then dam returned to home cage with pups. The EH procedure consisted of 
removal of the dam from the home cage, removal of the litter to a different cage and 
then immediate return to the home cage, and return of the dam to home cage with 
pups. Subjects were weaned at PND21 and same-sex littermates were caged together. 
Following weaning, all subjects were left to develop undisturbed except for regular 
cage-cleaning once a week until the start of behavioural testing during adulthood (4–
6 months). Subjects were sacrificed at the age of 12 months. Rats were decapitated 
and brains were frozen at -50
0
 C in isopentane/dry ice/ethanol and stored at -80
0
 C. 
Frozen brains were transferred on dry ice from Zurich to London for processing. 
 
2.1.2 Prenatal Dexamethasone  
 
2.1.2.1 Experimental Design and Materials 
 
The present study was designed as an experiment to investigate (a) effects of prenatal 
dexamethasone treatment on the volume of the brain regions, dorsal hippocampus, 
basolateral amygdala and nucleus accumbens and morphology of astroglial cells, and 




(b) effects of prenatal dexamethasone (DEX) treatment on the regulatory brain 
receptor systems (Figure 2.2). 
The material for the volumetric study (a) consisted of perfused fixed male Sprague-
Dawley rat brains, while that for the receptor study (b) consisted of fresh-frozen male 
and female Sprague-Dawley rat brains, offered by Professor Glenda Gilles of the 
Faculty of Medicine, Imperial College in London. It includes 12 brains each for 
study (a) and (b), six per group: control and DEX treated. The number of animals 
(n=6 per group) reflects the ethical restrictions that recommend reducing the numbers 
of animals to the necessary minimum. The post-mortem analysis was carried out at 
the Clinical Laboratory, Department of Life Sciences, University of Roehampton. 
2.1.2.2 Animals  
Sprague–Dawley (SD) rats (Harlan Olac, Blackthorn, Beicester, Oxfordshire, UK) 
were housed and timed matings were carried out in the Comparative Biology Unit at 
Charing Cross Hospital (Faculty of Medicine, Imperial College, London). All animal 
procedures were carried out under the license in accordance with the United 
Kingdom Animals Scientific Procedures Act of 1986. SD rats were under controlled 
lighting (on 0800–2000 h), temperature (21–23
o
C) and humidity (63%), with 
standard rat chow and drinking water (except as described below) provided ad 
libitum. Rats both, males and females were caged separately, and allowed to 
acclimatise to their new environment for 1 week, after which groups of one male and 
two female rats were housed together overnight and the presence of vaginal plugs the 
following morning was taken to confirm mating; pregnancy was confirmed 
approximately 6 days later by palpation. The timed pregnant rats were housed five 
per cage until gestational day (GD) 15, when they were caged singly in preparation 




for giving birth. From GD 19/20 pregnant rats were monitored several times a day 
and the day of birth was defined as day 0. Offspring were weaned at 3 weeks, after 
which male and female animals were housed separately in standard, wire-topped 
cages in groups of five per cage and were allowed to grow to young adulthood with 
no further treatment. At 68±2 days of age animals were killed by decapitation 




Figure 2.2 - Graphical representation of the prenatal Dex treatment experimental 
design (a) perfused fixed male rat brains for volumetric and morphological analysis 
(as used in chapter 4) and (b) fresh frozen male and female rat brains for receptor 
analysis (as used in chapter 5) 




2.1.2.3 Dexamethasone Treatment 
Dexamethasone (Faulding Pharmaceuticals Plc., Royal Leamington Spa, UK) was 
administered non-invasively using the method established by McArthur et al (2005) 
and is done by adding dexamethasone to the drinking water of pregnant or nursing 
dams between embryonic days 16–19 (E16–E19, 0.5 µg/ml) or postnatal days 1–7 
(P1–P7, 1 µg/ml). This route of administration also avoids potential confounding 
effects of injection stress and also handling of the newborn pups, which may itself 
produce long-lasting effects on behaviour and brain function in later life (Meaney et 
al, 2002). Using this oral route, dexamethasone is able to reach the developing 
foetuses or neonates via the placenta (Funkhouser et al, 1978) or milk (Tainturier et 
al, 1982), respectively.  
Previous studies carried out by McArthur et al (2005) used available 
pharmacokinetic data that allows estimating, from the amount of dexamethasone 
ingested by the dams, that similar concentrations are achieved in the fetus and 
neonate (~30 ng/ml). Allowing for the greater GC potency of dexamethasone, which 
is reported to be between one and two orders of magnitude greater than that of 
corticosterone, it would appear that the levels attained can be considered comparable 
to the GC potency that prevails following stress induced activation of the maternal 
HPA axis. On the basis that the mothers’ daily intake of water was approximately 50 
ml (McArthur et al, 2005), allows approximate calculation of the dexamethasone 
dosage (approximately 75 and 150 µg/kg/day for prenatal and neonatal treatments, 
respectively) which is within the range used clinically to mature the fetal lung in 
cases of threatened premature birth. As previously reported (McArthur et al, 2005; 
Theogaraj et al, 2005; McArthur et al, 2006a), these dexamethasone treatments had 




no significant effects on the outcome of the pregnancies, no discernable influence on 






Figure 2.3 - Diagrammatic representation of the overall methodology used in the 
present study. 
The above flowchart indicates stepwise experimental methods and techniques used in 
the thesis (as used in chapter 3, 4 and 5). Experimental rat models were sacrificed, 
dissected and were scanned to measure total brain volume. Further cryosectioned 
and stained for volume, cell count, morphology and autoradiography analysis. 
However, methods employed in Chapter 6 were not shown in this diagram.    




2.2 Brain tissue preparation  
The rats were deeply anesthetised with an overdose of sodium pentobarbital and 
intracardially perfused with phosphate-buffered saline (PBS) and then with 4% 
formaldehyde pH 7.4. Brains were immediately removed, post fixed overnight in the 
same fixative, and cryoprotected in glycerol/glycol solution. Those procedures were 
carried out at the ETH, Zurich (ED studies) or Imperial College London (DEX 
study). In DEX study (b), rat brains were quickly removed and frozen at -40
0
C to 
achieve best results with the receptor autoradiography. The brains were frozen and 
transferred on dry ice to Roehampton University and kept at −80 °C until pQCT total 
volume analysis and cryostat sectioning.  
 
2.3 Brain imaging - Peripheral Quantitative Computed Tomography 
(pQCT) 
The pQCT (Stratec Research SA+ scanner, Stratec Medizintechnik, Pforzheim, Germany) 
is an X-ray scanner based on the translation-rotation principle - where the X-ray 
beam passes through the specimen, its intensity is attenuated. Due to high atomic 
number compared to air, the high density is associated with a high attenuation of the 
beam which results into scan. pQCT has a relatively small gantry (compared to the 
usual CT scan) allowing the assessments of small objects (< 8 cm in diameter). The 
major difference with clinical CT scans is that it has a smaller gantry (8 cm vs 80 
cm) and relatively higher resolution (70μ vs 200μ). The major difference with μCT 
(micro CT) is that is has a larger gantry (for μCT typically ~ 1cm) a lower resolution 
(70μ vs 20μ). 




Most of all, the pQCT produces images (slice or tomography) where, for each pixel, 
the density is quantitatively measured. The pQCT has been widely used in the 
clinical field for investigation of the shape and density of the distal radius (Boonen et 
al. 1997). Some models have been adapted for the in vivo investigation of small 
animals (Turner et al. 2001 or morphology. On the other hand, such tools have been 
used for the in vitro investigation of human cancellous bone density (Bailey et al. 
1999). 
pQCT possesses 12 semiconductor detectors with amplifiers and a microfocus tube 
with    50-µm spot size (voltage 45–60 kV; anode current = 0.2– 0.5 mA; mean X-
ray energy 38–45 keV; width of energy beam after filtering = 25 keV). It provides a 
central gantry opening of 50 mm and uses attenuation profiles obtained at 1° angles 
to compute cross-sectional images. All images were obtained at a section thickness 
of 500 µm and at an in-plane pixel size of 70 × 70 µm. 
2.3.1 Key features of pQCT 
pQCT serves as a cost-effective means for detecting and characterizing soft-tissue 
structures and skeletal abnormalities. It requires less sample preparation time and 
relatively simple data post-processing which makes it user friendly. 
pQCT was not a useful tool since its introduction for laboratory investigations of soft 
tissues and small rodents, mainly because of limitations in spatial resolution. 
However, recent technical advances  have revolutionised the clinical diagnostic 
practice and have made it practical to obtain high-resolution CT images of small-
specimens mainly soft tissue and animals during research investigations. 




pQCT has become a mature technique that can augment or replace histological 
analysis in many research applications, with a major advantage being that it does not 
interfere with any additional anatomical or mechanical study on fresh or fixed tissue. 
The major application of pQCT to date has been in quantifying the density and 
architecture of bone, but there are rapidly growing applications in vascular studies 
and in the characterization of the phenotype of transgenic and knockout animal 
models during preclinical investigations. pQCT will probably become a standard tool 
in many laboratories in the future, as it provides accurate and precise data. 
2.3.2 pQCT Method 
 
Rat brains stored at -800C were scanned via the peripheral quantitative computed 
tomography technique (pQCT) on a Stratec Research SA+ scanner (Stratec 
Medizintechnik, Pforzheim, Germany) with settings of 50.5 V, 261.1 mA and 13.2 
W. Serial Coronal CT scans (302 x 302) with a pixel size of 0.1mm were performed 
at 1mm intervals covering the entire brain region. This technique is normally used 
for hard tissue (bone) analysis and the present application was novel and required 
method development as described below. 
Data analysis to measure volume was carried out by using software Avizo (version 5; 
Mercury Computer Systems, Chelmsford, MA, USA) (Options: full brain cross-
section selected with the 'magic wand' tool in 'Label Field', volumes obtained with 
the 'Surface Gen' option).  
 
 





Figure 2.4 - (a) Peripheral quantitative computed tomography (pQCT) Stratec 
Research SA+ scanner (Stratec Medizintechnik, Pforzheim, Germany) and (b) 
images obtained from it. 
2.3.3 Brain Holder device 
 
A bespoke brain holder device (Figure 2.5) was developed to maintain freezing 
conditions for rat brains. It consisted of several parts:    
 
Figure 2.5 - Image of the bespoke brain holder device designed for the present study. 
(a) (b) 




 Upper chamber, which went into the pQCT holder, filled with sponge and 
thermacol to avoid water dripping into pQCT. 
 Inner tube, which held brain tissue and acts as an interface between brain & 
dry ice. 
 Seal, which held dry ice. 
 Outer tube, which contained dry ice to provide freezing temperature. 
 Jacket, which reduced condensation. 
 
2.4. Cryostat sectioning 
After initially removing the olfactory bulb, both perfused fixed and frozen rat brain 
tissue was supported in optimum cutting tissue (OCT) embedding medium (RALamb 
Ltd, Eastbourne, UK) and equilibrated in the cryostat (Bright Instruments Co. Ltd, 
UK) in preparation for cutting coronal sections in an anterior – posterior direction. A 
stainless steel knife was used at an angle of 15 degrees. The specimen temperature 
was set at -15
0
C with the chamber temperature at -21
0
C. Coronal sections were cut at 
25μm thickness for volumetry and morphology analysis and 20µm thickness for 
receptor work, according to the rat brain atlas of Paxinos and Watson (5
th
 Edition) 
and collected on polylysine glass slides (3 sections per slide).  The sectioning 
procedure was designed such that the following brain regions of interest (ROIs) were 
represented (in brackets A/P coordinates from bregma, in mm): nucleus accumbens 
core (3.00 to 2.16), basolateral amygdala (-1.72 to -2.28), dorsal hippocampus (−2.04 
to -4.68). Figure 2.6 and Table 2.1 below shows detailed information.   











Figure 2.6 -  Diagrammatic representation of coronal rat brain sections showing the 
specified region of interest in rat atlas. (Paxinos & Watson – Rat brain atlas, 5th 
Edition) 
A. Nucleus accumbens region at bregma – 2.76mm, figure 12 of the Atlas 
B. Basolateral amygdala region at bregma - 1.92mm, figure 49 of the Atlas 




















Prelimbic cortex (PRL) 2.76 12 
Accumbens nucleus, core (AcbC) 1.80 18 
Lateral septal nucleus, dorsal part (LSD) 1.08 24 
Basolateral amygdaloid nucleus, anterior 
part (BLA) 
-1.92 49 
Paraventricular hypothalamic nucleus, 
medial magnocellular part (PaMM) 
-1.92 49 
Ventromedial hypothalamic nucleus 
(VMH) 
-1.92 49 
Central amygdaloid nucleus (CeM) -1.92 49 
Dorsal hippocampus  
(CA1, CA2, CA3, DG) 
-3.24 60 
Ventral hippocampus  
(CA1, CA2, CA3, DG) 
-4.92 74 
Dorsal and ventral raphe nucleus (DR & 
VR) 
-7.32 94 
Subiculum, transition area (SubTr) -7.32 94 
Table 2.1 - Brain regions analysed for oxytocin and 5HT-1A receptors using 
autoradiography and its representative location in the rat brain atlas (Paxinos & 
Watson – Rat brain atlas, 5th Edition). 
 




2.5 Histological procedures 
2.5.1 Hematoxylin staining  
 
The frozen rat brain sections (-80
0
C) mounted  on the polysine slides (Menzel-GlaserR, 
UK) (3 sections per slide) were taken out from the freezer and allowed to air dry for 1 
hour on tray at room temperature. Sections were then rehydrated in phosphate 
buffered saline (PBS, Oxoid, UK) (pH 7.4) (dissolve 10 PBS tablets  in 1000 ml of 
distilled water) for 5 minutes at room temperature. Rehydration was carried out in 
order to prevent the tissue damage due to swift changes in temperatures and ensure 
good cell membrane permeability. Sections were then stained for cell nuclei using 
hematoxylin (Sigma-Aldrich, UK) for 2 minutes at room temperature. They were 
rinsed in distilled water by three dippings in order to remove excess stain. In order to 
reduce the background staining differentiation was done using 1% HCl – 70% 
alcohol by 3 dippings. Again rinsing was done using distilled water by several 
dippings and then with PBS for 5 minutes at room temperature (RT). Sections were 
then washed using distilled water for 5 minutes at room temperature. The sections 
were then dehydrated using ethanol at increasing concentrations (50%, 70%, 90% 
and 100%) for 5 minutes each at room temperature. Sections were then air dried for 
15 minutes and protected with histological mounting medium (National diagnostics, 
UK) and covered with a cover slip (Fisher brand, UK).  
 
 
   
 




2.6 Immunohistochemistry procedures 
 
2.6.1 GFAP staining 
 
Day 1: 
 The frozen rat brain sections (stored at -800C) mounted  on the polysine slides 
(3 sections per slide) were taken out from the freezer and allowed to air dry 
for 1 hour on tray at room temperature. The sections were encircled with a 
wax pen, which ensures uniform contact of section with the solution.  
 Sections were then rehydrated in PBS (pH 7.4) for 15 minutes at room 
temperature. Rehydration is carried out to ensure good cell membrane 
permeability.  
 The presence of peroxidase enzyme in the tissue causes high background 
staining. Hence peroxide activity in the brain sections was inactivated by 
treating them with a peroxide inactivating solution containing 1.5% hydrogen 
peroxide (Sigma-Aldrich, UK) for 15 minutes. 
 This was followed by rinsing with PBS for 15 minutes at room temperature to 
remove excess solution. 
 Sections were then incubated in the blocking solution (1ml of normal horse 
serum + 8ml of 0.1% PBST + 1ml of 0.5% sodium azide solution) for 1 hour at 
room temperature on a tray. Extreme care was taken to prevent tissue drying. 
The purpose of blocking was to prevent non-specific antibody binding. 
 Again, the sections were rinsed with PBS – 5 minutes, PBST – 10 minutes, 
PBS – 5 minutes, at room temperature remove the excess blocking solution. 




 Sections were then incubated with a primary anti-GFAP monoclonal antibody 
(Sigma-Aldrich, UK) solution at 1:500 concentration and then placed in the 
fridge at 4
0
c for 24 hours incubation. 
Day 2: 
 On the following day, the sections were washed with PBS for 15 minutes at 
room temperature, to remove any unbound antibody. 
 Sections were then incubated with ready to use anti – mouse IgG biotinylated 
antibody – secondary antibody (Vectastain Elite ABC kit, Vector Laboratories) 
for 30 minutes at room temperature. The addition of normal horse serum 
(NHS) prevents non- specific antibody binding and prevents high background 
staining. 
 Towards the end of secondary antibody incubation the Avidin-Biotinylated 
horseradish peroxidise macromolecular complex (ABC solution, Vectastain 
Elite ABC kit, Vector Laboratories) was prepared and allowed to stand for 30 
minutes at room temperature. This earlier preparation and the standing time 
ensures optimal complex formation. 
 Meanwhile, the sections were rinsed with PBS for 15 minutes to remove 
excess and unbound secondary antibody at room temperature. 
 After 30 minutes, the sections were incubated in ABC solution for 20 minutes 
at room temperature. 
 Before starting the rinse following the ABC incubation, the pre–made 
diaminobenzidine (DAB, Sigma-Aldrich, UK) solution was taken out from 
the freezer and allowed to thaw in dark. 




 Meanwhile, the sections were rinsed in PBS for 15 minutes at room 
temperature.  
 Sections were incubated in DAB solution for 5minutes. 
 Rinsing in distilled water for 5x3 minutes using fresh distilled water every 
time. Care was taken to prevent spilling of DAB (potential teratogenic agent) 
and spills were inactivated with a concentrated bleach solution. 
 The sections were air dried for 30 minutes, before dehydration in ethanol at 
increasing concentrations (50%, 70%, 90% and 100%) for 5 minutes each at 
room temperature. 
 The sections were air dried and protected with histological mounting medium 
and covered with a cover slip. Then sections were visualized under the 
microscope fitted with Olympus BX51 camera and analysed using 
Neurolucida and StereoInvestigator, MBF packages. 
 
2.7 Stereological procedures 
 
2.7.1 Neuroanatomy analysis 
 
In order to outline the anatomy of different brain regions a Paxinos and Watson (5
th
 
edition) stereotaxic rat atlas was used. The rat atlas was also used as a reference 
during cryosectioning. Cross referencing the stained sections using rat atlas provides 
a clear boundary for different brain regions. 
Dorsal hippocampus volume: Both left and right dorsal hippocampus was measured 
covering entire region CA1, CA2, CA3, DG and hilus. 




Basolateral amygdala volume: Right side of the BLA was measured covering entire 
BLA. In some sections lateral amygdaloid nucleus, dorsolateral part was seen but it 
was demarked and only BLA was measured.  
Nucleus accumbens volume: Right side of the nucleus accumbens was measured 
including both core and shell.  
2.7.2 Sampling for volume estimation 
Dorsal hippocampus 
Twelve sections per brain were used with section interval of 10 covering bregma -
2.04 mm to -4.68 mm of stereotaxic rat atlas.  
 
Figure 2.7 Representation of the serial sectioning and sampling of a sample set with 
a section interval of 10. 
Basolateral amygdala 
Six per brain were used with section interval of 5 covering bregma -1.72 mm to -2.28 
mm of the stereotaxic rat atlas. 
Nucleus accumbens 
Five per brain were used with section interval of 10 covering bregma 3 mm to 2.16 
mm of the stereotaxic rat atlas. 




2.7.3 Sampling for cell count estimation 
Eight sections per brain were used with section interval of 10 covering bregma -2.04 
mm to -4.68 mm of the stereotaxic rat atlas.  
 
2.7.4 Volumetric analysis using Cavalieri principle – StereoInvestigator 
Examination of the hematoxylin (HX) stained sections was performed by means of 
an Olympus BX51 microscope fitted with a motorized stage and video camera. 
Quantification of the HX stained volumes of dorsal hippocampus, basolateral 
amygdala and nucleus accumbens was done using Cavalieri principle 
(StereoInvestigator, Version 9, MicroBrightField, Inc., Germany). Starting at a 
random position, every tenth section was analyzed, leading to an average of 12 
sections (for dorsal hippocampus), 6 sections (for basolateral amygdala) and 5 
sections (nucleus accumbens) per subject. The same sets of consecutive sections 
were used for the estimation of volumes for both control and test groups. The 
Cavalieri principle was used to estimate the volumes using the stereology 
workstation and investigator was blind to groups. A point counting grid (PCG) (i.e. 
d=50 μm) was used for volume estimation to obtain maximum efficiency. 
Representative area per point (a/p) for the dorsal hippocampus was 2500μm
2
 
respectively. After applying the PCG on the sampled sections in a systematic-random 
manner, the number of points hitting the region of interest was counted. These point 
counts were used for the estimation of volumes using the following formula; 
 
where a/p represents the area of each point on the point counting grid; ΣP is the total 
number of points hitting the pyramidal layer or hemisphere; t is the mean section 




thickness; and ssf (1/12) is the section sampling fraction (Gundersen, 1986; West et 
al., 1991). 
The efficiency of sampling and volume estimation was checked by estimation of the 
coefficient of error (CE) and coefficient of variation (CV) (Gundersen and Jensen, 




Figure 2.8 - Image showing in process measurement of hippocampus volume using 
cavalieri principle – Stereo-investigator. 
The above figure shows grids (+) overlaying the region  of interest. Using the 
stereoinvestigator tool grids intersecting inside the area of interest were selected. 
Once all the intersections on each section of same brain were marked, then the 
stereoinvestigator generates the volume of the measured region of interest.   
 
2.7.5 Cell count analysis using Optical Fractionator – StereoInvestigator 
Examination of the hematoxylin (HX) stained cells was performed by means of an 
Olympus BX51 microscope fitted with a video camera. Dorsal hippocampus 
subregional cell count was done for the areas CA1, CA2, CA3 and DG by using 




optical fractionator (StereoInvestigator, Version 9, MicroBrightField, Inc., 
Germany). 
An unbiased estimation of the total number of cells was obtained by choosing every 
8th section according to the systematic random sampling procedure (West et al., 
1991). A sampling area of 160/2500 μm
2
 was found to be optimal for this study. 
Dissector height was 6μm and a 2μm guard zone at the top and bottom part of the 
section was excluded from the analysis at every step. Thus, a thickness sampling 
fraction of 6μm/t was used, where t represents the mean section thickness. A semi-
automated stereology workstation for stereological analyses composed of a CCD 
digital camera (Nicon Coolpix E 4500, Tokyo, Japan), image capture card (Flash 
Point 3D, Integral Technologies, Indianapolis, IN, USA), personal computer and 
computer-controlled motorized specimen stage (Prior, Rockland, MA, USA), a 
microcator (Heidenhein, Traunreut, Germany) and a light microscope (Nicon, Eclips 
E 600, Tokyo, Japan) were used. HX-stained cells in the sub-regions of dorsal 
hippocampus were counted using a 100× Nicon Plan Apo objective (NA=1.30) 
which allowed accurate recognition. Each cell was counted according to the unbiased 
counting rules (West et al., 1991). Total cell count in sub-regions of dorsal 




where ΣQ represents the total number of neurons counted in all optically sampled 
fields of the hippocampus; ‘ssf’ is section sampling fraction (1/8); ‘asf’ is area 
sampling fraction (160/2500); and ‘tsf’ is thickness sampling fraction (defined by 




dissector height (6μm) divided by estimated mean section thickness) (West et al., 
1991).  
The efficiency of convenient number of sampled cells and parameters was checked 
by estimation of the coefficient of error (CE) and coefficient of variation (CV) (West 
et al., 1991). 
 
 
Figure 2.9 Image showing in process measurement of HX stained (a) and GFAP 
positive (b) cell counts using optical fractionator. 
Arrows indicate selected HX stained cells (a) or GFAP positive cells (b) which 
underlie inside of the counting frame (green and red lines).     
 
 
2.7.6 GFAP stained astroglia primary process length measurement using 
Neurolucida 
Morphologic analysis was performed on 80 astrocytes in each animal (10 astrocytes 
per section). Neurolucida software (Version 9, MicroBrightField, Inc., Germany) 
was used to trace the boundaries of the ROI’s and astrocytes. Astrocytes within the 
x400 x400 




ROI were traced in a systematic random manner, taking care to avoid those which 
were superimposed upon other astrocytes or blood vessels. The traced astrocytes 
were then analysed using Neurolucida explorer software (Version 9, 
MicroBrightField, Inc., Germany). Morphological analysis was performed by an 
observer who was blind to the experimental groups. Primary process length was 
measured using 100× objective (Nicon UPlan FLN, numerical aperture (NA)=1.30) 
and by counting the primary processes extending directly from the soma in both the 
lateral and central quadrants of astrocytes in the same sections. 
 
 
Figure 2.10 Image showing in process measurement of GFAP positive primary 
process length using neurolucida software. 
In the above figure each primary process length is traced individually by focusing 
microscope. Once all the processes are traced the neurolucida tool provides estimate 








2.8 Quantitative autoradiography – Receptor analysis  
 
Receptor autoradiography is a technique used to localise the radioactive ligands 
bound to specific receptors in the tissue. The energy emitted from the radioactive 
ligands or molecules collides with the nuclear emulsion or film due to which the 
distribution of the radioligand in the tissue is mapped on the film. Therefore, the 
autoradiogram obtained provides a detailed localisation of the specific targeted 
receptors of interest on the tissue subjected to the experimental condition. 
Autoradiography is a very sensitive technique which allows detection of the low 
levels of the receptors and is widely used in the histological studies to detect 
radiolabelled substances. Film autoradiographic technique consists of the following 
experimental steps: incubation of tissue with the selective and specific radioligand, 
exposure of films to apposed sections which contain traces of radioactivity retained 
in the tissue, film development and image analysis. 
 
2.8.1 Experimental Design 
A between-groups comparison experimental design was used to examine the 
potential effects of prenatal dexamethasone treatment on the distribution of the 
central oxytocin and 5HT-1A receptors in adult Sprague-Dawley rats. The sample 
(n=24) comprised of male and female rats and included two conditions (control and 
treatment, i.e. dexamethasone-treated in utero). The independent variables were 
gender (male vs. female) and condition (control vs. dexamethasone) of the subjects, 
while the dependent variable was the level of oxytocin and 5HT-1A receptor binding 
as determined by the autoradiography analysis in the ROIs. 
 




2.8.2 Autoradiography Procedures 
 
2.8.2.1 Oxytocin receptor – autoradiography protocol  
 Selected brain sections (144 slides) were taken from the freezer (-80°C) and 
left at room temperature for 2 hours to thaw. The sections consisted of the 
cingulate cortex, prelimbic cortex, dorsal hippocampus, ventral hippocampus, 
hypothalamus, septum, nucleus accumbens and raphe nucleus as regions of 
interest (ROI).  
 The slides were placed in two separate trays. Adjacent slides representing the 
same ROIs were designated for total and non-specific binding. As a result, 72 
slides were marked for total binding and 72 slides for non-specific binding.  
 [125I] OVTA radioligand with specific activity of 2200 Ci/mol (ARI 0191, 
American Radiolabeled Chemicals, Inc.) was used for the oxytocin receptor 
labelling following Insel and Shapiro, 1992 protocol. 
 The sections were incubated with 50 pM [125I] OVTA in 50mM Tris-HCl (pH 
7.4), 10mM MgCl2 (Sigma-Aldrich, UK), 0.1% BSA (Invitrogen, UK), and 
0.05% bacitracin for 60 minutes at room temperature for total binding. 
Controls for nonspecific binding were incubated with additional 1 mM cold 
oxytocin (Sigma-Aldrich, UK).  
 Following, the incubation slides were quickly rinsed with washing buffer 
containing 50mM Tris-HCl with 0.1% BSA, 0.01% Triton X-100 (Sigma-
Aldrich, UK), and 100mM choline chloride (Sigma-Aldrich, UK) to stop the 
binding reaction and were placed into slide holding racks.  
 Each rack with slides then underwent washing rinses for 3x8 minutes in the 
washing buffer. Later, sections were quickly dipped in ice-cold distilled 
water. 




2.8.2.2 5HT-1A receptor - autoradiography protocol 
The autoradiography procedure was carried out according to Leventopoulos et al 
(2009). 
 144 polysine glass slides containing the appropriate sections were taken from 
the freezer (-80
0
C) and placed onto plastic trays to thaw at room temperature 
for 2 hours prior to pre-incubation. In order to avoid confusion, the slides 
were separated in total binding and nonspecific binding groups.   
 Meanwhile, all solutions and working reagents were prepared fresh (refer 
Appendix for details). Stock [
3
H]WAY-100635  (Amersham Biosciences, UK) 
vial was taken out from the freezer (-20
0
C) and left to reach room 
temperature before using.   
 Slides pre-incubated in 50 mM Tris-HCl buffer, pH=7.5, at room temperature 
for 30 minutes. Approximately 0.5ml of solution was used to cover the 
sections on each slide.  
 The pre-incubated buffer was removed from the slides and the remainder was 
blotted with filter paper in order to avoid over dilution for the next step.  
 The sections were incubated in 50 mM Tris-HCL buffer, pH=7.5 containing 
10µM pargyline (Sigma-Aldrich, UK) and 2nM [
3
H]WAY-100635 radioligand 
for 2 hours at room temperature. In order to determine non-specific binding, 
10µM 5-HT (Sigma-Aldrich, UK) (Serotonin hydrochloride) solution was 
incubated into an adjacent (serially cut) sections for similar period. 
 After incubation with the radioligand and the block, the slides were placed 
inside small plastic microscope rack trays and dipped 3 times in ice cold 
buffer, in glass containers. 




 Then, the sections were washed 2x2 minutes in ice cold Tris-HCl buffer, 
pH=7.5. 
 Finally, the sections were quickly dipped in 40C distilled water three times, 
and left overnight to dry under an air stream. 
 
2.8.3 Exposure stage  
All the radiolabelled and blocked slides were placed in a specific manner inside the 
cassette where total and nonspecific binding slides were placed adjacent to each 
other in same cassette. Empty space was covered with blank slides. Before placing 
the slides, 2-3 layers of paper were cut at the same size as the film and were placed 
on top of the film. Standards were also placed inside the middle of each cassette. All 
cassettes containing the appropriate slides were transferred from the radioisotope lab 
to the dark room for exposure. All sources of lights were covered, room lights were 
switched off and a DL10 safelight (Ilford Imaging Ltd) was used. One hyperfilm was 
then carefully taken and placed onto the slides with the emulsion side of the film 
facing the slides and shinny side upwards. To further check the correct direction of 
the film the notch (cut) on the film was on the top left corner of the cassette. 
The cassette was firmly closed with 3-4 layers of paper placed on top of the film. The 
cassettes were additionally wrapped around with silver foil for further light 
protection, sealed and labelled accordingly. All the cassettes were finally placed into 
a black colour bag and were stored in cool and dry place for the remaining exposure 
duration.    





Figure 2.11: Photograph of the slide layout inside the hypercassettes during and after 
exposure.  
The above image represents the placement of one set of the blank, total binding, 
nonspecific binding and standard slides in a hypercassette which is ready for film 
exposure. 
 
2.8.4 Film development 
After the incubation period forty eight hours for oxytocin and seven weeks for 5HT-
1A, film development was carried out in the dark room of the laboratory at 
Roehampton University. First, three solutions were prepared: Developer (Kodak 
TM
 
processing chemicals, Sigma Aldrich, UK), Fixer (Kodak 
TM
 processing chemicals, 
Sigma Aldrich, UK) and Distilled water with a drop of acetic acid.  
Each film was taken off the hypercassettes carefully and was placed into the 
developing tray with the shiny slide down for one minute with slight agitation 
ensuring the film is completely dipped in the solution at all times. Next, the film was 




removed and placed directly into the distilled water mixed with a drop acetic acid 
again for 1 minute and later was placed in fixer solution for three minutes with 
constant agitation. During the procedure, extreme care was taken to ensure that the 
film was not in contact with the bottom of the tray, which otherwise might have 
caused damage or scratch to the film affecting its quality. The films were then 
transferred into the cold running water tray for 30 minutes. Finally, the films were 
hung up and left to dry out at room temperature overnight. The sample of these 
developed films is shown in the Figure 2.12, below. 
 
 
Figure 2.12 Image of the developed film exposed to oxytocin receptor radioligand.  
It shows different brain sections representing various ROIs and microscale 
standards. 




2.8.5 Image analysis using MCID 
The MCID
TM
 Basic (Version 7.0, Interfocus imaging research Ltd, England) image 
analysis platform system was used for quantitative densitometry of the 
autoradiographic films. Images were captured by means of a lightbox-desktop 
illuminator (Northern Light Precision Illuminator) and a digital colour video camera 
(CoolSNAP
TM
cf, Photometrics). The programme provides data into ligand binding 
per unit of tissue mass (for example fmol/mg tissue weight) or isotope concentrations 
(for example nCi/mmol tissue weight). Before sampling and analysis of the films the 
MCID
TM 
system needs to be calibrated and adjusted. The procedure used in order to 
analyse all of the autoradiographic films and images was as follows: 
 
2.8.5.1 Magnification and focus adjustments 
The light box was left to warm up for 10 minutes. Room lights were switched off and 
the prepared autoradiographic film was placed on the lightbox with the shiny side 
upwards, in order to adjust the magnification and focus. The image was digitized and 
magnification was obtained by moving the height of the camera at the point where 
the section image was inside the view field. The numerical aperture and focus was 
adjusted at which a clear focused image was generated.  
 
2.8.5.2 Flat field corrections 
In order to perform the accurate densitometry, the uneven illumination or shading 
error over the field of view, something typical with the camera generated images, 
was corrected for using the MCID
TM
 FFC tool. First, the film was removed from the 
field of view and a pseudocolour image was presented by pressing F2. The lightbox 




illumination intensity was adjusted so that the background appeared bluish-pink. The 
FFC was then performed following the MCID
TM
 manual guidelines 
(www.mcid.co.uk).  
 
2.8.5.3 Distance calibration 
Distance calibration was performed using a glass scale calibration reticule. 
 
2.8.5.4 Density calibration 
Density calibration was done in order to express the autoradiographic data in units of 
an isotope or ligand concentration. To achieve this, a set of isotope standards was co-
exposed with the sections. A calibration table is shown below. The standard values 
were created by entering the list of standards provided by the supplier. The standard 
values were corrected for the decay factors as applicable. A standard curve was 
constructed which converts relative optical density to standard values (for example, 
nCi/mg). It was always ensured that during sampling a homogeneous area was 
covered. Either linear or 3
rd
 degree polynomial curve was chosen as appropriate and 
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Table 2.2 - Tables of the standard calibration micro-scales for (A) - tritium [
3
H] and 




2.8.5.5 Sampling  
Before sampling, all sections of the film were digitised and saved with their 
calibration curve (Figure 2.13). In all the sections, the ROI was identified using rat 
brain atlas (Paxinos and Watson, 2005). A specific sampling grid was designed and 
allocated to each ROI. Both right and left hemisphere was sampled from each 
section. Values were estimated in nCi/mg and were converted into fmol/mg. The 
mean value of the left and right hemisphere data was calculated and was used for 







1 0.931 0.68 
2 1.457 1.06 
3 2.18 1.58 
4 2.193 1.59 
5 3.32 2.41 
6 3.444 2.50 
7 5.304 3.85 
8 5.93 4.31 
9 8.316 6.04 
10 13.6 9.87 
11 21.088 15.31 
12 33.55 24.36 




2.8.6 β counting 
In order to know if the radiologand dilutions were correct prior to the 
autoradiography, 10µl of the working solutions (total binding and block) used in the 
incubation step was added to scintillation vials and labelled. Then 5ml of the 
scintillation cocktail was added to all vials using the dispenser. All vials were 
thoroughly mixed. The scintillation vials were placed inside the β-counter (Beckman 
Coulter
TM
, USA) and was counted using a program for either beta (Tritium) or 










Figure 2.13 Representative autoradiographic image of rat brain coronal sections 
showing sampling grid (red shaped) used for receptor binding quantification of the 



















Cg – cingulate cortex, PrL – prelimbic cortex, BLA – basolateral amygdala, CeM – 
central amygdala, D-Hippo - dorsal hippocampus, DG - dentate gyrus, V-Hippo – 
ventral hippocampus, CA1 - coruna ammonis 1, VMH – ventromedial hypothalamus, 




2.9 In vitro neural stem cell procedures 
 
2.9.1 Neural stem cell cultures (NSC) 
The NSC proliferation media were freshly prepared prior to cell trypsinisation. It 
comprised of 49ml D-MEM/F12 containing L-glutamine and was further 
supplemented with 1ml B27 supplement minus the Vitamin A hormone mixture and 
combination of 30µl of growth factors (Growth factors: 20µl of 20ng/ml fibroblast 
growth factor (FGF) and 10µl of 20ng/ml epidermal growth factor (EGF)). Media 
was stored in the Heracell 150i CO2 incubator (Thermo Scientific, UK) with 
temperature and CO2% parameters set to 37
0
C and 5% of BSA-1% and BSA-4% 
were prepared on the day using original 7.5% stock solution. The 7.5% BSA was 
diluted with Lebovitz’s L-15 medium (Gibco-Invitrogen). 
 
2.9.2 Isolation of E16-18 mice cortex cells – preparation of neural stem 
cells for in vitro cultures 
NSC (kindly provided by Dr. Molina-Holgado, Stem Cell Bank, University of 
Roehampton, UK) were isolated from cortex dissection at gestation day E16-18 from 
C57BL/6J (Wild type – WT) mice (Harlan, UK) (as described in Reynolds and 




Weiss, 1992; Molina-Holgado et al, 2007), where day E0 was the day a gestational 
plug formed. Likewise, primary neurospheres were generated as per the above 
published protocols. These cells were then grown in untreated T75cm
2 
Nunclon 
flasks (Nuc, 156499, Roskilde, Denmark) for 7-10 days. Subsequent to this period, 
cells were passaged by mechanical dissociation to acquire secondary cultures. 
All the animal care procedures and their handling were in accordance with the 
European Council instruction guidelines (86/609/EEC), the Home Office Animals 
Scientific Procedures Act, 1986 (Schedule 1, UK) and procedures conducted in 
agreement with the European Union Legislation (86/609EEC). The study handled 
generation of NSC originating from the cortex, hence it was possible to generate 
neuronal as well as non-neuronal lineage. 
 
2.9.3 Recovery of cryo-preserved neurospheres and their preparation for 
further sub-culturing 
Neurospheres were spun down in a universal and then re-suspended in 0.5ml 10% 
DMSO-containing media. Thereafter, cells were immediately placed into liquid 
nitrogen, which enabled long term storage. Prior to use, cryovials containing frozen 
NSC were removed from the liquid nitrogen. Each cryovial contained 0.5ml of NSC 
sample. Cryopreserved neurospheres were then rapidly thawed. 1ml of fresh pre-
warmed media (Dulbecco’s Modified Eagel Medium: nutrient mixture F12) was 
immediately added to each vial and was mixed gently. As the cells began to thaw, 
samples were then transferred into the pre-warmed media (15ml conical falcon 
centrifuge tubes, BD Facon
TM
, BD Biosciences) were then defrosted completely. 
8.5ml media was later added into the WT strain yielding a final volume of 10ml. 
Following this, samples were centrifuged (sigma laborzentrifugen) resulting in a 




pellet. The supernatant, containing 10% dimethyl sulfoxide (DMSO) was aspirated 
and pellets were re-suspended in 10ml of proliferation NSC media, comprised of 
DMEM F-12 with L-glutamine (Gibco) supplemented with B27 hormone mixture (in 
house), 20ng/ml of FGF-2 (Recombinant Human, Peprotech 100-18B) and 20ng/ml 
of EGF (Murine, Peprotech 315-09). NSC were incubated at 37°C, 5% CO2. Primary 
culture was maintained for 7-10 days. A secondary culture was then generated by 
single cell sub-culturing: the single cell sample was then mixed thoroughly and 
transferred into untreated T75cm
2
 Nuclon flasks (Roskilde, Denmark) allowing 
neurospheres to grow (7-10 days). The initial experiments were carried out after 3-7 
passages. 
Since cells were previously frozen additional time to reactivate their mitotic 
processes was required. The cell forming neurospheres were supplemented (every 3-
4 days) with a 6µl mitogenic factors mixture (10µl EGF and 20µl FGF) per flask. 
The present study commenced at sub-culturing the ninth generation of WT – NSC 
strain. Throughout the study, NSC were sub-cultured and passaged further; the study 
ended at WT – 11
th
 generation.    
 
2.9.4 Generation of secondary neural stem cells 
Prior to serial dilution assays and cell challenges with drugs, formed clusters were 
passaged when they reached 60-70% confluence (approximately 5-7 days after initial 
plating). Evaporation of NSC proliferation media was calculated at 10% per 7 days. 
Neurosphere – containing media of WT strain were collected. Firstly, the flasks was 
gently shaken to detach the attached neurospheres. Then the bottom of the flask was 




rinsed several times to collect as many detached cells as possible. Thereafter, the 
medium containing the floating neurospheres was transferred to 50ml tube and 
centrifuged. Subsequent to centrifugation, a pellet for each strain was formed.  
The supernatant was then aspirated and 1ml 0.05% trypsin/EDTA (Gibco) was added 
to pellets of each strain to dissociate clusters of cells and produce a single cell 
suspension. The solution was gently disaggregated and aggregating cells previously 
forming neurospheres were separated. The samples were then placed in the incubator 
and the digestion reaction was allowed for 10 minutes. However, at eight minute, 
samples were disaggregated and at the ninth minute the trypsinisation reaction was 
stopped by adding 2-3ml of 4% BSA solution to each strain containing 50ml Falcon 
tube. The volume was then adjusted to a level of 10ml using 1%BSA; this 
subsequently blocked trypsinisation. In order to isolate the single cells that had 
disaggregated, both samples were centrifuged. The supernatant was aspirated and 
pellets were supplemented and re-suspended in 10ml NSC proliferation media 
containing supplements and growth factors. Medium – cell mixture samples were 
then filtered through at cell strainer (BD Biosciences, UK) in order to remove all 
debris that could potentially interfere with cell proliferation. Further, subsequent to 
several strokes, the number of NSC/ml per each strain was determined (special cell 
counter divided into nine main squares, where each square contained nine mini 
squares), using an inverted microscope and manual cell counter (Tamaco). Cells 
were then finally plated into T75 flask at a density of 100,000 cells/ml.   
 




2.9.5 Assessment of cell death (LDH) 
Cytotoxicity was evaluated by release of the cytosolic enzyme lactate dehydrogenase 
(LDH) into the culture medium by dead and dying cells (CytoTox-96 LDH assay, 
Promega, Southampton, UK).  Total LDH release was calculated by incubating 
untreated cells with 0.1% Triton X-100 for 10 min (37
o
C, 5% CO2, 95% air) to 
induce maximal cell lysis. Absorbance was measured at 490nm.  Treatment values 
were then expressed as a percentage of the total LDH release. Background LDH 
release (media alone) was subtracted from the experimental values. (Molina-Holgado 
et al., 2008)  
 
2.9.6 Differentiation Protocol   
To evaluate the effects of dexamethasone on neural stem cell differentiation of WT 
strain this experiment was performed. Initially, coverslips were coated with 50µg/ml 
poly-ornithine in water for overnight at room temperature. The following day 
washing with distilled water was done twice for 2 minutes each. Then, coverslips 
were coated with 5 µg/ml laminin in PBS for overnight at room temperature. 
Washing with PBS was done for 5 minutes. Plate cells (20,000/well) were then 
incubated in NS-A media with 10ng/ml EGF/FGF. Then, the media were replaced to 
NS-A with 5ng/ml FGF and B27. After two days dexamethasone (Sigma Aldrich, 
UK) was added and maintained for 48h. Finally cells were fixed using 4% 
paraformaldehyde (PFA) solution and then the coverslips were used for 
immunocytochemistry procedures. 






Firstly, plate neurospheres were directly placed onto coverslips (coated for 4-6 h with 
poly-D-Lysine (Sigma Aldrich, UK) for 1hr or, alternatively, cells were 
mechanically dissociated at a density of 30,000 cells/cm
2
 for 1-4 hr. This was 
followed by cell fixation procedure using 4% paraformaldehyde for 25 min. Rinsing 
was then done using PBS buffer for 2 x 5 minutes. Overnight incubation with 
primary antibodies, i.e. GFAP (1:500) and S100 (1:400) was done at 4C.  
Immunostaining vehicle solution used was PBS + 0.1% Triton X-100 + 2% NHS. 
Next day, the first step was washing with PBS solution for 2 x 5 minutes. Then, 
secondary antibody (anti-mouse with TritC – 1:200 and anti-rabbit with FITC – 
1:200) in immunostaining vehicle solution were incubated for 1 hr. This was 
followed by PBS washing 2 x 5 minutes and with water 1 x 5 minutes. The 
coverslips (cells upside down) were then carefully removed from the wells using 
forceps and were mounted on plain glass slides with a drop of mounting medium 
with DAPI (Vecatshield
®
, Vector Lab) in order to visualize cell nuclei. Nail polish 
was used to further seal the edges of the coverslip on glass slide (Rubio-Araiz et al., 
2008). After air drying for 30 minutes in dark, cells were analysed using fluorescent 









2.10 Statistical analysis 
 
All the statistical analysis was performed using the Statistical Package for Social 
Sciences (SPSS version 17.0, Inc., USA). Preliminary analysis was undertaken to 
show that data were normally distributed (Kolmogorov–Smirnov test) and that 
variances were equal (Levene’s Median test). One-way ANOVA with a post hoc 
Tukey test was performed, comparing between group and within group differences 
(eg. NH vs EH vs ED). Two-way ANOVA was used to find interactions between 
variables (eg. Sex x Treatment). Independent t-test was performed to measure the 
difference between two groups (eg. Control vs Dex treated). Pearson correlation test 
and linear regression were used to find relationships between brain weight and 
volume (eg. pQCT analysis). Statistical significance was set at p<0.05. Results are 
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As indicated in Chapter 1, early life environment plays a critical role in the 
regulation of brain and behaviour (Levine, 1960; Newport et al., 2002; Pryce and 
Feldon, 2003).  In mammals, the mother – infant relationship plays a key role in the 
development of the offspring where mother provides thermal, somato-sensory, 
olfactory, visual and auditory stimulation, which are essential for postnatal 
development (Pryce, 1996). Clinical and preclinical studies have shown the 
importance of early life environment and adversities caused by early life stress, such 
as social neglect, loss of parents, abuse, which leads to neurobiological and 
psychiatric disorders in adulthood (Heim and Nemeroff, 2001; Kaufmann et al., 
2000).  
Animal models with disrupted maternal care may result into depression like 
behavioural phenotypes (Rüedi-Bettschen et al., 2006). In preclinical approach, it is 
possible to model a relation between early life stress and depression by early 
deprivation (ED). Such experimental modelling reflects similar human traits such as 
neglect like behaviour and reduced motility towards reward (Pryce et al, 2005) and 
results in long-term neurobehavioral changes (Pryce et al., 2002a). Studies have 
shown reduced 5-HT1A receptor binding (Leventopoulos et al., 2009), reduced CA-
hippocampal field volume (Lehmann et al., 2002) and reduced astroglial density 
(Leventopoulos et al., 2007) in response to early life manipulation in the form of 
deprivation.  
The recent research suggests a role for an epigenetic mechanism in maternal care 
disruption, which influences the development of the offspring (Weaver et al, 2004;  
Murgatroyd et al., 2009; Murgatroyd and Spengler, 2011). However, it is estimated 
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that a 40-50% chance of having a mood disorder such as depression is genetic 
(Nestler et al, 2002). In the present study, two rat strains of different responsiveness 
to ED: Wistar (showing neuro-behavioural responses to ED) and Lewis strain 
(resistant to ED) were investigated (based on personal communication, Dr. C Pryce) 
(Kosten and Ambrosio, 2002). This helps to assess the power of environmental 
effects against genetic trends.  
A series of studies have implicated the role of HPA axis alteration in stress related 
vulnerabilities (Heim and Nemeroff, 2001; Heim et al., 2004; Pryce et al., 2011) and 
the hippocampus, the regulator of HPA axis and involved in learning and memory, is 
the region sensitive to stress and stress hormones and has abundant glucocorticoid 
and mineralocorticoid receptors (de Kloet et al., 2005) which suggests its possible 
involvement in stress disorders. 
Hippocampal volume losses have been observed in patients suffering with 
posttraumatic stress disorder (e.g. Bremner et al., 1995; Apfel et al., 2011), major 
depression (e.g. Bremner et al., 2000; Sheline et al., 2003) and schizophrenia 
(Heckers, 2001). Clinical reports of significant volume losses in patients suffering 
from childhood sexual abuse (Sapolsky, 2000) and neglect (Teicher et al, 2004) also 
add to the early life stress vulnerability. Meta-analysis by Viderbech and Ravnkilde 
(2004) concluded hippocampal volume reduction on average by 8% in the left and 
10% in the right hemisphere in patients suffering from depression. Even preclinical 
studies have also reported stress induced hippocampal vulnerability in the tree 
shrews (Ohl et al., 2000; Czeh et al., 2006), macaque (Jackowski et al., 2011) and 
rodents (Lehmann et al., 2002; Czeh et al., 2010). These results clearly suggest early 
life stress, possibly via hippocampal dysfunctioning, leads to the development of 
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stress related disorders in later stages of life (Heim and Nemeroff, 2001; McEwen, 
2003).  
It should be noted that hippocampal plasticity is a well-replicated finding in stress 
related disorders (Pryce et al., 2011). However, other brain limbic regions such as 
amygdala, prefrontal cortex are also involved and affected by neurological disorders. 
MRI studies carried out in depressed patients have shown a reduction in the 
amygdala (Sheline et al, 1998) and hippocampus (Frodl et al., 2010) whilst another 
study reported an increase in the amygdala volume in both men and women suffering 
from depression (Bremner et al, 2000).  
Until now most of the human and animal studies hypothesised various possibilities 
supporting hippocampal volume loss such as dendritic remodelling, death of neurons 
due to excess of glucocorticoids (Sapolsky, 2000) and loss of CA3 pyramidal cells 
(Sapolsky, 1985). It should also be noted that no stereological quantification was 
performed in the mentioned studies. Currently, unbiased stereological cell counting, 
volumetric and morphological techniques are the method of choice for evaluating 
changes in specific brain regions.  
Volume reductions in the hippocampus suggest plastic rearrangements within this 
brain subregion and hence depression with its hippocampal atrophy is now 
recognised as a disorder of neuroplasticity (Mc Ewen, 2001 and 2005; Duman 2002a, 
2002b; Duman 2004; Fuchs et al., 2004; Czéh and Lucassen, 2007). A decrease in 
the rate of neurogenesis in the adult hippocampal dentate gyrus has also been 
considered as a causative factor in hippocampal shrinkage (Henn & Vollmayr, 2004). 
Various animal studies suggest that stress and glucocorticoids are among the potent 
inhibitors of neurogenesis in the adult dentate gyrus (Gould et al, 1997; Czeh et al, 
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2002; Mirescu & Gould, 2006). However, most of the research studies have focused 
primarily on neurones and less attention has been given to glial cells, which 
markedly outnumber neurones in the brain (Joelving et al, 2006) and constitute a 
major population of the hippocampal volume fraction. And due to this, change in 
glial number or morphology can significantly affect hippocampal shrinkage (Czeh & 
Lucassen, 2007). 
Recent clinical studies have demonstrated a reduced ratio of glia per pyramidal 
neurone numbers, consistent with a reduction in the glial cells in major depressive 
disorder patients (Cobb et al, 2006); reduced GFAP stained astroglial cells in 
hippocampus have been reported by Muller et al (2001). Reduced astroglial GFAP-
immunoreactivity has also been found in the prefrontal and cingulate cortex, 
basolateral amygdala and hippocampus (Leventopoulos et al, 2007). There is 
growing evidence that astroglia, as defined by their selective marker GFAP, play a 
role in the pathophysiology of depression (Harrison, 2002; Miguel-Hidalgo et al 
(2000); Müller et al (2001); Bowley et al., 2002; Rajkowska and Miguel-Hidalgo, 
2007) and stress-related and depression-like conditions in animal models (e.g. Czéh 
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3.1.1 Aims and Hypotheses 
 
The previous study findings support the view that early life stress modulates 
hippocampal functioning and thus it is of relevance to study experience - dependent 
hippocampal  remodelling. The present study investigates the ED effects on the 
regional brain volumes and astroglial morphology using the stereology quantification 
technique. It is hypothesised that ED leads to reduction in the volume of the 
hippocampus and impoverishment of astroglial morphology in Wistar rats. The 
specific hypotheses of the present study were as follows: 
 ED will result in a reduction of the volume of hippocampus, amygdala and 
nucleus accumbens without affecting total cell density. 
 ED will be associated with reductions in GFAP positive astroglial cell 















3.2.1 Brain Weight and Volume  
No significant treatment effects on the brain weight were observed in both Wistar [F 
(2, 15) = 1.662, p= 0.223] and Lewis rats [F (2, 15) = 1.862, p= 0.211]. A significant 
difference was observed between the two strains [F (1, 24) = 4.302, p< 0.05] and no 
change was seen in strain vs treatment [F (2, 24) = 0.628, p = 0.542]. 
 
  NH EH ED 
Wistar 
Brain Weight (mg) 2020  1920 1910 
Brain Volume (mm
3
) 1986.4 1978.5 1908.7 
Lewis 
Brain Weight (mg) 2056  2080  2003 
Brain Volume (mm
3
) 2032.9 2105.3  1974.3  
 
Table 3.1 - Whole brain weight (g) and brain volume (mm
3
) as measured by means 
of pQCT. Data are expressed as mean values. 
 
The pQCT analysis indicated no significant treatment effects on the whole brain 
volume in Wistar rats (One-way ANOVA with post hoc Tukey test, F (2, 15) = 
1.380; p= 0.282, ED vs NH (p = 0.314), ED vs EH (p= 0.388) and EH vs NH (p= 
0.987) (Table 3.1).  
However, significant change was seen between ED vs EH (p< 0.05) in Lewis rats 
[F(2,9) = 5.968, p< 0.05],  ED vs NH: 0.260, EH vs NH: 0.460. Changes were also 
seen between strain - Wistar vs Lewis [F (1, 24) = 4.745, p<0.05], NH (p= 0.688), 
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EH (p= 0.029), ED (p= 0.121). No significant change was observed in strain vs 
treatment [F (2, 24) = 0.551, p = 0.583]. 
 
 
Figure 3.1 – Scatter plot showing the strong positive linear relationship between 
brain weight and volume (n=30). 
In the course of the method validation a strong positive linear correlation and 
regression demonstrated a significant positive relationship between brain weight and 
volume (F (1, 28) = 87.635, p<0.001, R
2
 = 0.758) (Pearson correlation, Figure 3.1). 
The whole brain volume analysis was highly reproducible with coefficient of 
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3.2.2 Dorsal Hippocampal volume 
For dorsal hippocampus volume, estimated by means of stereology with Cavalieri 
principle, there was a significant effect of Group (F (2, 15) = 20.422, p < 0.001) 
(Figure 3.2, Table 3.2). Volume was significantly decreased in ED vs NH rats (mean 
decrease of 12.5%, p<0.001) and in EH vs NH rats (7.5%, p<0.01). The reduction in 
ED vs EH rats (5.5%) was borderline non-significant (p = 0.054). There was a 
significant effect of Group on dorsal hippocampus volume as a percentage of whole 
brain volume (F (2, 15) = 4.417, p<0.05) with this parameter being significantly 
reduced in ED vs NH rats (9.0 %, p<0.05). No significant changes were observed in 
dorsal hippocampal volumes in Lewis rats (absolute = F (2, 11) = 0.763, p = 0.490 & 
relative = F (2, 9) = 0.778, p = 0.488).  
There was no significant strain effect observed [F (1, 26) = 0.075, p = 0.786] and 
interestingly significant strain vs treatment effect was seen [F (2, 26) = 4.573, p< 
0.05]. There were no significant differences between the left and right hemispheres 




























Figure 3.2 - Effects of early deprivation on the dorsal hippocampal volume in adult 
Wistar and Lewis rats.  
Data presented as mean ±SEM, n=6 per NH, EH and ED in Wistar’s and n=3 NH, 
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Absolute volume values(mm3) 
 NH EH ED 
WISTAR 
Dorsal Hippocampus 37.25 ± 0.50 34.47 ± 0.39 32.6 ± 0.63 ***# **Δ 
Basolateral Amygdala 0.93 ± 0.02 0.91 ± 0.03 0.88 ± 0.02 
Nucleus Accumbens 2.67 ± 0.1 2.75 ± 0.13 2.71 ± 0.09 
LEWIS 
Dorsal Hippocampus 34.3 ± 1.2 35.5 ± 1.1 34 ± 0.7 
Basolateral Amygdala 0.94 ± 0.02 0.93 ± 0.01 0.93 ±0.01 
Nucleus Accumbens 3.15 ± 0.09 3.11 ± 0.05 3.06 ± 0.08 
 
Table 3.2 - Brain regional volume analysis – Hippocampus, Amygdala and Nucleus 
accumbens. 
Data presented as mean ±SEM, n=6 per NH, EH and ED in Wistar’s and n=3 NH, 
n=5 EH and n=6 ED in Lewis rats. 
*p<0.05, **p<0.01, ***p<0.001, # vs NH, Δ vs EH 
 
 
3.2.3 Basolateral Amygdala and Nucleus Accumbens volume 
There was no significant effect of Group on the volume of the basolateral amygdala 
in both Wistar (F (2, 15) = 1.458, p = 0.264) and Lewis rats [F(2,11) = 0.223, p = 
0.804]. No strain [F (1, 26) = 3.746, p = 0.064] and strain vs treatment [F (2, 26) = 
0.616, p = 0.548] effects were observed in basolateral amygdala (Figure 3.3).  
The nucleus accumbens volume also showed no changes in both Wistar (F (2, 15) = 
0.137, p = 0.873) and Lewis rats [F (2, 11) = 0.375, p = 0.696] (Figure 3.4). 
However, significant strain effect was seen [F (1, 25) = 25.316, p< 0.001] with no 
strain vs treatment effect [F (2,25) = 0.248, p = 0.782]. 





Figure 3.3 - Effects of early deprivation on the basolateral amygdala volume in adult 
Wistar and Lewis rats. 
Data presented as mean ±SEM, n=6 per NH, EH and ED in Wistar’s and n=3 NH, 














Figure 3.4 - Effects of early deprivation on the nucleus accumbens volume in adult 
Wistar and Lewis rats. 
Data presented as mean ±SEM, n=6 per NH, EH and ED in Wistar’s and n=3 NH, 
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3.2.4 Hematoxylin stained total cell numbers 
 
There was no significant effect of Group on the total number of hematoxylin stained 
cells any sub-region of the dorsal hippocampal sub regions - CA1 (F (2, 15) = 0.119, 
p = 0.889), CA2 (F (2, 15) = 0.130, p = 0.879), CA3 (F (2, 15) = 0.523, p = 0.603) 




Figure 3.5 - Numbers of hematoxylin positive cells in the dorsal hippocampal sub-
regions of non-handled (NH), early handled (EH) and early deprived (ED) adult 
Wistar rats. Data presented as mean ±SEM, n=6 per group. 
 






Hematoxylin stained nuclei numbers estimated per hippocampal sub-region (x10
3
) 
  NH EH ED 
CA1 851.3 ± 23.1 823.8 ± 57.4 839.8 ± 31.3 
CA2 122.1 ± 6 116 ± 8.2 119.8 ± 10.8 
CA3 539.7 ± 27.4 500.3 ± 33.1 506.5 ± 27.2 
DG 801.4 ± 26.3 776.3 ± 23.2 824.5 ± 31.3 
GFAP +ve cell numbers estimated per region (X10
3
) 
CA1 120.3 ± 3.1 112.8 ± 4 110.8 ± 3.2 
CA2 17.7 ± 0.8 16.6 ± 0.9 15.8 ± 0.5 
CA3 70.7 ± 2.6 66 ± 1.8 54.3 ± 3.1              **#  *Δ 
DG 108.5 ± 4 102.8 ± 3.3 97.8 ± 3.4 
 
Table 3.3 - Estimate of the total hematoxylin stained cell numbers and GFAP-
positive cell numbers per dorsal hippocampal sub-region in Wistar rats. 
Data are expressed as mean values ± SEM, n=6 per group 
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3.2.5 GFAP positive astroglial cell number 
In dorsal hippocampus, there was a significant effect of Group on the total number of 
GFAP positive astroglial cells in Wistar’s in CA3 (F (2, 15) = 11.093, p < 0.001) the 
number was reduced by an average of 23% in ED vs NH rats (p<0.01) and 18% in 
ED vs EH rats (p<0.05). There was no significant effect of Group on this measure in 
CA1, CA2 and DG (Figure 3.6, Table 3.3). 
 
 
Figure 3.6 - Numbers of GFAP positive cells in the dorsal hippocampal sub-regions 
of non-handled (NH), early handled (EH) and early deprived (ED) adult Wistar rats.  
Data presented as mean ±SEM, n=6 per group, *p<0.05, **p<0.01 
 
    
  Chapter 3 Early postnatal deprivation effects 
113 
 
3.2.6 GFAP positive astroglial cell morphology 
Morphometric data for GFAP-positive astroglia are presented in Table 3.4. There 
was a significant effect of Group on the total length of primary processes in 
hippocampal sub-regions: this parameter was decreased in ED vs NH in CA1 (32%, 
p < 0.001), CA2 (19%, p < 0.01), CA3 (35%, p < 0.001) and DG (23%, p < 0.01), 
and in ED vs EH in CA1 (23%, p < 0.01), CA2 (7%, p < 0.01) and CA3 (25%, p < 
0.01).(Figure 3.7) Significant effect of Group on the mean length of primary 
processes in hippocampal sub-regions: this parameter was decreased in ED vs NH in 
CA1 (30%, p < 0.001), CA2 (20%, p < 0.05), CA3 (32%, p < 0.001) and DG (21%, p 
< 0.01), and in ED vs EH in CA1 (23%, p < 0.01) and CA3 (21%, p < 0.01) (Figure 
3.8). There was no significant effect of Group on the number of primary processes 















Figure 3.7 - Total primary process lengths of GFAP positive cells in the dorsal 
hippocampal sub-regions of non-handled (NH), early handled (EH) and early 
deprived (ED) adult Wistar rats.  
















Figure 3.8 - Mean primary process lengths of GFAP positive cells in the dorsal 
hippocampal sub-regions of non-handled (NH), early handled (EH) and early 
deprived (ED) adult Wistar rats.  













Figure 3.9 - Number of primary processes of GFAP positive cells in the dorsal 
hippocampal sub-regions of non-handled (NH), early handled (EH) and early 
deprived (ED) adult Wistar rats.  










GFAP - astroglia morphology 
 Regions NH EH ED 
Total primary process length (µm)  
CA1 7142.8 ± 358.8 6367 ± 153.2 4852.3 ± 366.7 ***# **Δ 
CA2 5130.0 ± 211.9 4440.8 ± 315.7 4132.9 ± 185.7   **# Δ 
CA3 6422.1 ± 280.7 5605.8 ± 204.9 4180.2 ± 202.0 ***# **Δ 
DG 6073.3 ± 233 5479.1 ± 294.2 4687.4 ± 247.4   **#  
Primary process mean length (µm)  
CA1 22.6 ± 0.8 20.3 ± 0.6 15.68 ± 1          ***# **Δ 
CA2 17.7  ± 0.8 15.2  ± 1.1 14.2 ± 0.4             *# 
CA3 21.0  ± 0.6 18.2 ± 0.7 14.3 ± 0.5         ***# **Δ 
DG 21.8  ± 0.8  19.3 ± 0.9 17.2 ± 0.9           **# 
Number of primary process  
CA1 315.8 ± 6.7 314.8 ± 3.4 307.8 ± 4.9 
CA2    290  ± 6.2     293 ± 6.1 290.7 ± 10.9 
CA3 305.2 ± 6.9     308 ± 7.9 291.3 ± 7.7 
DG    278 ± 5.6  283.5 ± 6.9 272.2 ± 6.5 
 
Table 3.4 - Astroglia (GFAP positive) cell primary process total and mean length 
and number of primary processes in Wistar rats. 
Data are expressed as mean values ± SEM, n=6 per group 
*p<0.05, **p<0.01, ***p<0.001; # vs NH, Δ vs EH 
 
 





The present study based on the stereological estimation found significant dorsal 
hippocampal volume reductions in the male adult Wistar rats which had experienced 
early deprivation (12.5% ↓) and early handling (7.5% ↓) with no significant 
treatment effects in Lewis rats.  
The study aimed to assess the early life stress effects on brain remodelling using the 
volume of specific brain regions involved in stress and depression as the dependent 
variable. The implication of astroglia was also studied by morphological and cell 
count analyses. Two rat strains of different responsiveness to stress - Wistar and 
Lewis were compared. Wistar rats have been found to respond to ED - behavioural 
and receptor changes have been observed (Leventopoulos et al., 2009). Lewis rats 
seem to show no negative behavioural response to ED (communication with Dr. 
Pryce; Kosten and Ambrosio, 2002).  
Until now only a few studies in early life stress have used stereological quantitative 
approach, which allows for unbiased quantitative estimation of brain volume and cell 
morphology (Schmitz and Hof, 2005). The use of peripheral quantitative computed 
tomography to estimate the whole brain volume was also a novel attempt towards 
refinement of volumetric regional analysis, as discussed below. Limbic brain regions 
which respond to stress such as the hippocampus and amygdala were assessed in 
order to understand the underpinning neurobiological mechanisms. Brain regions 
such as dorsal hippocampus, basolateral amygdala and nucleus accumbens which are 
closely linked to the behavioural symptoms of depressive disorders were the regions 
of interest. 
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The present study critically considered the fact that changes in the size of whole 
brain should be measured and specific brain regions should be scaled to individual 
brain size, which itself can be a dependent variable. However, assessing brain size is 
not straightforward and brain weight rather than volume is normally used as the 
scalar whilst brain regions are usually quantified as volumes. In order to develop a 
volume-based brain size variable for scaling brain region volumes, we quantified the 
rat brain volume using the peripheral quantitative computed tomography (pQCT) 
technique (Shende et al., FENS 2010). 
The whole brain volume measurement using pQCT was validated to check its 
accuracy and reproducibility. The present technique showed a strong correlation 
between the total brain volume and its weight, and a high precision of the method 
developed. To our knowledge, this is the first application of pQCT to rat brain 
volume analysis as part of regional volumetry. With this rigorous methodological 
approach, no significant treatment effects on the total brain volume were observed. 
Behavioural and experimental studies suggest rat strain differences in the response to 
stress. Lewis rats are relatively nonresponsive to stress, as indicated by reduced 
synthesis and secretion of CRH and are known for their decreased responsiveness to 
the negative feedback loop of ACTH and CRH in the HPA axis (Grota et al, 1997). 
Differences in mineralocorticoid receptor messenger RNA expression, receptor 
numbers, receptor affinity, or receptor activation has not been detected between the 
two strains (Oitzel et al, 1995), suggesting that possible difference may lie in the 
transduction of negative feedback signals. It has been suggested that differences in 
neuroendocrine and/or neurochemical (more specifically dopaminergic) state may be 
responsible for the differential response to early manipulation (Varty and Geyer 
  Chapter 3 Early postnatal deprivation effects 
120 
 
1998; Kinney et al. 1999). It is of interest to note that maternal deprivation in Wistar 
rats leads to an increase in mRNA expression for tyrosine hydroxylase within the 
substantia nigra pars compacta resulting in hyper-responsiveness to stress (Rots et al. 
1996). It has also been suggested that the reduced level of corticosterone released by 
the Lewis rat is insufficient to terminate inflammatory responses, and as a result, they 
show an increased susceptibility to autoimmunity (Sternberg et al, 1992). 
 
The present data provide support for the theory that genetic and environmental 
factors may contribute to the overall development of the brain and brain function 
(Kinney et al, 1999), and suggest that early life deprivation may represent an 
interesting tool for studying the interaction between genetic and early stressful life 
events. 
The extent of the observed hippocampal volume reduction is similar to the studies 
reported in the clinical (Viderbech and Ravnkilde, 2004) and experimental studies 
(Czeh et al., 2010). Various in vivo imaging studies of patients with major depressive 
disorder have shown selective functional and structural changes in the hippocampus 
(Sheline et al, 1996). Another in vivo MRI study documented significant reduction 
(10 -15%) in hippocampal volume supporting the present study (Cambell et al, 2006; 
Videbech & Ravnkilde, 2004). A stereology study carried out on maternally deprived 
Wistar rats reported similar decrease in hippocampal volume with no evidence of cell 
loss and significant reduction in astrocytic process length (Opacka-Juffry et al, 
2008).  
It should be noted that the change observed in the present study appear to be region-
selective as neither amygdala nor nucleus accumbens show treatment-dependent 
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volume changes. Also, only few stereological analyses have been performed and 
currently unbiased stereological cell counting for volumetric and morphological 
techniques are the method of choice for evaluating changes in specific brain regions. 
There are various mechanisms which could underpin the observed hippocampal 
shrinkage in early deprived and early handled rats, such as a stress-induced reduction 
in neurogenesis, alterations in gliogenesis, glial numbers and morphology, apoptosis 
or cell death, extracellular space and fluid content (review by Czéh and Lucassen, 
2007). The present study suggests the implication of astroglial density and 
morphology in the hippocampal volume loss. It is also plausible that these could be 
the reasons for volumetric changes reported in patients suffering from stress-related 
depressive disorders. 
The amygdala responds to fearful stimuli (Whalen et al, 1998) whereas nucleus 
accumbens most consistently respond to rewards (Ernst et al, 2005). Studies have 
shown ED in rats leads to anhedonia indicating brain reward system to  be likely 
implicated (Leventopoulos et al., 2009). Together the amygdala and nucleus 
accumbens mediate detection and reaction to motivating stimuli.  
To date there are a number of neuroimaging studies carried out in patients suffering 
from depression which suggests volumetric changes in the limbic system. Patients 
with major depressive disorder have shown disturbed activation in the limbic brain 
structures (Monk et al, 2008).   
Studies have suggested role of MePD and MeA regions of amygdala in several 
sexually dimorphic social behaviors in the adult animal has been observed with 
increase in their regional volume and neuronal soma size (Morris et al., 2005). Also 
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structural magnetic resonance imaging (MRI) studies indicates an abnormal growth 
pattern in the amygdala marked by precocious enlargement in autism patients 
(Sparks et al., 2002; Schumann et al., 2004). But contradictory results have been 
found in amygdala volumes in major depression. A study carried out by Bremner et 
al (2000) identified an increase in right amygdala volume. A study carried out by 
Yossuck et al (2006) showed no significant differences in the basolateral amygdala 
volume in rats exposed to corticosteroid. However,  study carried out by Sheline et al 
(1998) in MDD patients have found a reduction in the amygdala core nucleus 
volume.  
Very few post-mortem experimental animal studies have been performed to confirm 
the volumetric changes in amygdala and nucleus accumbens. Also less focus has 
been on basolateral amygdala which is involved in the emotional memory formation 
and its link with hippocampus related memory formation. The amygdala and nucleus 
accumbens are difficult structures to measure, since in many areas the cortical 
amygdala merges with surrounding cortex, and specific boundaries selected varied 
greatly in different studies and also it is difficult to differentiate between the nucleus 
accumbens boundary and its surrounding areas. 
No significant differences were found in both basolateral amygdala and nucleus 
accumbens volume in both Wistar and Lewis rats, thus indicating that the 
hippocampus is the most vulnerable region of early life stress. 
Animal behavioural studies have shown involvement of the amygdala and 
accumbens in the emotional regulation and early life stress. In the present study no 
volumetric changes were seen in basolateral amygdala and nucleus accumbens 
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suggesting there may be other mechanisms involved which disrupts their functioning 
like receptor changes and/or implications of neuronal and glial cells. 
The present study also focussed on the hippocampal astroglia considering their major 
role in maintaining brain plasticity at the level of synapses and cells (Theodosis et 
al., 2008) and the evidence that astrocytes are reduced in depression (Harrison, 
2002). In terms of methodology, GFAP immunolabelling of astroglia which was used 
in the present study occasionally attracts criticism that it does not label all astroglial 
cells in the brain (Reichenbach and Wolburg, 2005). However, a study compared 
S100 and GFAP (both are selective marker for astroglial cells) showed that both 
markers stain almost 80% the hippocampal astroglial cells (Ogata and Kosaka, 2002; 
Wei et al., 2009). Accepting the limitations of GFAP labelling, the present study 
aimed at estimating the length and numbers of primary astrocytic branches where 
GFAP is reliably detectable (Theodosis et al., 2008).   
Both early deprivation and early handling compared to non handling led to 
significant reduction only in the hippocampal CA3 – GFAP positive cell numbers in 
Wistar rats. No changes in the total hematoxylin stained cell count were observed 
across all experimental groups. Similar changes in the astroglial cell loss were 
reported in female rats exposed to prenatal stress (Behan et al., 2011) and in WKY 
rats exposed to stress (Gosselin et al, 2009).  Rajkowska and Miguel-Hidalgo (2007) 
postulate that decreased density of astroglia and reduced GFAP expression are 
associated with early onset depression. 
The current study also found a significant decrease in the length of the total and 
mean primary processes, with no changes in the number of primary processes in the 
hippocampal CA1, CA2, CA3 and DG subregions in ED relative to NH and EH rats.  
  Chapter 3 Early postnatal deprivation effects 
124 
 
The present observed astroglial morphological abnormalities of hippocampus which 
are likely to have functional implications, as a reduction in the length of primary 
processes would affect glia-occupied space and glia-neurone interactions which are 
essential for hippocampal activity (Theodosis et al., 2008). Interestingly, an increase 
in astrocytic primary process length in response to enriched environment was 
recently reported in male mice (Viola et al., 2009).  
On the basis of the present findings, the ED effects on astroglia can be interpreted as 
a manifestation of long-term reductions in brain plasticity. As such the present study 
findings support the growing consensus that it is astrocytic-neuronal plasticity which 
is a major dynamic feature of the brain when responding to positive or negative 
environmental events (Theodosis et al., 2008). 
The observed impoverishment of astroglial morphology in the present study can be 
treated as a demonstration of glial plasticity, a phenomenon that deserves more 










The present study demonstrates long-term effects of early life stress on hippocampal 
remodelling with the contribution of astroglia; this effect appears to be rat strain-
dependent. In terms of methodology, peripheral quantitative computed tomography 
was employed as a novel approach to measure total brain volume post-mortem in a 
high-precision manner, which is important as overall brain size itself is a variable in 
neuroanatomy and neurobiology research. In this respect, the present study shows 
that pQCT can be used as a tool for soft tissue (brain) and not only hard (bone) tissue 
volume analysis. This approach is of relevance to volumetric studies on 
neuroplasticity where regional volumes need to be scaled to the total brain volume. 
The current finding of hippocampal volume shrinkage is of relevance to elucidating 
the significance of decreased hippocampal volume to the neuropathology of 
depression.  
Stereological estimation of the basolateral amygdala and nucleus accumbens volume 
show no significant effects, which suggests an involvement of a different mechanism 
which disrupts emotional regulation and motivation stimuli towards reward observed 
in vivo.  
The study demonstrates that early life stress in the form of repeated disruption of 
mother - infant interactions leads to long-term effects on the dorsal hippocampus in 
terms of reduced volume, impoverished astroglial morphology in subregions CA1, 
CA2, CA3 and DG, and reduced numbers of GFAP-positive astroglial cells in CA3. 
Therefore, the present study provides evidence for long-term remodelling of 
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As overviewed in Chapter 1, the prenatal period of life is the most critical and 
sensitive phase where non-genetic/programming factors could mark permanent 
alterations in behaviour and physiological functions (Barker, 1995; Seckl, 2001). The 
environmental challenges affecting foetal development of the pregnant female are 
due to stress, which increases the HPA axis activity leading to increased plasma 
glucocorticoid (GC) – the natural GC receptor (GR) ligand (Seckl, 2004). However, 
synthetic GC, such as dexamethasone (Dex), also act through specific binding to the 
GR and are one of the programming factors during prenatal/developmental plasticity 
(Welberg et al., 2001). Dex is also known to modulate the expression of the genes 
that contain GC responsive elements in their promoter (De Kloet et al., 1998). 
Therefore, both prenatal stress and prenatal GC exposure result in GR activation in 
the foetus. 
 
The foetal exposure to synthetic corticosteroids during the prenatal period affects the 
normal brain development, causing long term changes in the brain structure and 
function with cognitive, behavioural and emotional disturbances (Matthews, 2000; 
Yossuck et al., 2006). Prenatal corticosteroid treatment started in 1972 (Liggins & 
Howie, 1972) having been considered as safe and without side effects (NIH 
consensus, 1994; 1995) and  used clinically (Matthews, 2000). In the 1990’s, 98% of 
the British obstetric clinicians prescribed repeated courses of the prenatal corticoid 
therapy (Brocklehurst et al., 1999). About 85% of the neonates with prenatal 
corticosteroid therapy received multiple courses (Empana et al., 2004). 




The proportion of preterm births is considerable, for example in England and Wales 
in 2005 alone over 11,500 infants (8%) were born prematurely at less than 33 weeks 
of gestation (Moser et al., 2007) and dexamethasone is commonly administered to 
ventilator-dependent premature infants with chronic lung insufficiency to improve 
lung function (Romagnoli et al., 2002; Charil et al., 2010) and normal foetal 
development (Ward, 1994).  
Neurodevelopmental effects of prenatal dexamethasone treatment need more 
attention as there are associations between GC and risk of neuropsychiatric disorders 
including depression and schizophrenia (Koenig et al., 2002; Huttunen et al., 1994; 
Yu et al., 2008; Steckler et al., 1999). Neurodevelopmental delay and cerebral palsy 
along with differences in morphology and structure of the offspring’s brain treated 
with Dex have been reported in humans (Shinwell et al., 2000; Halliday, 2002; 
Murphy et al., 2001; Choi et al., 2004). Corticosteroids are also involved in the 
regulation of prostaglandin synthesis, gluconeogenesis in liver cells and modulation 
of immune response (Wiegers and Reul, 1998).  In rats, both prenatal stress and 
prenatal GC exposure have been associated with increased anxiety (Estanislau and 
Morato, 2006; Welberg et al., 2001), impaired HPA negative feedback (Weinstock, 
2005; Welberg et al., 2001) and impaired memory (Brabham et al., 2000; Zagron and 
Weinstock, 2006) in adulthood. Prenatal stress has been also linked with increased 
behavioural despair (Smith et al., 2004) and impaired social behaviour (Patin et al., 
2005). 
 
It is plausible to assume that the behavioural effects couple with anatomical changes 
in the brain as preclinical studies have demonstrated that dexamethasone plays a role 




in brain development by terminal maturation, remodelling of axons and dendrites and 
cell survival (e.g. Yehuda et al., 1989).  Indeed, premature infants treated with 
dexamethasone postnatally had cortical brain volume reduced by 35% when 
compared to full term controls (Murphy et al., 2001). Previous studies have also 
suggested effects of corticosteroids on the HPA axis, which lead to changes in their 
negative feedback and result in hippocampal damage with cell and volume loss (Uno 
et al., 1990; 1994). However, the neurobiological mechanisms of perinatal 
corticosteroid treatment remain unclear. 
 
During the prenatal period (lasting from fertilisation to birth), the HPA axis 
components start to emerge and function (Challis et al., 2001). In rodents, it is 
gestational day 18 when the foetal HPA axis is responsive (Ohkawa et al., 1991). The 
foetal HPA axis can be activated by maternal CRH via placenta which makes the 
prenatal period complex and interesting where the stress system of the mother can 
influence their offsprings stress system (Weinstock, 2005). The foetal exposure to 
corticosteroid associates a link between prenatal environment and disorders with 
HPA axis dysfunctioning (Seckl, 2004). Prenatal corticosteroid exposure causes 
elevated levels of basal and stress induced plasma corticosterone in adult rats (Levitt 
et al., 1996) which leads to attenuation of the HPA axis feedback mechanism (Seckl, 
2004). Reduction in the hippocampal glucocorticoid and mineralocorticoid receptor 
density may result in HPA axis dysfunction (Welberg et al., 2001). Moreover, 
development of the adult hyperglycaemia and hypertension along with behavioural 
changes and HPA axis activation are associated with the prenatal dexamethasone 
exposure (Lewitt et al., 1996; Welberg et al., 2001). The sensitivity of the developing 
hippocampus is of particular concern, because it becomes an important brain center 




after birth, involved in the regulation of the hypothalamic–pituitary–adrenal (HPA) 
axis. 
 
Postnatal corticosteroid effects have been well researched (McEwen., 1994; 
Sapolsky., 1996; Joels., 2001) but less attention has been paid to prenatal 
corticosteroid treatment effects (Matthews., 2000). As prenatal corticosteroid 
administration is the practised treatment to improve lung function it is important to 
understand its chronic effects.  
Two possibilities of foetal programming - foetal malnutrition or foetal over exposure 
to glucocorticoids, have direct or indirect effects on foetal development (Barker et 
al., 1993a; Matthews, 2000). Exposure to the synthetic glucocorticoid like Dex may 
affect the specific foetal brain structure and/or general cell processes related to CNS 
accounting for long term effects. Although Dex is very potent, especially because it 
is not readily metabolised by the foetus, the pharmacological studies support the 
view that the placental transfer of maternal cortisol is a primary mediator of maternal 
stress effects on foetal development (Dodic et al., 2002; Kay et al., 2000; Pepe and 
Albrecht, 1987). 
 
As mentioned earlier, the direct effects of glucocorticoids on brain development are 
mediated through corticosteroid receptors: the mineralocorticoid receptor (MR) and 
the glucocorticoid receptor (GR). Prenatal glucocorticoid treatment is often GR 
specific where dexamethasone, binds exclusively to GR (Reul and de Kloet, 1985). 
The GR is identified throughout the brain; however both GR and MR are highly 
expressed in hippocampus. During the foetal and postnatal life these receptors follow 
a unique pattern of expression especially in the hippocampus (Rosenfield et al., 




1988; Vazquez et al., 1996). Studies have shown that disruption in the maternal care 
causes alterations in the GR development causing altered hippocampal function 
(Francis et al., 1999; Liu et al., 1997). 
 
Prenatal corticosteroids such as betamethasone (5–16 doses, 12 mg each, 
administered twice weekly) have shown short term effects like transient hypertrophic 
cardiomyopathy in newborns (Yunis et al., 1999). Long term effects such as 
increased mortality, decreased foetal growth and birth weight, adrenal suppression 
and reduced head circumference were observed with multiple betamethasone 
prenatal administration (French et al., 1999; Banks et al., 1999). Long term prenatal 
stress, indicated with prolonged increased maternal corticosteroid levels, was 
associated with increased neurological dysfunction, developmental delay (late or 
poor walking, speech deficits), and behavioral disturbances (such as restlessness and 
poor interpersonal skill development) in children (Stott., 1973). In rodents, prenatal 
corticosteroid exposure has multiple effects on the hippocampal cell proliferation, 
neurotransmitter turnover and receptor expression (DeKloet et al., 1998; Seckl., 
1998). Prenatal dexamethasone causes decrease in body and brain weight in rats 
(Carlos et al., 1992), decrease in postnatal protein/DNA ratio (Slotkin et al., 1992) 
and decrease in both GR and MR in the hippocampus (Welberg et al., 2001).  
 
Studies designed to assess perinatal dexamethasone exposure outcomes have 
suggested a close association between environmental challenge during pregnancy, 
altered foetal growth, development and later pathophysiology (Seckl, 1998) along 
with its involvement in mediating the detrimental effects of stress (Coe & Lubach, 




2005). Increased prevalence of schizophrenia has been observed in children subject 
to prenatal maternal stress (Huttunen et al., 1994; Van Os & Selten, 1998) suggesting 
perinatal environment as critical phase for plasticity. 
 
Human infants treated with prenatal dexamethasone administration had lower birth 
weight (Stark et al., 2001), smaller head circumference, lower IQ scores, poor motor 
and visual - coordination skills during their school age (Yeh et al., 2004). Premature 
infants treated with Dex often suffer from affective and cognitive disorders in 
adulthood such as autism, attention deficit hyperactivity disorder, learning 
difficulties and depression (Thompson et al., 2001; O’Donnell et al., 2009). 
Interestingly, prenatal exposure to the stress of a moderately severe natural disaster 
(ice storm crisis in the Canadian province of Québec) is also associated with lower 
cognitive and language abilities (Laplante et al., 2008). In rats, spatial learning 
impairment is one of the consistent findings in the offspring of mothers treated with 
dexamethasone prenatally in drinking water (Brabham et al., 2000). High anxiety 
behaviour (Vallee et al., 1997), changes in spontaneous motor activity (Diaz et al., 
1997), altered performance in the open field and forced swim test (Welberg et al., 
2001) are other observations in rats exposed to prenatal dexamethasone.  
As mentoned in the general introduction, the brain limbic system plays an important 
role in the regulation of emotion, behaviour and memory processes (Sapolsky, 2000). 
During the prenatal brain developmental period, the limbic regions, such as the 
hippocampus and amygdala, are sensitive to both endogenous and exogenous 
corticosteroid (Matthews, 2000; Halasz et al., 2002). Exposure to corticosteroids 
during the critical period of foetal development affects the limbic structures resulting 




in cognitive and neuroendocrine dysfunction (Matthews, 2000). Several lines of 
evidence indicate an alteration in the cytoarchitecture of hippocampus, a region with 
high glucocorticoid receptor density, as a result of prenatal stress. Spatial learning 
impairment (Lemaire et al., 2000), long term potentiation reduction (Son et al., 2006) 
and decline in cognitive processes (Hayashi et al., 1998) correlates with hippocampal 
dysfunctioning observed in the rats exposed to  prenatal stress. The prevalence of 
cognitive impairments was higher in males than in females following dexamethasone 
administration (Brabham et al., 2000). 
 
Magnetic resonance imaging (MRI)  studies in the prematurely born children treated 
with dexamethasone have confirmed brain structural abnormalities (Murphy et al., 
2001). The cortical brain volume reduction due to postnatal corticosteroid treatment 
is one of the published examples (Murphy et al., 2001). Reductions in the regional 
volume of the hippocampus, amygdala and corpus callosum were reported in the 
prematurely born children (Abernethy et al., 2002; Peterson et al., 2000; Nosarti et 
al., 2002). However, the mechanisms underlying these brain volume changes in 
association with the corticosteroid treatment used for prevention of chronic lung 
disease in premature babies are not fully understood (Tijsseling et al., 2012). 
Hippocampal atrophy and volume loss have been revealed by means of the MRI 
technique in the children who survived from very low birth weight (Abernethy et al., 
2002) and also in monkeys and rats treated with high GC doses (Woolley et al., 
1990; Sapolsky et al., 1990). Prenatal exposure to DEX has been shown to cause 
degeneration of hippocampal neurones and reduce hippocampal volume in 
adolescent rhesus macaques (Uno et al., 1990). Coe et al. (2003) also observed 
volume loss by 10-12% in the offspring of stressed pregnant rhesus monkeys. 




Degeneration of hippocampal CA1 and CA3 cells and dendritic branches under 
dexamethasone exposure have been reported in preclinical rodents (Haynes et al., 
2001; Sousa et al., 1999) and primate studies (Sapolsky et al., 1990). Prenatal 
exposure to dexamethasone has been shown to delay maturation of neurons and 
inhibit neurogenesis in rats (Lupien et al. 2009). Hippocampal glucocorticoid 
receptors, brain-derived neurotrophic factor, corticotropin releasing hormone (CRF) 
and neuropeptide Y, have all been recognised as possible targets of prenatal 
corticosteroid treatment resulting into reprogramming of these molecules (Velisek., 
2005).    
 
In addition, studies have reported delays in the maturation of astrocyte and capillary 
tight junction, and myelination of the corpus callosum in sheep (Antonow-Schlorke 
et al., 2009) and a significant decrease in spine density of the hippocampus in rats 
(Hayashi et al., 1998) following exposure to prenatal synthetic glucocorticoids. 
Morphological changes in astroglia have also been reported in response to stress. 
Thus studies have shown long lasting astroglial reactions (increased cell area of 
GFAP positive cells and high S100 protein levels) and decreased dendritic 
arborisation in response to prenatal stress (Barros et al., 2006) and increase in the 
glial fibrillary acidic protein (GFAP) immunoreactivity in the hippocampal CA1 
region and striatum following repeated immobilisation stress (Kwon et al., 2008). 
There is growing appreciation for the importance of astrocytes, non-neuronal glial 
cells, in the overall brain functioning. Reduction in glial cell numbers has been 
reported in the post-mortem studies on patients suffering with major depressive 
disorder (Bowley et al., 2002). Studies have also shown reductions in glial cell 
proliferation in vitro (Crossin et al., 1997) and in vivo (Wennstrom et al., 2006) in the 




course of corticosteroid exposure. Till date no reports have been published on effects 
of prenatal GC treatment on astroglial cells although evidence for the role of 
astroglia in brain plasticity has increased in recent years (Jauregui-Huerta et al., 
2010).  
 
4.1.1 Aims and Hypotheses 
 
The present study was designed to investigate the effects of prenatal exposure to 
dexamethasone on the volume of the hippocampus and the morphology of its 
astroglia in an attempt to evaluate hippocampal remodelling and the role of astroglia 
in this process. The specific aims of the present study were to investigate if: 
 Prenatal dexamethasone exposure will be associated with a reduction in the 
volume of hippocampus, amygdala and nucleus accumbens regions. 
 Prenatal dexamethasone exposure will not affect the total cell number in 
hippopcampus, basolateral amygdala and nucleus accumbens regions.  
 Prenatal dexamethasone exposure will result in reductions of GFAP positive 












4.2.1 Whole brain volume and brain weight 
Independent t-test was performed to test the treatment effect between groups (Table 
4.1). No significant difference was observed suggesting no treatment effect on whole 
brain volume (p= 0.376) and brain weight (p = 0.442). The results suggest that the 
prenatal dexamethasone exposure does not alter the whole brain volume and brain 
weight. 
 
  Control Dex Treated 
Brain Weight (g) 1.74 ± 0.02 1.77 ± 0.03 
Brain Volume (cc) 1650.18 ± 17.75 1681.24 ± 28.43 
 
Table 4.1 - Effects of prenatal dexamethasone exposure on brain weight and volume 
of male adult Sprague Dawley rats. The brain weight and volume are expressed as 
mean ± SEM (n = 6 per group). 
 
 
4.2.2 pQCT analysis 
In order to estimate the precision and reproducibility of the technique, repeated 
pQCT scanning was done 5 times for the same rat brain and whole brain volume was 
estimated. The data obtained showed 0.26% of coefficient of variation (CV) and -
0.0001% of average measurement error. 
 





Figure 4.1 - Scatter plot showing the strong positive linear relationship between 
brain weight and volume (n=12). 
The Pearson correlation test was used to identify the relationship between brain 
weight and volume. A strong positive linear correlation (r = 0.983, p<0.01) was 
observed between brain weight and volume. Also, linear regression demonstrated a 
significant positive relationship (F (1, 10) = 278.472, p<0.001, R
2
 = 0.965) (Figure 
4.1). 
 
4.2.3 Regional volume analyses  
 
4.2.3.1 Dorsal Hippocampus 
 
The dorsal hippocampus volume was estimated using stereology with Cavalieri 
principle (StereoInvestigator, MBF). Independent t-test was used for statistical 
(gm) 
(cc) 




analysis in order to compare the means representing the control and DEX treated 
group. DEX treated rats showed a significant decrease in the dorsal hippocampal 
volume by 6.5% vs control (p<0.05). There was a significant reduction by 8% 
(p<0.05) in the relative volume of the dorsal hippocampus expressed as percentage of 




Figure 4.2  Effect of prenatal dexamethasone treatment on the dorsal hippocampal 
volume in adult male Sprague Dawley rats.   
The prenatal dexamethasone exposure resulted in reduction of dorsal hippocampal 
volume. Independent sample t-test revealed significant differences (*p<0.05)  
 






  Control Dex Treated 
Absolute values (mm3)     
Dorsal Hippocampus 32.8 ± 0.46 30.8 ± 0.50 * 
Basolateral Amygdala  0.81 ± 0.02 0.80 ± 0.02 
Nucleus Accumbens 2.28 ± 0.06 2.26 ± 0.07 
Relative values (as % brain volume)     
Dorsal Hippocampus 1.99 ± 0.04 1.83 ± 0.04  * 
Basolateral Amygdala  0.046 ± 0.001 0.048 ± 0.001 
Nucleus Accumbens 0.138 ± 0.004 0.135 ± 0.005 
 
Table 4.2 – Effects of prenatal dexamethasone exposure on the regional brain 
volume of male adult Sprague Dawley rats. 
Data are expressed as mean ± SEM (n = 6 per group). *p<0.05 
 
4.2.3.2 Basolateral Amygdala and Nucleus Accumbens 
The basolateral amygdala and nucleus accumbens volume (right side) were estimated 
using stereology with Cavalieri principle (StereoInvestigator, MBF). Independent t-
test was used for statistical analysis to compare the means between the control and 
DEX treated groups. No significant differences were observed between the treatment 
groups in the amygdala (p= 0.834) and nucleus accumbens (p= 0.905) (Table 4.2). 
 
 
4.2.4 Total and GFAP positive cell numbers 
The total number of HX stained cells in the dorsal hippocampal sub regions CA1 
(Pvalue= 0.821), CA2 (Pvalue= 0.975), CA3 (Pvalue= 0.991) and DG (Pvalue= 0.959) did 
not reveal a significant main effect of treatment (independent t-test). The total 
number of GFAP positive astroglial cells in the dorsal hippocampal sub regions was 
estimated. There were no significant changes seen in GFAP-positive cell population 




in the dorsal hippocampal sub regions (independent t-test) CA1 (p= 0.607), CA2 (p= 
0.517), CA3 (p= 0.500) and DG (p= 0.424) in response to the DEX treatment (Table 
4.3).   
Hematoxylin stained cell numbers estimated per region (X103) 
  Control Dex Treated 
CA1 706.8 ± 8.8 714.1 ± 29.7 
CA2 95.9 ± 3.4 95.8 ± 2 
CA3 491.3 ± 37.2 490.7 ± 32.6 
DG 791.4 ± 31.6 789.1 ± 30.6 
GFAP +ve cell numbers estimated per region (X103) 
CA1 219.4 ± 6 213.6 ± 9.1 
CA2 26.8 ± 1.1 25.8 ± 1 
CA3 110.9 ± 6.1 104.4 ± 6.9 
DG 201 ± 4.7 195.3 ± 5.1 
 
Table 4.3 – Effects of prenatal dexamethasone exposure on the number of total and 
GFAP positive cells in male adult Sprague Dawley rats. 
Data are expressed as mean ± SEM (n = 6 per group). 
 
Hematoxylin stained cell numbers estimated per region (X103) 
  Control Dex Treated 
Basolateral amygdala 52.86 ± 3.4 58.79 ± 2.4 
Nucleus accumbens 146.58 ± 6.8 139.61 ± 6.4 
GFAP +ve cell numbers estimated per region (X103) 
Basolateral amygdala 23.68 ± 1.9 25.71 ± 2.1 
Nucleus accumbens 20.73 ± 1.8 18.28 ± 2.0 
 
Table 4.4 – Effects of prenatal dexamethasone exposure on the number of total and 
GFAP positive cells in male adult Sprague Dawley rats in basolateral amygdala and 
nucleus accumbens region. 
Data are expressed as mean ± SEM (n = 6 per group). 




The total number of HX stained cells (p= 0.180) and GFAP positive cells (p= 0.495) 
in the basolateral amygdala did not reveal a significant main effect of treatment 
(independent t-test). The total number of HX stained cells (p= 0.474) and GFAP 
positive cells (p= 0.384) in the nucleus accumbens did not reveal a significant main 




4.2.5 GFAP positive - Astroglia cell morphology 
Morphological analysis of the GFAP positive astroglia revealed significant changes 
in the total primary process length and primary process mean length. Independent t-
test analysis showed significant treatment effects in the total primary process length: 
reduction by 32% in CA1 (p<0.05) by 50% in CA3 (p<0.001) and by 25% in DG 
(p<0.01) (Figure 4.3). Changes were also observed in the primary process mean 
length: reductions by 25% in CA1 (p<0.01), by 45% in CA3, (p<0.001) and 25% in 
DG (p<0.01) (Figure 4.4). No treatment effects were seen in the number of primary 














Figure 4.3 – Effect of prenatal dexamethasone treatment on the total primary process 
length in dorsal hippocampal sub regions in male adult Sprague Dawley rats.  




















Figure 4.4 – Effect of prenatal dexamethasone treatment on the mean primary 
process length in dorsal hippocampal sub regions in male adult Sprague Dawley rats.  






















Figure 4.5 – Effect of prenatal dexamethasone treatment on the number of primary 
processes in dorsal hippocampal sub regions in male adult Sprague Dawley rats.   









Morphological analysis of the GFAP positive astroglia revealed no significant 
changes in the total primary process length (p= 0.674), primary process mean length 
(p= 0.808) and number of primary processes (p= 0.566) in the basolateral amygdala 
region (independent t-test analysis, Table 4.5).  
 
GFAP - astroglia morphology 
  Control Dex Treated 
Total primary process length (µm)   
Basolateral amygdala 5761.8 ± 582.6 6123.5 ± 598.9   
Nucleus accumbens 4033.4 ± 403.9 3890.1 ± 489.2       
Primary process mean length   
Basolateral amygdala 26.8 ± 1.6 27.5 ± 2.1           
Nucleus accumbens 22.7  ± 1.8 20.8 ± 1.7            
No. of primary process   
Basolateral amygdala 213 ± 11.4 221 ± 9.1           
Nucleus accumbens 178  ± 8.5 185 ± 10.6            
 
Table 4.5 – Effects of prenatal dexamethasone exposure on the morphology of 
GFAP-positive astroglia in male adult Sprague Dawley ratsin the basolateral 
amygdala and nucleus accumbens region.   
Data are expressed as mean ± SEM. (n = 6 per group) 
 
Morphological analysis of the GFAP positive astroglia revealed no significant 
changes in the total primary process length (p= 0.826), primary process mean length 
(p= 0.470) and number of primary processes (p= 0.593) in the nucleus accumbens 
region (independent t-test analysis, Table 4.5).  
 






The present study revealed that prenatal exposure to dexamethasone induced a 
selective hippocampal volume reduction with no evidence of cell loss accounting for 
it. With the use of stereology, changes in astroglial  morphology were observed, 
which may underpin the observed hippocampal volume reduction. To my 
knowledge, this is the first stereology approach to the analysis of anatomical brain 
changes caused by prenatal dexamethasone in adult rats. Stereology is the method of 
choice for evaluating changes in regional volume and cell numbers as it offers an 
unbiased approach to volumetry and morphometry.  
As mentioned in the Chapter 3, stress or emotional trauma in early life is associated 
with risk of depression (Watson et al., 1999; Heim et al., 2004) and schizophrenia 
(Howes et al., 2004) later in life. Similar risks are also expected to develop in cases 
of childhood sexual and physical abuse (McCauley et al., 1997) and psychological 
stressor (Huttunen et al., 1994). Autism (Kinney et al., 2008a) and attention-deficit 
hyperactivity disorder (ADHD) (Li et al., 2010) are also associated with prenatal 
stress. Animal studies  have compared  prenatal dexamethasone treatment with 
neurobehavioural  models of stress and depression-like behaviours (Gregus et al., 
2005) with observations such as enhanced fear (Corodimas et al., 1994), reduced 
body weight (Barr et al., 2000; Kalynchuk et al., 2004), glucocorticoid receptor 
downregulation (Vyas et al., 2002), HPA dysfunctioning (Pryce et al., 2011) and 
decreased hippocampal neurogenesis (Pham, 2003). The corticosteroid treated 
animals possess a major advantage due to less variability in comparison with 
physical stress models, which avoids individual differences in HPA axis regulation 
(Gregus et al., 2005). 




4.3.1 Effects of dexamethasone treatment on brain weight and volume 
Various neurobiological studies are focused mainly on specific brain regions but 
overall brain size, sometimes measured by weight and sometimes by volume, is also 
an essential factor which needs to be assessed. The present application of pQCT to 
measure total brain volume is of relevance to volumetric studies on neuroplasticity 
where regional volumes need to be scaled to the total brain volume. 
Glucocorticoid exposure during pregnancy often leads to a reduction in birth weight 
in animal models, including primates and humans (Bloom et al., 2001; Newnham et 
al., 2001). However, another study reported no significant effect on the brain weight 
and growth of the preterm delivered babies treated with single and multiple courses 
of antenatal corticosteroids (Murphy et al., 2001). Similar observations were seen in 
the rats exposed to single betamethasone treatment (Yossuck et al., 2006). 
 
Perinatal corticosteroid exposure is also correlated with a decrease in brain weight. A 
single dose of betamethasone to pregnant sheep at about 70% of gestation resulted in 
a reduction in the brain weight by 10% at term and multiple doses resulted into 21% 
reduction (Huang et al., 1999). Significant brain weight reduction was also reported 
in rhesus monkeys treated prenatally with corticosteroids (Uno et al., 1990). 
Repeated doses of dexamethasone on E17–19 resulted in a significant brain weight 
reduction of the newborn rats (Carlos et al., 1992). In the present study no 
differences in brain weight were observed between dexamethasone treated and 
control group.  
 




The brain volume of the adolescents who were born very preterm (i.e. born before 33 
weeks) was reduced by 6% (Nosarti et al., 2002). Another MRI study in primates, 
revealed no significant differences in the brain volume between DEX and vehicle 
group (Uno et al., 1994). The present study also found no treatment effects on the 
whole brain volume as measured by pQCT. One of the factors which can affect the 
brain weight and volume is the amount of corticosteroid administration; in the 
present study only a minimal dose was given. 
4.3.2 Effects of dexamethasone treatment on regional brain volume 
Reductions in the regional brain volume in areas such as hippocampus, amygdala and 
corpus callosum are reported in the premature born children (Abernethy et al., 2002; 
Isaacs et al., 2000). Smaller amygdala, hippocampus, cerebellum, basal ganglia and 
corpus callosum were also found in 25 cases of 8 year old preterm children (Peterson 
et al., 2000). Cortical brain volume decrease by 35% was exhibited in premature 
infants treated with dexamethasone relative to full term controls (Murphy et al., 
2001). On the other hand, Yossuck et al. reported no effect of single betamethasone 
antenatal dose on regional brain volumes, particularly limbic system (Yossuck et al., 
2006). 
 
One of the key regions affected by both perinatal and postnatal exposure to 
corticosteroids is the hippocampus, which develops primarily during foetal period 
(Rice and Barone, 2000). Hippocampal atrophy and volume loss are seen following 
administration of corticosteroids in monkeys and rats (Woolley et al., 1990; Sapolsky 
et al., 1990). Human adolescents who were born very preterm have been found to 




have hippocampal volume loss by 15.6% in the right and 12.1% in the left sides 
(Nosarti et al., 2002).  
 
The present study reports a significant 8% hippocampal volume loss (expressed as % 
of total brain volume) in dexamethasone treated rats when compared with controls, 
even though the total brain volume remains unaffected. No changes were seen in the 
basolateral amygdala and nucleus accumbens volume, which indicates a selective 
treatment effect on the hippocampus. Hippocampus is the region where neuronal cell 
proliferation is pronounced and its volume loss might manifest in impaired 
hippocampus-dependent memory functioning. 
 
The present reduction of the hippocampal volume is moderate but statistically 
significant. Previous publications report a wide range of losses in the hippocampal 
volume across several species. Thus studies have demonstrated an overall 30% 
reduction in the hippocampal volume in the 9 month old juvenile monkeys treated 
with DEX which was later confirmed with MRI study, for long term effect, 
indicating similar volume changes after 2 years (Uno et al., 1994). Coe et al. also 
found hippocampal volume decrease by 12% and 10% in the offspring of rhesus 
monkeys exposed to early (GD 50 to 92) and late (GD 105 to 147) natural acoustic 
startle stressor, respectively (Coe et al., 2003). In animals, four weeks of cortisol 
treatment or psychosocial stress resulted in hippocampal volume loss by 5-10% (Ohl 
et al., 2000). Chronic social defeat stress also showed mild but significant 
hippocampal volume shrinkage in adult rats (Czeh et al., 2010).  




4.3.3 Effects of dexamethasone treatment on cell numbers and 
morphology  
The present findings indicate no significant treatment effects on the total cell counts, 
which suggests no cell loss as such, although it is theoretically possible that  
unidentified neuronal and/or glial cell losses might account for the hippocampal 
shrinkage.      
The present results are consistent with the published animal studies on effects of 
cortisol or chronic stress exposure, using a stereological approach, which showed no 
hippocampal cell loss (Leverenz et al., 1999; Sousa et al., 2002; Vander Beek et al., 
2004 and Vollmann-Homsdorf et al., 1997). A human study also reported no 
evidence of significant cell loss in hippocampus in response to corticosteroid treated 
and depressed patients (Lucassen et al., 2001a; Muller et al., 2001).    
 
The present study focused on the effect of dexamethasone treatment on the astroglia 
cell numbers and morphology. To my knowledge this is the first study to report the 
data on astroglial cell count and morphology estimated by means of stereology in 
adult rats that were prenatally treated with dexamethasone. Although the most 
consistent finding in animals treated with glucocorticoid or exposed to chronic stress 
is a selective reduction in volume of the hippocampus (Fuchs and Flugge, 2003), in 
the studies on the mechanisms underlying the glucocorticoid-induced volume 
reductions, the attention has been focused on neurones. As a result, neuronal cell loss 
is well researched and documented and various dexamethasone treatments were 
found to lead to neuronal loss in rats (Haynes et al., 2001; Sousa et al., 1999) and 
primates (Uno et al., 1990; Sapolsky et al., 1990) mostly in the hippocampal CA3 




and dentate gyrus. However less attention has been given to astroglial cells, the most 
important non-neural cells implicated in the maintenance of brain homeostasis.  
 
Inhibition of glial cell proliferation in response to exogenous glucocorticoids or 
stress were reported in in vitro (Crossin et al., 1997; Sabolek et al., 2006) and in vivo 
(Wennstrom et al., 2006) studies. GFAP is an intermediate filament protein that 
provides support for cell structure and movement, cell communication, and blood–
brain barrier (BBB). Other studies also suggest that treatment with corticosterone or 
synthetic glucocorticoids such as dexamethasone inhibit GFAP expression in the 
neonatal and adult rat brain (Nichols et al., 1990a,b; Laping et al., 1991; Tsuneishi et 
al., 1991 and O’Callaghan et al., 1991) suggesting that astrocytes can be affected by 
glucocorticoid overload. In a clinical context, post mortem studies in depressed 
patients have reported reductions in the numbers of glial cell in the prefrontal cortex 
and amygdala brain regions (Rajkowskal., 2000; Bowley et al., 2002). 
 
Hippocampal volume losses could be also caused by impoverished morphology of 
neurones and/or glial cells as they respond to environmental stimuli. There are 
several animal studies that have documented neuronal dendritic shrinkage after 
corticosterone administration or chronic stress (Magarinos et al., Sousa et al., 2000; 
1996; Wolley et al., 1990; Watanabe et al., 1992 and Morales Medina et al., 2009). 
However, one study observed short term effect in the dendritic reduction (granule 
cells 35%, CA3 25% and CA1 13-20%) which showed improvement in the structure 
later on after the recovery which correlated with marked improvement in behaviour 
(Sousa et al., 2000). In support of astroglial plasticity, one of the recent studies 




reported an increase in astrocytic primary process length in response to the enriched 
environment (Violaa et al., 2009).  
It is now evident that non-genetic/environmental factors acting in early life result in 
permanent alterations of the physiological systems. Perinatal programming and/or 
plasticity of the physiological system in extreme conditions like stress or foetal 
corticosteroid exposure may result in long term abnormalities (Barker et al., 1993; 
Maccaria et al., 2003). Interestingly, similar long-term effects on the adult brain were 
observed in postnatally deprived rats (Shende et al., 2011) suggesting that exposure 
to stressors either prenatally or postnatally regulates the long term brain functioning, 
and in humans is a major aetiological factor in neurological disorders (Pryce et al., 
2011). 
  






To conclude, the present stereological analysis of GFAP-positive astroglia showed 
significant changes in the total and mean primary process lengths in the hippocampal 
subregions CA1, CA3 and dentate gyrus, as a long-term effect of prenatal exposure 
to dexamethasone. It is plausible to assume that these changes contribute to the 
losses in the hippocampal volume found in the same animals. The observed 
dexamethasone-induced impoverishment of astroglial morphology can be treated as a 
demonstration of glial plasticity, a phenomenon that deserves more research in the 
context of effects of corticosteroid overload and stress-related pathologies. 
These lines of evidence support the concept that the perinatal period is indeed a 
sensitive window for neuroplastic changes, which may lead to heightened cell 
vulnerability by determining permanent changes in the expression of molecular 
regulation of neuroplasticity (primarily neurotrophic factors) and in the neurogenic 
process. The regional selectivity of these modifications suggests that such 
vulnerability is not widespread but, instead, affects specific cell populations or 
neuronal pathways. This is of potential  relevance to stress-related psychiatric 
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5.1 Introduction   
As discussed in the Chapters 1 and 4, early life experiences especially during the 
prenatal period, when the nervous system is developing can lead to long term 
consequences. Prenatal stressors such as psychological stress, malnutrition in later 
gestation, maternal viral infection were recently linked to schizophrenia (Sullivan, 
2005; Lee et al., 2007) and autistic disorder (Beversdorf et al., 2005). The various 
types of experimental models of prenatal stress include, but are not limited to, in 
utero glucocorticoid treatment, maternal infection, maternal nutritional deficiency or 
maternal exposure to psychological stress (Meyer and Feldon, 2010). The most 
common animal model widely studied/used for prenatal stressful manipulation is the 
foetal exposure to corticosteroids (Hauser et al., 2006, 2008, 2009; Slotkin et al., 
2006).  
Prenatal exposure to high levels of glucocorticoids affects neuronal cell sensitivity 
and apoptosis of cerebellar granule cells to specific stimuli, such as oxidative stress 
(Ahlbom et al., 2000). Experimental rats exposed to prenatal stress (exposure to 
bright light) showed decrease in the hippocampal granule neuronal cell proliferation, 
decreased BDNF levels (Van Den Hove et al., 2006) and deficits in the learning tasks 
(Lemaire et al., 2000). Altered BDNF and TrkB mRNA expression was also 
observed in response prenatal dexamethasone exposure in rats (Hossain et al., 2008).  
Research published on prenatal stress has reported various alterations in behaviour, 
neuroanatomical architecture, neurochemical functioning and neuroendocrine 
activity. However, less attention has been paid to the role of neuropeptide systems in 
prenatal stress. At the same time, neuropeptides, such as oxytocin and vasopressin 
have been implicated in the regulation of social behaviour (Ferguson et al., 2001; 
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Donaldson and Young, 2008) and in response to stress (Gimpl and Fahrenholz, 
2001). It has been suggested that the timing of the early life stressor either prenatal 
and/or postnatal is critical to the neurochemical development as it can lead to 
behavioural abnormalities in later stages of life.  
There is consensus that GCs such as cortisol in primates and corticosterone in 
rodents play an important role in prenatal programming of the brain and 
neuroendocrine systems. Excessive prenatal exposure to GCs, either endogenous 
under conditions of sustained stress, or exogenous during e.g. dexamethasone 
treatment, can lead to long-term dysregulation of GC receptors and impairment of the 
feedback mechanism, which controls the HPA axis and its reactivity to stress. Such 
dysregulation can have long-term neuro-behavioural implications (Welberg and 
Seckl, 2001). 
Foetal exposure to GCs results in the reprogramming of the HPA axis and long term 
changes in the neurotransmitter function (Seckl, 2004). Dexamethasone (Dex) 
administration during late gestation induces anxiety-like behaviour consistent with 
excessive sensitivity of HPA axis in male offspring (Nagano et al., 2008) and 
impairments in startle response (Kleinhaus et al., 2010). The type of above 
mentioned behavioural changes triggered by prenatal exposure to Dex in children 
and experimental animals raises a question whether those implicate oxytocin, which 
plays an important role  in the regulation of social behaviour (Ferguson et al., 2001, 
Gimpl and Fahrenholz, 2001, Donaldson and Young, 2008), anxiety (Windle et al., 
2006) and responses to stress (Gimpl and Fahrenholz, 2001). A link between prenatal 
exposure to DEX and oxytocin is plausible as it has been known that central oxytocin 
receptors undergo changes in the binding during process of neurodevelopment 
 Chapter 5 Prenatal dexamethasone and receptors 
157 
 
(Tribollet et al., 1989).   
5.1.1 Effects of prenatal stress on oxytocinergic system 
The  neuropeptide oxytocin (OT) is synthesised in the paraventricular and supraoptic 
nucleus of the hypothalamus and released into the blood from the neurohypophysis 
and centrally within the brain;  it is known for its important role in sexual functions, 
parturition, lactation and maternal behaviour (Gimpl and Fahrenholz, 2001).  
Oxytocin receptors are regulated by glucocorticoids in the CNS (Insel and Winslow, 
1991; Kremarik et al., 1993). OT is a hypophysiotrophic hormone which under 
stressful situation controls ACTH release. This oxytocin-induced ACTH secretion is 
blocked by adrenal glucocorticoid hormone (Gibbs, 1986). Hence, oxytocin regulates 
the HPA axis functioning by reducing ACTH release which in contrast is helpful in 
treating stress-HPA induced pathologies (Boutet et al, 2006). Preclinical and clinical 
studies have shown that the plasma OT concentrations increase under various 
stressful stimuli such as conditioned fear stimuli, electric foot shocks and restraint 
stress (Onaka, 2004; Pierrehumbert et al., 2010). 
Administration of OT intracerebroventrically is found to regulate sexual behaviour 
(Argiolas and Gessa, 1991) and decrease in anxiety in male rats (Ring et al., 2006)  
and anxiolytic effects (Windle et al., 1997) were also observed in female rats.  In 
humans, intranasal administration of OT result into enhanced trust (Kosfeld et al., 
2005), social support (Heinrichs et al., 2003), positive social memories (Guastella et 
al., 2008) and reduction of aggression and anxiety (Huber et al., 2005; Heinrichs and 
Domes, 2008). 
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Central oxytocin receptors in the brain are expressed by both neurones and glial cells 
(Discalaguenot and Strosser, 1995). In the rat brain oxytocin receptors are found in 
regions such as the limbic system, cortical areas, the basal ganglia and the thalamus 
(Gimpl and Fahrenholz, 2001).  
Studies have reported oxytocin receptor activation in the medial amygdala (Ferguson 
et al., 2001, Timmer et al., 2011) and intracerebral administration of oxytocin in 
amygdala of oxytocin-knockout mice (Winslow and Insel, 2002, Lukas et al., 2011) 
resulting into improved social recognition skills hence suggesting the role of 
oxytocin in the social cognition. Another study concluded decreased oxytocin levels 
in the amygdala and paraventricular hypothalamic nucleus mediated via oxytocin 
receptor alpha and beta involved mechanisms (Choleris et al., 2003). 
Association between oxytocin receptor mRNA and its interaction in the regulation of 
social behaviour in male mice have been confirmed through a gene expression study 
(Murakami et al., 2011). Oxytocin is found to decrease amygdale-mediated fear 
response both in humans (Kirsch et al., 2005) and rodents (Viviani et al., 2011) 
which supports its potential therapeutic use for clinical related fear conditions (Bartz 
et al., 2011). Oxytocin also facilitates hippocampal neurogenesis and neural 
proliferation in adult rats following dexamethasone overexposure suggesting its 
neuroprotective role (Leuner et al., 2011). 
Oxytocinergic system can play a role in the pathophysiology of various mental 
disorders such as autism (Andari et al., 2010), schizophrenia (Rubin et al., 2011) and 
borderline personality disorders (Simeon et al., 2011).  A significant reduction in 
cortisol levels after the social stress exposure in individuals with low emotional 
regulation has been observed (Quirin et al., 2011). 
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A strong interaction between the oxytocinergic system (part of the neurohypophysial 
system) and HPA axis (regulator of stress system) by means of the bidirectional 
regulatory mechanism has been suggested (Engelmann et al., 2004). Stressful 
experiences in the form of foot shock and forced swimming has been found to 
increase the central oxytocin secretion in both male and female rats (Bruhn et al., 
1986). Disruption in the oxytocin activity and learning and memory tasks was 
observed under the glucocorticoid administration (0.02 mg/kg -  intraperitoneal) in 
rats (Furstenau de Oliveira et al., 2007). Prenatal corticosteroid exposure leads to 
decrease in the oxytocin mRNA levels in the hypothalamic paraventricular nucleus 
and an increase in the oxytocin receptor binding in central amygdala (Lee et al., 
2007). Oxytocin receptor binding is also reduced in the rats underwent maternal 
separation (Lukas et al., 2010).       
Human studies have also reported altered oxytocin status in relation to early life 
stress and depressive traits (Heim et al., 2009; Opacka-Juffry and Mohiyeddini, 
2011). 
Considering the fact that the oxytocinergic system undergoes alterations during the 
prenatal – foetal nervous system development  it is plausible to hypothesise that 
oxytocin receptor binding will be affected by prenatal dexamethasone exposure 
(Tribollet et al., 1989). Previous studies also suggest altered oxytocin receptor 
system was brain region dependent in response to early life stress experiences (Lee et 
al., 2007).  
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5.1.2 Effects of prenatal stress on serotonergic system 
There is strong correlation between the brain serotonin system and the HPA axis and 
alteration in any one of them can result in functional impairment (e.g. Holmes et al., 
1995). These systems are found to be impaired by stress and/or depression 
(Bhagwagar et al., 2002). 
As mentioned earlier, links between prenatal corticosteroid exposure and various 
psychological, behavioural and cognitive disorders are demonstrated in animal 
experiments (Huizink et al., 2002, Charil et al., 2010). Studies have reported changes 
in the glucocorticoid receptor expression which in turn leads to HPA axis 
destabilisation (Takahashi et al., 1991; Shoener et al., 2006) in rats exposed to high 
synthetic glucocorticoid levels.  The HPA axis activity is also regulated by the 
serotonergic system (Klaassen et al., 2002).  
Serotonin or 5- hydroxyl tryptamine (5-HT) is the key regulator in various forms of 
behaviours including sleep, mood and emotions (Stockmeier, 2003; Slotkin et al., 
1996). Serotonin pathways and receptors are involved in the aetiology of depression 
and its treatment, with the 5HT-1A receptor being most likely implicated (Hoyer et 
al., 2002; Stockmeier, 2003).  
5HT-1A receptors exist as presynaptic somatodendritic autoreceptor mainly found in 
the raphe nuclei and postsynaptic heteroreceptor mainly found in cortex and limbic 
system (Drevets et al., 2007). The presynaptic autoreceptors mainly function to 
inhibit neuronal firing and reduce serotonin release (Celada et al., 2001). Both the 
pre and postsynaptic 5HT-1A receptors have a substantial effect on the stress and 
anxiety as summarised below.  
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Exposure to stress and glucocorticoids has prominent effects on the expression of the 
5HT-1A receptor expression (Leonard, 2005). Over-expression and increased 
production of 5HT-1A receptor mRNA is seen around the gestational day (GD) 12 in 
rats (Hillion et al., 1993) and high concentration of 5HT-1A receptor binding in the 
human embryonic brain is observed in the cortex and hippocampus at the age of 16 - 
22 week during pregnancy (Olmo et al, 1998, Andrews et al., 2004). During 
depression both the HPA axis and the serotonergic system is found to be abnormal 
(Slotkin et al., 1996).  
It has been suggested that an increase in the presynaptic 5HT-1A receptor in the 
raphe nuclei can act as an anti-anxiety factor (Andrews et al., 1994) but increase in 
the postsynaptic 5HT-1A receptor located in the hippocampus and amygdala may 
lead to anxiety (Holmes et al., 1994). The deletion of the 5HT-1A receptor in mice 
showed an increase in the anxiety like behaviour in the open field and novelty 
suppressed feeding paradigms suggesting the importance of the 5HT-1A receptor 
(Gross et al., 2000). Presynaptic 5HT-1A receptors inhibit the tyrosine hydroxylase 
synthesis which can result in serotonergic suppression (Stockmeier, 2003). 
Experimental animal studies have also reported an increase in the serotonin turnover 
in the nucleus accumbens, hypothalamus and amygdala regions under stress exposure 
(Holmes et al., 1994). Serotonin receptor sensitivity and density appear to be affected 
by anxiety (Harvey et al., 2003).  
The 5HT-1A receptor is the main element of the serotonin system which is involved 
in the aetiology and treatment of depression (Hoyer et al., 2002; Savitz et al., 2009). 
5HT-1A receptors are found majorly in the limbic system of the brain in particular in 
the hippocampus (Andrews et al., 2003). Reduction in the 5HT-1A receptor was seen 
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in the patients suffering from depression (e.g. Drevets et al., 2007) along with high 
levels of glucocorticoid hormones (Holmes et al., 1995; Stockmeier, 2003). 
Glucocorticoid exposure results in altered 5HT-1A receptor binding which could be 
the possible reason to the less therapeutic response of the serotonin receptor agonist 
in the depression (Savitz et al., 2009).  
5.1.3 Aims and Hypotheses 
 
The present study aimed to investigate the long term effects of prenatal 
dexamethasone administration on the oxytocin and 5HT-1A serotonin receptor 
binding in male and female rats. Brain regions i.e. amygdala, hippocampus, nucleus 
accumbens, ventromedial hypothalamus, lateral septum and raphe nuclei were 
investigated considering their involvement in the key processes like memory and 
learning, stress related conditions, fear, social recognition, reward and pleasure and 
sexual behaviour; where oxytocinergic system also plays a regulatory role in these 
processes (Insel and Young, 2000; Gimpl and Fahrenholz, 2001; Kirsch et al., 2005; 
Ross and Young, 2009). Also, the fact that very few studies have researched the 
prenatal period, as most of the reported studies have analysed the postnatal period, 
motivates the present study. 
The specific hypotheses tested were as follows: 
 Prenatal dexamethasone exposure will result in a significant reduction in the 
oxytocin receptor binding in the limbic brain regions.  
 Prenatal dexamethasone exposure will decrease the 5HT-1A receptor binding 
in the brain regions that regulate stress and depression like behaviour in rats.  
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5.2 Results  
5.2.1 Oxytocin receptor binding  
The autoradiograms of the brain sections labelled with [
125
I] OVTA demonstrate a 
high density of oxytocin receptors in the amygdala, subiculum, nucleus accumbens, 
septal nuclei, ventromedial hypothalamic nuclei and hippocampal subregions (e.g. 




Figure 5.1 – Autoradiograms of Dex treated coronal female rat brain sections 
labelled with [
125
I] OVTA ligand representing the frontal cortex (A), lateral septal 
nuclei (B), dorsal hippocampus (C), ventral hippocampus (D) and raphe nuclei (E) 
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Receptor binding values were higher in control females when compared with control 
males in the prelimbic cortex (F=38.38, p<0.001), lateral septum (F=11.834, p<0.01), 
nucleus accumbens (F=22.60, p<0.001), basolateral amygdala (F=39.93, p<0.001), 
central amygdaloid nucleus (F=66.68, p<0.001), ventromedial hypothalamus 
(F=35.61, p<0.001), dorsal hippocampal CA2 (F=5.15, p<0.05), dentate gyrus 
(F=12.87, p<0.01) and raphé nucleus (F=10.27, p<0.01). Interestingly, control males 
also showed significantly higher oxytocin receptor binding compared to females in 
the subiculum transition area (F=10. 8, P<0.01) and ventral hippocampal CA1 (F=29. 
2, P<0.001), CA2 (F=79. 45, P<0.001) and CA3 (F=10. 52, P<0.01). 
Significant reduction in the oxytocin receptor binding was observed in ventral 
hippocampus (CA1, CA2, and CA3) and PVN region in males and LSD and VMH in 
females. However, a significant increase was seen in the dorsal hippocampal CA2 
and PVN regions in females only.  
A significant main effect of treatment was observed in the basolateral amygdala 
(F=9. 34, p<0.01), and a significant main effect of sex in BLA (F=57. 86, p<0.001) 
and central amygdala (CEM) (F=72. 1, p<0.001) was found. The sex x treatment 
interaction analysis revealed no significant changes in BLA (F=0.003, p>0.05) and 
CEM (F=0.71, p>0.05) regions (Table 5.1). In terms of the OTR binding, no 
significant changes were seen in BLA (males - 16%↑, p>0.05 & female - 11%↑, 
p>0.05) and CEM (males - 3%↓, p>0.05 & female - 11%↓, p>0.05) regions (Figure 
5.2). 
In the present study, post hoc analysis indicated significant reductions in the oxytocin 
receptor (OTR) binding in LSD in Dex treated females (27%, p<0.05) and no effect 
was seen in males (11%, p>0.05) when compared with control. There was also a 
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significant main effect of sex (F=15.31, p<0.01) and treatment (F=7.01, p<0.05) in 
the LSD region. 
Univariate ANOVA analysis showed no significant main effect of treatment in the 
prelimbic cortex (PrL) (F=0.69, p>0.05) and nucleus accumbens (NAcc) (F=0.02, 
p>0.05) regions. However, a significant main effect of sex was seen in the PrL 
(F=94.11, p<0.001) and NAcc (F=40.69, p<0.001) regions. There was also a 
significant reduction in OTR binding in the NAcc region in DEX males (23%, 
p<0.01) but not females, compared to controls. 
 
Figure 5.2 - Oxytocin receptor binding in the prelimbic cortex (PrL), lateral dorsal 
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amygdala (CEM) in male and female rats in response to prenatal dexamethasone 
exposure.  
Data expressed as mean values ± SEM in fmol/mg; n = 6 per group. 
**p<0.01 DEX versus control 
The observed results in the dorsal hippocampal sub areas show significant main 
effects of sex: CA1 (F=8.75, p<0.01), CA2 (F=9.81, p<0.01) and DG (F=28.45, 
p<0.001). In DEX-treated females, there was a significant increase in the OTR 
binding in the CA2 region (67%, p<0.001 versus control). No changes in the OTR 
binding were observed in the other dorsal hippocampal subregions of DEX treated 
males when compared with controls (Figure 5.3). There were significant sex x 
treatment interactions in CA2 (F=28.35, p<0.001) and CA3 (F=5.04, p<0.05) with no 
effects in CA1 (F=4.11, p>0.05) and DG (F=0.49, p>0.05) (Table 5.1). 




Figure 5.3 - Effect of prenatal dexamethasone exposure on the oxytocin receptor 
binding in the dorsal hippocampal sub regions in male and female rats.  
Data expressed as mean values ± SEM in fmol/mg; n = 6 per group. 









Figure 5.4 - Effect of prenatal dexamethasone exposure on the oxytocin receptor 
binding in the ventral hippocampal sub regions in male and female rats.  
Data expressed as mean values ± SEM in fmol/mg; n = 6 per group. 
*p<0.05 **p<0.01 DEX versus control 
 
Significant main effects of sex were observed in the ventral hippocampal CA1 
(F=31.99, p<0.001), CA2 (F=96.68, p<0.001) and CA3 (F=15.94, p<0.01). The OTR 
binding in DEX-treated males showed significant reductions in CA1 (40%, p<0.05), 
CA2 (25%, p<0.05) and CA3 (38%, p<0.01) with no changes in DG, when compared 
with controls. In DEX-treated females, a significant reduction in the OTR binding 
was observed in CA3 (22%, p<0.05) with no significant treatment effects in CA1, 
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interaction between Sex x Treatment in CA1 (F=4.46, p<0.05) with no effects in 
CA2 (F=0.27, p>0.05), CA3 (F=2.17, p>0.05) and DG (F=3.77, p>0.05) (Table 5.1). 
A significant main treatment effect was observed in the ventro-medial hypothalamus 
(F=7.08, p<0.05). A significant reduction was seen in the OTR binding in DEX-
treated females vs control (25%, p<0.01) in the VMH region with no treatment effect 
in males (0.5%, p>0.05) in the VMH region (F=6. 84, p<0.05) (Figure 5.5).  
In addition, there was a significant sex x treatment interaction in the PVN (F=27.42, 
p<0.001) with no effects observed in STR (F=0.33, p>0.05) and raphé nuclei 
(F=0.003, p>0.05, Table 5.1). 
No significant main effect of treatment was observed in the paraventricular nucleus 
(PVN) (F=1.13, p>0.05), subiculum transition area (F=0.18, p>0.05) and raphé (both 
dorsal and ventral) (F=0.09, p>0.05). A significant main effect of sex was found in 
PVN (F=24.49, p<0.001), subiculum transition area (F=19.69, p<0.001) and raphé 
(F=17.73, p<0.001) (Table 5.1). There were significant differences between DEX 
and control groups: OTR binding was significantly reduced in the PVN in males (by 
45%, p<0.01) but increased in females (by 29%, p<0.05) (Figure 5.5). 




Figure 5.5 - Oxytocin receptor binding in the subiculum transition area (STR), raphe 
nuclei, ventromedial hypothalamic nucleus (VMH) and paraventricular hypothalamic 
nucleus (PVN) in male and female rats in response to prenatal dexamethasone 
exposure.  
Data expressed as mean values ± SEM in fmol/mg; n = 6 per group. 
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Table 5.1 - presents the results of a univariate analysis of variance between sex and 
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5.2.2 5HT-1A receptor binding  
 
Tritium-labelled WAY100635 is a selective 5HT-1A antagonist radioligand used for 
in vitro (Khawaja et al., 1995) and in vivo (Hume et al., 1994) studies. The present 
study employed the same ligand to identify 5HT-1A receptors by autoradiography 





Figure 5.6 - Autoradiograms of Dex treated coronal male rat brain sections labelled 
with [
3
H]WAY-100635 tritium ligand representing the dorsal hippocampus (A), 
ventral hippocampus(B), lateral septal nuclei (C) and raphe nuclei (D). 
 
In the present study, 5HT-1A receptor binding was significantly increased in the 
dexamethasone (Dex) treated male rats compared with non treated control in the 
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CA2 and DG sub-regions. Binding was also significantly increased in Dex treated 
female rats versus non treated control in the cingulate and prelimbic cortex, septum, 
nucleus accumbens, ventromedial hypothalamus, dorsal hippocampal DG, ventral 
hippocampal - CA2 and CA3, and basolateral amygdala regions.  
Univariate ANOVA analysis showed a significant main effect of treatment in the 
cingulate cortex (F=24. 38, p<0.001), prelimbic cortex (F=14. 37, p<0.01), lateral 
septum (F=11. 23, p<0.01) and nucleus accumbens (F=21. 62, p<0.001) regions. 
However, no significant main effect of sex or sex x treatment interaction was seen in 
these regions. There was significant increase in 5HT-1A receptor binding in both 
Dex treated males and females compared to controls in Cg (males (174%, p<0.01) 
and females (93%, p<0.05), PrL (males (67%, p<0.05) and females (48%, p<0.05)) 
and the Nacc (males (127%, p<0.01) and females (292%, p<0.05) regions. Only 
females, Dex treated vs controls, showed increase in the LSD region (40%, p<0.05) 
(Figure 5.7). 




Figure 5.7 - 5HT-1A receptor binding in the cingulate (Cg) and prelimbic cortex 
(PrL), lateral dorsal septum (LSD) and nucleus accumbens (NAcc) in male and 
female rats in response to prenatal dexamethasone exposure.  
Data expressed as mean values ± SEM in fmol/mg; n = 6 per group. 





** *  * * * 




Figure 5.8 - 5HT-1A receptor binding in the basolateral amygdala (BLA), 
ventromedial hypothalamic nucleus (VMH) and raphe nuclei in male and female rats 
in response to prenatal dexamethasone exposure.  
Data expressed as mean values ± SEM in fmol/mg; n = 6 per group. 
*p<0.05 DEX versus control 
 
A significant main treatment effect was observed in the basolateral amygdala 
(F=7.09, p<0.05) and ventro-medial hypothalamus (F=5.71, p<0.05). A significant 
increase was seen in the 5HT-1A receptor binding in DEX-treated females vs control 
in the VMH (59%, p<0.05) and BLA (179%, p<0.05) region. No treatment or sex 
effect was seen in the raphe nuclei (Figure 5.8). None of these regions showed 









Figure 5.9 - Effect of prenatal dexamethasone exposure on the 5HT-1A receptor 
binding in the dorsal hippocampus region in male and female rats. 
Data expressed as mean values ± SEM in fmol/mg; n = 6 per group. 
*p<0.05 DEX versus control 
The observed results in the dorsal hippocampal subregions show a significant main 
effect of sex in CA1 (F=8.061, p<0.05). In DEX-treated females, there was a 
significant increase in the 5HT-1A receptor binding in the DG region (24%, p<0.05 
versus control). 5HT-1A receptor binding was increased in the dorsal hippocampal 
subregions of DEX treated males when compared with controls in CA1 (53%, 
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x treatment interactions observed. Significant main effect of treatment was also seen 
in CA1 (F=13.02, p<0.01), CA2 (F=10.25, p<0.01), CA3 (F=6.48, p<0.05) and DG 
(F=13.67, p<0.01) dorsal hippocampal subregions (Table 5.2). 
 
Figure 5.10 - Effect of prenatal dexamethasone exposure on the 5HT-1A receptor 
binding in the ventral hippocampal sub regions in male and female rats.  
Data expressed as mean values ± SEM in fmol/mg; n = 6 per group. 
*p<0.05 DEX versus control 
 
The 5HT-1A receptor binding in DEX-treated males showed no significant changes 
whereas an increase in the binding was observed in females in the CA2 (70%, 
p<0.05) and CA3 (60%, p<0.05) sub regions, when compared with controls (Figure 
* 
* 
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5.10). There was a significant main effect of sex in the CA2 (F=7.22, p<0.05), CA3 
(F=9.61, p<0.01) and DG (F=5.14, 0.05) area. Interaction between sex x treatment 
showed no significant differences. Main effect of treatment was seen in CA1 (F=7.1, 
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Table 5.2 - presents the statistical results of a univariate analysis of variance between 
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5.3.1 Oxytocin receptor binding 
 
The present study findings suggested that oxytocin receptor binding was affected by 
prenatal glucocorticoid treatment. It also indicated sex-dependent differences in the 
oxytocin receptor (OTR) binding amongst the control rats. Study found high 
intensity (24.05±1.21) of OTR binding in the central amygdaloid nucleus (CEM) in 
the females compared to male rats which supports the previously published findings 
(Liberzon and Young, 1997; Viero et al., 2010). 
The secretion and release of oxytocin is oestrogen dependent, which may upregulate 
oxytocin in females and protects females against some of the factors affecting male 
social behaviours (Gimpl and Fahrenholz, 2001). This explains why major changes 
were observed in males compared to females in the present study. 
Oxytocin receptors are widely distributed in the amygdala nuclei and have found to 
play a regulatory role in social recognition in the experimental mice (Ferguson et al., 
2001; Winslow and Insel, 2002) and fear related behaviour in humans (Kirsch et al., 
2005). Male rats exposed to prenatal stress showed significant increase in the levels 
of OTR mRNA expression in the central amygdala (Lee et al., 2007).  
Considering the role of the amygdala in a range of social behaviours (Ferguson et al., 
2001, Winslow and Insel, 2002) and its gender-specific functioning (Choleris et al., 
2003), it is quite plausible to imply that behavioural changes observed in the 
prenatally stressed animals (Lee et al., 2007, Nagano et al., 2008) might be regulated 
by the altered oxytocinergic functioning in the amygdaloid nuclei. Also the fact that 
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development of the amygdaloid nuclei takes place earlier, as compared to the other 
brain regions, in the process of foetal maturation it is possible that prenatal 
dexamethasone treatment might affect the normal development and result into altered 
oxytocinergic systems (Lee et al., 2007). 
The observed significant changes in the lateral septal nuclei region which is involved 
in the stress response (Ebner et al., 2000) supports the previous similar findings in 
the male rats (Lukas et al., 2010) and in female mice (Bales et al., 2011). Currently 
the specific functions of the oxytocin in the lateral septal nuclei remain unclear. 
However, there may be a possible link between the anti-anxiety action of the 
oxytocin (Gimpl and Fahrenholz, 2001) and the involvement of the septum in stress 
response (Ebner et al., 2000) which may suggest the altered mechanism of 
neurobiological response to stress induced by prenatal dexamethasone treatment. 
The role of oxytocin as a regulator in social mating, partner preference and 
attachment which are mediated via nucleus accumbens (Ross et al., 2009a) which 
may suggest involvement of the oxytocin and dopamine pathways via mesolimbic 
reward circuit (Baskerville and Douglas, 2010). Therefore oxytocinergic system 
could play a role in the drug addiction and withdrawal behaviour acting via the 
nucleus accumbens. 
Hippocampus being the crucial region involved in learning and memory processes 
(Woon et al., 2010) and also an area with abundant expression of glucocorticoid 
receptors (Liberzon and Young, 1997) is a likely target in prenatal dexamethasone 
exposure. Oxytocinergic system is also considered to be involved in the learning and 
memory regulation (Gimpl and Fahrenholz, 2001) which makes it a potential target 
to be affected by dexamethasone. 
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Previously decreased OTR expression in the dorsal hippocampus region was reported 
in postnatally stressed rats (Noonan et al., 1994). Glucocorticoids have shown an 
inhibitory effect on the hippocampus-mediated neurogenesis in the dentate gyrus 
(Woon et al., 2010) observed by lower levels of BDNF expression (Lemaire et al., 
2000). Recently, Leuner et al. (2011) has reported that oxytocin supports 
hippocampal neurogenesis and neuronal proliferation in rats in the presence of 
glucocorticoids. Therefore, there is a need for further investigation to understand the 
role of oxytocin in hippocampal neurogenesis, which may become a potential 
therapeutic target.   
Increased levels of OTR expression in the ventral hippocampal region in male rats 
exposed to chronic stress and corticosteroids have been observed (Liberzon and 
Young, 1997). Animal studies suggest an involvement of oxytocin in memory 
regulation (Popik et al., 1992) which suggests a role for the hippocampus. Green et 
al. (2011) observed reductions in the level of GC receptor protein in the 
hippocampus of male offspring exposed to unexpected maternal environmental 
stress, suggesting the link with the altered HPA axis negative feedback mechanism. 
Intracerebral infusion of oxytocin following stress exposure resulted in lower levels 
of GC receptor expression in the hippocampus in rats (Cohen et al., 2010).   
Given the established interactivity of the central glucocorticoid and oxytocinergic 
systems (Gimpl and Fahrenholz, 2001), it is therefore reasonable to suggest that 
prenatal stress exposure inducing reductions in the cerebral GR expression might 
lead to elevated levels of the oxytocin receptors in the particular brain areas, in which 
the interaction between the GRs and the OTRs is intensive. However, this hypothesis 
needs to be expanded to include consideration of the gender-specific regulatory 
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mechanisms in the brain, such as the oestrogen receptors regulation of the OT-Rs in 
various areas. 
In the brain, oestrogen has found to have pronounced effect on the OT receptor 
regulation. Literature suggests increased OTR’s affinity (Caldwell et al., 1994) and 
increase in both density and area of OT binding (Coirini et al., 1991) in the VMH 
nucleus upon oestrogen administration. Oxytocin receptor mRNA expression in the 
VMH was also affected by oestrogen (Devidze et al., 2005). Therefore, the present 
findings of high levels of OTR binding in females in comparison to males could be 
due to the involvement of oestrogen. Observed reductions in the VMH - OTR 
binding in response to dexamethasone exposure prenatally might have similar 
mechanisms involved as seen in the altered VMH mediated sexual functioning and 
behaviour in rats exposed to early life stress (Lukas et al., 2010). 
In the present study the high intensity (25.07±1.02) of OTR binding was seen in the 
subiculum transition (STR) area. The STR has not yet received much attention as its 
particular role in the CNS is not been recognised. However, Lowry (2002) suggests 
that subiculum may play an inhibitory role in the HPA axis reactivity to stress via the 
GABAergic neurones in the median raphe nucleus which project to hypothalamic 
nuclei (Lowry, 2002). Experimental studies in rats have shown high density of OTR 
binding in the subiculum area in the developing brain (Yoshimura et al., 1996, 
Barberis and Tribollet, 1996) suggesting subiculum area may play a regulatory role 
in the HPA axis function (O’Mara, 2005). 
Interestingly, OTR binding in male rats was high in comparison to females which 
suggest gender variable may play a role. Melis et al (2009) reported oxytocin 
administration into the ventral subiculum resulted into increase in the levels of 
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dopamine in the nucleus accumbens and penile erection in male rats. The observed 
findings were concluded as ventral subiculum region might play a role in the reward 
and motivation behaviour via the mesolimbic dopaminergic reward pathway (Melis 
et al., 2009). Hence, it is justified to assume subiculum play a diverse role in the 
CNS, especially in relation to stress and reward pathway and needs further 
investigation.   
 
5.3.2 5HT-1A receptor binding 
The present study results highlight the observed altered brain regional sensitivity to 
prenatal dexamethasone exposure on the 5HT-1A receptor binding. However, there 
are only limited previous published data with which the present study can be 
compared (Fernandes et al., 1997; Andrew et al., 2003; Slotkin et al., 2006). 
The interaction between the corticosteroids and the serotonergic system was first 
studied using autoradiography where increase in the 5HT-1A receptor binding was 
observed in the rats which underwent bilateral adrenalectomy after one week (Biegon 
et al., 1985). 
Slotkin et al (2006) observed a significant increase (25% higher than the control) in 
the 5HT-1A receptor binding in brain subregions in rats exposed to dexamethasone 
during the GD 17-19 (0.05mg/kg dose). These Dex effects have been more 
pronounced in males (13%) than females (5%); they have been dose dependent 
(Slotkin et al., 2006).  The present data are also in line with the above mentioned 
studies since as an increase in the 5HT-1A receptor binding was observed in 
response to dexamethasone administration (E16–E19, 0.5 mg/ml – present study). 
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Most of the previously published studies on the effects of glucocorticoids have 
focused on the hippocampal region considering its involvement and function in the 
CNS, e.g. (Fernandes et al., 1997; Andrew et al., 2003). The present study analysed 
several brain regions which also play an important part in emotional and cognitive 
behaviour and cognition. Previous studies have indicated that early stress exposure in 
the form of prolonged maternal separation did not influence the 5HT-1A receptor 
density or its mRNA expression in the dorsal raphe nucleus in rats (Arborelius et al., 
2004). Whilst there is a discrepancy in the published data as to the direction of 
changes observed in the 5HT-1A receptor binding when analysed post mortem in 
depression (Stockmeier, 2003).  
An increase in the 5HT-1A receptor density within the amygdala nuclei has been 
reported in adult rats exposed to brief maternal separation (Vicentic et al., 2006). The 
present study found an increase in the 5HT-1A receptor binding in the basolateral 
amygdala in female rats in response to prenatal dexamethasone administration. 5HT-
1A receptor changes can play a role in disinhibiting amygdala responses to emotional 
stimuli (Fisher et al., 2006), potentially contributing to the pathological emotional 
behavior associated with mood disorders (Drevets & Raichle., 1992; Drevets, 2001). 
The present study observed an abnormal increase in the cingulate and prelimbic 
cortex region, with no changes in the raphe nuclei in terms of the 5HT-1A receptor 
binding. These findings indicate an increase in the 5HT-1A receptor binding in the 
cortex could play a role in modulating the 5-HT release during stress (Haddjeri et al., 
2000). It also seems that 5HT-1A receptor in raphe nuclei is not sensitive to 
circulating corticosteroids (Chalmers et al 1993). 
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A reduction in the 5HT-1A receptor sensitivity in the raphe nucleus in rats exposed 
to chronic dexamethasone treatment has been reported (Fairchild et al., 2003). In 
early deprived male Wistar rats 5HT-1A receptor binding has been significantly 
reduced in the cingulate and motor cortex and in the dorsal raphe nuclei 
(Leventopoulos et al., 2009).  Significant decrease in 5HT-1A receptor binding in 
vivo was found in the raphe in depressed patients (Drevets et al., 2000, 2007). 5HT-
1A receptor binding in raphe nuclei was found to reduce (Kassir et al 1998) and 
increase (Stockmeier et al 1998) in suicide victims compared to controls. However, 
there is a discrepancy in the findings of the 5HT-1A receptor binding in the cortex 
region where no difference between suicide and control samples has been found 
(Arranz et al 1994; Matsubara et al 1991; Stockmeier et al 1997) and in another study 
in suicide victim’s increase was seen (Arango et al 1995).  
Studies have shown changes in the glucocorticoid level affecting the function and the 
expression of the 5HT-1A receptors in the hippocampus (Rasmuson et al., 1998). 
Hippocampus is one of the most studied and affected region against the 
glucocorticoids for the obvious reason being, as high density of 5HT-1A receptors is 
expressed in the hippocampus (Zhong et al., 1995) and due to its important function 
in CNS. Hippocampus plays an important modulatory role in the affective and 
cognitive function (De Kloet et al., 1991). Enriched environment also results in the 
elevation of the hippocampal 5HT-1A receptor mRNA expression in rodents 
(Rasmuson et al., 1998). The highest number of glucocorticoid receptors has been 
found in the hippocampus region making it more sensitive to corticosteroid exposure 
(Harvey et al., 2003). 
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Substantial decrease has been observed in the 5HT-1A mRNA in the hippocampus in 
rats (Lopez et al., 1999). Leventopoulos et al (2009) reported a reduction in the 
motivation for reward and the suppression of 5HT-1A binding in anterior ventral 
hippocampal CA1, ventral dorsal raphe and cingulate cortex in early deprived Wistar 
rats. A significant reduction in the 5HT-1A receptor binding in the hippocampus was 
found in rats exposed to corticosteroids subcutaneously (Fernandes et al., 1997). The 
present study findings supports the earlier observations by Andrew et al. (2003) 
supports where  the effect of dexamethasone on 5HT-1A receptors in guinea pigs 
exposed for 3 weeks during pregnancy period showed significant increase in the 
expression of the 5HT-1A receptors in the hippocampal CA1 and DG sub region 
(Andrew et al., 2003). 
However, it is important to note that most of the previous studies were in response to 
postnatal manipulations and only a few studies reported effects of prenatal 
glucocorticoid exposure on the serotonergic system. 
It is of relevance to point out that in the present study male rats showed a significant 
increase in the 5HT-1A receptor binding in the dorsal hippocampal subregions and 
not in the ventral hippocampal sub-regions. It could be due to the functional 
involvement of these regions: dorsal hippocampus is largely implicated in learning 
and memory whilst ventral hippocampus is involved in emotional processing 
(Bannerman et al., 2004). 
   
Moreover, the hippocampal mediated learning and memory process is understood 
and animal studies have also shown that prenatal glucocorticoid therapy results into 
disruption of these processes (Emgard et al., 2007; Noorlander et al., 2007). Present 
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study findings might also suggest that 5HT-1A dysfunction can be the factor 
involved in the suppression of hippocampus-mediated function. 
Considering the literature and present study findings along with general speculations 
the following possibilities could be the reason for 5HT-1A receptor alterations. 
Possible mechanism underlying the increase in the 5HT-1A receptor binding could 
be due to the changes in the HPA axis programming, which occur at the time of 
dexamethasone treatment. It is reported that dexamethasone administration during 
the third week of gestation (14-19) results in the HPA axis alteration in the 
developing neuroendocrine system (Shoener et al., 2005, 2006). Dexamethasone 
exposure results in the maternal cortisol level reduction and dexamethasone 
preferentially binds to the GR receptors, which in turn alters the negative feedback 
regulation of 5HT-1A expression (Meijer & De Kloet, 1994; Welberg & Seckl, 
2001). Therefore, this disruption may lead to the increase in the 5HT-1A receptor 
upregulation.     
Another plausible explanation for the altered 5HT-1A receptor system links with 
membrane cholesterol. Studies have shown that increase in the cholesterol 
concentration could have a direct impact on the affinity of 5HT-1A receptors 
(Pucadyil & Chattopadyay, 2004).  However, not many research studies have been 
carried out on the link between cholesterol and serotonin system under corticosteroid 
exposure but the increase in corticosterone is coupled to an increase in plasma 
cholesterol level (Barker, 1995).  Further, it is known fact that 5HT-1A receptors are 
GPCRs that require cholesterol to function properly which also support the idea of 
cholesterol contributing to 5HT-1A receptor function (Peirce et al., 2002; Pucadyil & 
Chattopadyay, 2004). Further research should address the relationship between 
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corticosterone production and elevation in the brain cholesterol levels seen under 
stressful situation.   
 
Interestingly, Slotkin et al (2006) have suggested that the effects of dexamethasone 
on the 5HT-1A receptor upregulation were observed regardless of serotonin levels. 
Ideally, an increase in 5HT-1A receptors due to the presynaptic serotonin release 
may lead to compensatory down-regulation of the postsynaptic receptors (Slotkin et 
al., 2006). However, this disconnection indicates an important mechanism underlying 
the effects of dexamethasone on serotonergic system activity.  
Therefore, the present study findings and the previously reported literature suggest a 
myriad of interactions between the hypothalamic-pituitary adrenal axis and the 
serotonergic system (Chaouloff 1993), including findings that corticosteroids may 
attenuate post-synaptic 5HT-1A receptor function (Joels et al. 1991; Haleem 1992). 
This has led to the suggestion that the impairment in serotonergic neurotransmission 
seen in depression may be caused by the action of corticosteroids (Young et al. 1994) 
and it is plausible to assume possible mechanisms via which the observed 5HT-1A 
receptor changes might causally contribute to the behavioural changes seen in stress 









Prenatal dexamethasone exposure induced significant alterations in the oxytocin 
receptor and serotonin 5HT-1A receptor binding in a number of brain regions, which 
regulate responses to stress, social cognition, emotional and sexual behaviour. These 
findings are particularly important as they emphasise the potential long-term 
responses to foetal overexposure to glucocorticoids and highlight the significance of 
a multifaceted interactions between the cerebral neuroendocrine system and neural 
adaptation to stress. It is tempting to extrapolate the present findings to human 
conditions supporting concern over widespread glucocorticoid therapy for pregnant 
women (Koenen et al., 2007). Considering the role of oxytocin and serotonin system 
in the central nervous system and in the mediation and regulation of social 
behaviour, the present findings suggest a need for further investigation of the roles of 
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As observed in the Chapters 3 and 4, postnatal early deprivation and prenatal 
dexamethasone exposure results in altered glial cell morphology in the form of 
reduced primary process length. Therefore, the present study has led to a further 
investigation of the in vitro effects of dexamethasone (Dex) exposure on neural stem 
cells (NSC)  assessing glial cell markers. 
As mentioned in Chapter 1, glucocorticoids (GCs) are important hormones which 
play a critical role in the intrauterine programming during the developmental period. 
GCs are involved in various functions – they control and regulate receptor 
expression, enzymes, various growth factors, ion channels and can act directly on 
genes and/or indirectly, affecting, other hormones (Buckingham, 2006). It is also 
well known that GCs are important for the adaptation to stress; still excess GC 
secretion can cause adverse effects on the central nervous system (de Kloet et al., 
2005; McEwen, 2007).  
Dex, a synthetic glucocorticoid, is used in many studies on GC effects both in vivo 
and in vitro. Previous studies have reported GC effects on neurodevelopment such as 
stunting of somatic growth, outright cerebral atrophy, and endocrine disruption 
(McEwen, 1992; Fuxe et al, 1994; Matthews, 2000; Maccari et al, 2003; Welberg 
and Seckl, 2001). Previous research studies have also reported Dex exposure leading 
to decreased cell proliferation (Noorlander et al., 2008), apoptosis (Yu et al., 2010), 
reduced cell size (Kreider et al., 2006) and ability to retard neuronal migration 
(Fukumoto et al., 2009). GC administration in rodents affects hippocampus, 
hypothalamus, cortex and cerebellum by an increased programmed cell death 
(Duksal et al., 2009; Zhang et al., 2002; Li et al., 2010). Experimental studies also 
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suggest that stress and glucocorticoids are among the potent inhibitors of 
neurogenesis in the adult dentate gyrus (Czeh et al, 2002; Mirescu & Gould, 2006). 
A decrease in the rate of neurogenesis in the adult hippocampal dentate gyrus has 
shown to account for the hippocampal volume loss (Henn & Vollmayr, 2004; Czeh 
& Lucassen, 2007). 
It has been shown that the production of various cytokines is differentially affected 
by GCs, both in vivo and in vitro (Barnes, 1996; Brattsand and Linden, 1996). 
Cytokines, known as immunomodulating agents, mediate the neural components of 
the host response to infection and are involved in the neurodegenerative processes 
resulting from brain trauma, ischaemia and chronic neurodegenerative diseases. 
However, they are also involved in CNS repair and recovery (Molina-Holgado and 
Molina-Holgado, 2010). Interleukin- 1β (IL-1β), an important pro-inflammatory 
cytokine, is involved in the development of brain inflammatory responses during 
infection, trauma and neurodegenerative processes (Hopkins and Rothwell, 1995; 
Dinarello, 1998). IL-1β plays a key role in a number of brain pathologies by inducing 
astrogliosis and promoting neuronal cell death directly or indirectly via the 
production of toxic mediators such as inflammatory cytokines, reactive oxygen 
intermediates and nitric oxide (Sparacio et al. 1992; Lee et al. 1995; Rostworowski et 
al. 1997; Pearson et al. 1999). However, brain injury is associated with an enhanced 
release of glucocorticoids (due to HPA axis activation) which inhibits IL-1β 
production and transcription (Berkenbosch et al. 1987; Lee et al., 1988; Linden and 
Brattsand, 1994). 
Astroglial cells, known to be regulated by glucocorticoids, play a pivotal role in brain 
inflammation in response to trauma, ischemia and infection, and are the most 
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important cell type involved in the tissue repair in central nervous system (Ridet et 
al. 1997; Newman, 2003). As it has been reviewed in the general introduction, 
impaired astroglial function is reported in many medical conditions (Seifert et al., 
2006) such as loss and morphological alteration in depressive disorders (Bowley et 
al., 2002; Rajkowska and Miguel-Hidalgo, 2007) and astroglial overactivation and 
hypertrophy in Alzheimer’s disease (Mrak and Griffin, 2005). Evidence also 
suggests that glucocorticoids produced during an inflammatory response may 
directly modulate astrocyte functions and inhibit astrocyte proliferation (Crossin et 
al. 1997; Huang and O'Banion 1998; Pousset et al. 1999). A recent study also 
demonstrates the importance of astrocytic functioning and IL-1 signalling, being 
critical for the hippocampal-dependent learning and memory processes (Ben 
Menachem-Zidon et al., 2010). 
Therefore, the purpose of the present study was first to study the effects of the 
synthetic glucocorticoid Dex on the expression of the glial marker, glial acidic 
fibrillary protein (GFAP), and secondly, the proliferation, differentiation and fate 
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6.1.1 Aims and Hypotheses 
As dexamethasone affects the volume of hippocampus in a long-term, and as adult 
hippocampal plasticity implicates neurogenesis, the present study evaluated the 
effects of dexamethasone on the proliferation and differentiation of neural stem cells. 
The specific research questions were as follows: 
Does in vitro dexamethasone treatment affect the cell survival? 
Does dexamethasone treatment result in a reduction in the proliferation and glial cell 



















6.2.1 LDH cytoxicity assay 
 
LDH analysis indicated no significant treatment effect in wild type (WT) [F (3, 8) = 
3.030, p>0.05] mice. (ANOVA with Post Hoc - Tukey test, n=4 per group). 
 
Figure 6.1 – LDH assay reveals no cell death under Dex exposure (0.1, 1 and  10 
µM) in NSC cultures (t=24h) from WT mice.  
(Data are presented as mean±SEM, n=4 per group) 
 





Dexamethasone treatment induces decrease in the proliferation of neural stem cells in 
WT [F (3, 12) = 4.180, P<0.05] mice assessed by total cell numbers in a dose 
dependent manner (Figure 6.2). However, Control x 10µM dose showed high 
significant difference in both WT (P<0.05) mice. (ANOVA with Post Hoc - Tukey 
test, n=4 per group). 
Figure 6.2 – Dexamethsone treatment showed a decrease in the proliferation (t=48h) 
rate of NSC from WT mice.  
(Data presented as mean ±SEM, n=4 per group) (*p<0.05, **p<0.01) 
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6.2.3 Differentiation  
 
Dexamethasone treatment results into decrease in the differentiation of GFAP 
positive cells in WT [F (3, 12) = 5.458, P<0.05] mice assessed by GFAP positive cell 
numbers. However, Control x 10µM dose showed high significant difference in WT 
(P<0.05). (ANOVA with Post Hoc - Tukey test, n=4 per group). 
 
 
Figure 6.3 – Decrease in the number of GFAP positive cells was seen in WT mice 
with dexamethasone exposure (t=48h).  
(Data are presented as mean ±SEM, n=4 per group). *p<0.05 vs control. 
 









Figure 6.4 - The micrographs represent the role of dexamethasone in the 
differentiation of the NSC from WT mice. Dexamethasone induces a decrease in the 
differentiation of GFAP positive cells (indicated by white arrow) in WT mice in 
different concentration dependent manner.  
Panels show phase contrast images of untreated NSC (Cont – A) and NSC exposed 













Figure 6.5 – The micrographs represent the effect of Dex on GFAP (red) (indicated 
by white arrow) and S100 (green) (indicated by yellow arrow) positive cell 
differentiation in WT mice. Dex induces a decrease in NSC proliferation in different 
concentration dependent manner. 
Panels show phase contrast images of untreated NSC (Cont – A) and NSC exposed 









The astroglial changes observed in the rats exposed to prenatal dexamethasone (Dex) 
(E16-19) (refer Chapter 4) and underwent early deprivation (P1-14) (refer Chapter 
3), in patients suffering from depression (Bowley et al., 2002), in relation to stress 
(Leventopoulos et al., 2007, Czeh et al., 2010) and its involvement in brain plasticity 
(Jauregui-Huerta et al., 2010) supports to the further analysis of in vitro effects of 
Dex on neural stem cells (NSC). Therefore, the present study aimed to identify the 
effects of Dex on the GFAP positive astroglial cell proliferation, differentiation and 
its cytotoxicity in NSC.       
6.3.1 Impact of dexamethasone on astroglial cell 
The present study findings indicate that transient exposure of NSC cultures to 
dexamethasone limits proliferation of neural progenitors. Dexamethasone also 
decreases the GFAP positive cell differentiation in WT mice.  
As described previously (Chapters 1 and 4), preclinical and clinical studies have 
found damaging effects of dexamethasone exposure which leads to disruption of 
HPA axis (Seckl, 2004), reduction in glial cell proliferation both in vitro (Crossin et 
al., 1997) and in vivo (Wennstrom et al., 2006). Neurodevelopmental delay and 
cerebral palsy along with differences in morphology and structure of the offspring’s 
brain treated with dexamethasone have also been reported (Halliday, 2002; Murphy 
et al., 2001; Choi et al., 2004). 
On the other hand, clinical studies have shown Dex to induce protective effects 
against the damaging effects resulted from the CNS inflammatory response and 
lumbar cerebrospinal fluid (CSF) pressure resulting from bacterial meningitis (Lebel 
et al., 1988; Odio et al., 1990). Dex therapy is also found to decrease the 
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concentrations of IL-1β and TNFα in CSF of patients with bacterial meningitis 
(Mustafa et al., 1989). Hence these findings indicate Dex plays a neuroprotective role 
in the bacterial meningitis by reducing the IL-1β  levels in the CNS.  
The present study findings suggest that Dex affects the proliferation of NSCs. In 
support of these findings, Bose et al. (2010) have also found that Dex  (1µM, t= 48 h) 
leads to decrease in the proliferation of NSC with no changes seen in the cell 
viability or differentiation. Sundberg et al. (2006) also reported a decrease in the 
NSC proliferation in rats exposed to Dex (100µg/kg, t=72 h) during the prenatal 
period (E14). In terms of cellular mechanisms, the decrease in NSC number induced 
by Dex that was observed in the present study was not associated with an increase in 
cell death which evidently indicated an alteration in the proliferation and or 
differentiation rate.  
Astrocytes play a major role in restoring homeostasis to the damaged brain and IL-1β 
regulates multiple astrocytic responses after injury (Basu et al., 2004; John et al., 
2005). It is also know that astrogliosis and astroglia function play a crucial role in the 
pathogenesis of many neurological disorders (Mucke & Eddleston, 1993; Basu et al., 
2002). In inflammation an increase in the size and number of astroglia cells is 
observed in the guinea pig ileum (Gabella, 1984; Bradley; 1997).  
6.3.2 Dexamethasone cytotoxicity in brain cells 
The current study findings suggest that the presence or absence of Dex did not affect 
the NSC survival and had no toxic effects on NSC in the presence of dexamethasone 
confirmed by LDH cytotoxicity test.   
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6.3.3 Effect of dexamethasone on neuronal and glial cells in vitro 
Glucocorticoid hormone, in order to mediate its function, acts via its receptors that 
have been identified in vitro in both neurones and astroglia (Chou et al.1991; Bohn et 
al. 1994). Studies have also shown that in vitro, glucocorticoids suppress the 
production and activities of proinflammatory cytokines on cells of the monocyte-
macrophage lineage and astrocytoma cell lines (Kern et al. 1988; Lew et al. 1988; 
Nishida et al. 1989). It is also known that cytokines in association with the activated 
glia may affect or regulate neuronal function (Srinivasan et al., 2004). Hence the 
present study aimed to identify the effect of dexamethasone on the neuronal and 
astroglial cell in a concentration dependent manner. No changes were seen in the 
beta III positive neuronal cells in WT mice. 
 
6.4 Conclusions 
Transient exposure of neural stem cell culture to Dex limits proliferation of neural 
progenitors, which is manifested by an decrease of NSC differentiation rate, 
evaluated by cell numbers in a concentration dependent manner. Dex treatment also 
affects the GFAP differentiation in NSC from WT mice. 
Cytotoxicity tests (LDH assay) suggest that Dex does not affect NSC survival and 
has no toxic effects on NSC.  
The present study provides evidence, in support to Chapter 4, for the effects induced 
by Dex in NSCs and supports the idea that prenatal exposure of GC may induce 
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The aim of the present study was to investigate the long term effects of early life 
stress, during the prenatal and postnatal period, with a main focus on the brain 
remodelling in relation to the regional volume and astroglial morphology in adult 
rats. 
7.1 Highlights of the present findings 
Study 1 – Long term effects of ED on the hippocampal volume and astroglial cell 
morphology (Chapter 3) 
This study was carried out in male adult Wistar (stress normo-responsive) and Lewis 
(stress low-responsive) rats which underwent postnatal manipulations in the form of 
ED and EH, using the model of early life deprivation developed at the animal facility 
of the Swiss Federal Institute of Technology, Schwerzenbach, Switzerland. The 
results obtained in this study indicate that postnatal ED resulted in a region specific 
hippocampal volume loss (by 12.5%) in Wistar’s with no changes in Lewis rats. 
Significant differences were not seen in the basolateral amygdala and nucleus 
accumbens in both Wistar and Lewis rats. ED in Wistar rats also affected GFAP-
positive astroglial cell morphology in the dorsal hippocampus – a significant 
reduction in the primary process length and number was observed. ED did not affect 
the total brain volume measured by using the pQCT scanning technique. 
Study 2 - Prenatal dexamethasone exposure affects hippocampal volume and 
astroglia morphology (Chapter 4) 
In this study, male adult Sprague Dawley rats exposed prenatally to dexamethasone 
(glucocorticoid) were studied as an animal model of stress-related prenatal 
manipulations established at the Faculty of Medicine, Imperial College London, UK. 
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Moderate yet significant volume loss (by 8%) and reduction in the astroglial primary 
process length was observed with no changes in the total and astroglial cell number 
in the hippocampus. No treatment effects in the total brain volume were seen as 
measured by means of pQCT.  
Study 3 – Altered oxytocin and 5-HT1A serotonin receptor system in male and female 
adult rats exposed prenatally to dexamethasone (Chapter 5)  
It was an extension of study 2 with an aim to investigate effects of prenatal exposure 
to dexamethasone on the selected neuro-regulatory processes implicated in responses 
to stress and glucocorticoids. The findings indicate a decrease in the oxytocin 
receptor binding in the Nacc, ventral hippocampal CA1, CA2 and CA3 and in the 
PVN region in males. In females, a decrease was seen in the LSD, ventral CA3 and 
VMH regions. An increase in the oxytocin receptor binding was observed in dorsal 
CA2 and PVN region in females.  
5-HT1A receptor binding was found to be increased in Cg, PrL, Nacc, dorsal – CA1, 
CA2 and DG in males. In females, increase was observed in the Cg, PrL, Nacc, LSD, 
ventral - CA2 and CA3, dorsal DG, BLA and VMH regions. 
Study 4 – Dexamethasone affects proliferation and differentiation of the neural stem 
cells in a concentration dependent manner (Chapter 6) 
The aim of this study was to investigate the effects of dexamethasone on the 
expression of the glial marker GFAP in the NSC proliferation and differentiation. 
Cortex-derived NSCs of C57BL/6J - WT mice were exposed to dexamethasone at 
several concentrations (0.1 µM, 1 µM and 10µM). Cytotoxicity assay did not show 
dexamethasone dependent cell death. A decrease in the NSC proliferation rate was 
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observed in response to increasing Dex concentration. The study also found a Dex-
dependent reduction in the GFAP positive cell differentiation.  
 
7.2 Present findings on the background of existing research 
The outcomes of the present study 1on the postnatal early deprivation, and study 2 on 
the prenatal dexamethasone exposure, indicate that both prenatal and early postnatal 
environmental manipulations lead to a region-selective hippocampal volume loss. 
The present hippocampal volume reductions corroborate the observations reported in 
the clinical studies in human patients suffering from depression (Viderbech and 
Ravnkilde, 2004), PTSD (Apfel et al., 2011), following sexual abuse (Sapolsky, 
2000) and childhood neglect (Teicher et al, 2004), and in the experimental studies on 
chronic psychosocial stress in the tree shrew (Czeh et al., 2006), early life 
deprivation in rats (Lehmann et al., 2002; Opacka-Juffry et al, 2008) and 
corticosteroid exposure in primates (Uno et al., 1990; 1994).  
Hippocampus is the region involved in, the processes of learning and memory and 
the regulation of the HPA axis functioning. It is sensitive to stress and stress 
hormones; its cells express abundant glucocorticoid and mineralocorticoid receptors 
(de Kloet et al., 2005) and adult hippocampus shows neuronal cell proliferation 
(Gould et al, 1997; Czeh et al, 2002; Mirescu & Gould, 2006). The present 
hippocampal volume losses, apparently modest, in the range of 8% - 10% are similar 
in their extent to the changes reported in humans (Cambell et al, 2006; Videbech & 
Ravnkilde, 2004). They may have behavioural implications in the form of 
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hippocampus-dependent memory malfunctioning (Woon et al., 2010). However, the 
limitation of the present study is a lack of direct behavioural observations. 
Study 3 also found altered oxytocin and 5-HT1A receptor binding in the 
hippocampus region. It is known that the hippocampus, apart from the above 
mentioned abundant expression of glucocorticoid and mineralocorticoid receptors, 
also has a high density of 5-HT1A receptors (Zhong et al., 1995).  
The central 5-HT1A receptor undergoes alterations in response to stress (Lopez et 
al., 1999; Arborelius et al., 2004) and depression (Drevets et al., 2007). The HPA 
axis effects on 5-HT1A receptor binding has been suggested in the hippocampus 
region (Lucki et al., 1998).  
Dex administration during the prenatal period (G14-19) results in the HPA axis 
alteration in the developing neuroendocrine system (Shoener et al., 2005, 2006). As 
mentioned earlier, hippocampus plays a role in the CNS, is involved in the HPA axis 
negative feedback mechanism and the rich presence of 5-HT1A receptors, makes it 
an important brain region and likely target in stress related disorders.  
ED has shown to affect the HPA axis functioning with attenuated ACTH and 
corticosterone stress responses in rats (Nunez et al., 1996; Pryce et al., 2001; 
Lehmann et al., 2002). Elevated glucocorticoid levels are being observed with ED in 
rats (Levine et al., 1988; Dent et al., 2000; Oomen et al., 2009). Therefore it is 
plausible to assume that there is a common factor, namely glucocorticoid 
overexposure, in both early deprivation (study 1) and prenatal Dex treatment (study 
2) animal models. 
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Excessive exposure to GCs can underly both the present increase in the 5-HT1A 
receptor binding (study 3) and the morphological changes seen in the hippocampus 
(studies 1 and 2), which result from the ED and/or dexamethasone treatment. It is 
also important to note that, in studies 1 and 2, no significant treatment effects on the 
total brain volume and non-hippocampal regions were observed, which suggests an 
involvement of the hippocampal mediated vulnerability (Heim and Nemeroff, 2001; 
McEwen, 2003). 
Oxytocin has been found to increase the astroglial proliferation rate in the cultured 
cortical and hypothalamic cells (Lucas and Salm, 1995) and astroglial cells express 
both oxytocin and 5-HT receptors in the brain (Whitaker et al., 1993). GFAP 
expression is found to fluctuate during the pregnancy and lactation period where 
oxytocin plays an important role (Gomora-arrati et al., 2010). The present 
observations suggest that Dex exposure alters the GFAP positive glial cell - 
morphology (study 2), proliferation and differentiation (study 4) and the OTR and 5-
HT1A receptor alterations (study 3). The above supports the view of a common 
mechanism, which underpins the findings of these three studies, although it needs to 
be further investigated in future studies. 
An important and novel finding of the present study was a reduction in the primary 
process length of GFAP positive astroglial cells in the hippocampus, observed in 
both the early life stress and prenatal exposure to glucocorticoids. A previous ED 
study in stress hyper-responsive Fischer rats has shown a reduction in the astroglial 
density (Leventopoulos et al., 2007). Both preclinical and clinical studies have 
shown changes in glial cells in terms of proliferation (Crossin et al., 1997; 
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Wennstrom et al., 2006), reduced cell numbers (Rajkowskal., 2000; Bowley et al., 
2002) and expression (Nichols et al., 1990a,b; Tsuneishi et al., 1991).  
It is tempting to interprete the ED and prenatal Dex effects on astroglia as a 
manifestation of some long-term reductions in the brain plasticity. Also the observed 
changes in the astroglial  morphology in the form of primary process length 
reduction may underpin the observed hippocampal volume loss. It is possible to 
assume that glial responses could also be the reasons for the volumetric losses 
reported in patients suffering from depressive disorders (Miguel-Hidalgo et al 2000; 
Müller et al 2001; Bowley et al., 2002; Rajkowska and Miguel-Hidalgo, 2007). 
 
7.3 Novelty of the present study 
The present thesis has provided some novel and interesting developments and 
findings in terms of both methodolgy and data. It has delivered new knowledge and 
indicated further directions in the understanding of the mechanisms involved in long 
term effects of early life stress. 
The present study was the first one to compare the experimental ED - Wistar (stress 
normo-responsive) and Lewis (stress non-responsive) rats in terms of total brain and 
regional volumetry and astroglia morphology. Previous ED studies have analysed 
only one rat strain at the time (Pryce et al., 2001a; Leventopoulos et al., 2007; 
Leventopoulos et al., 2009; Oomen et al., 2009). Wistar and Lewis rat strains have 
been compared for behaviour in the Morris water maze (Teunissen et al., 2001), Y 
maze learning task (Sida et al., 2003), open field test (Rex et al., 1996) and forced 
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swimming test (Armario et al., 1995). However the present study has compared ED 
effects on these rat strains at the anatomical and cellular level for the first time. 
Another novel approach of the present study was the comparison between NH, EH 
and ED groups. Previous studies have compared these three groups only in terms of 
behaviour (Pryce et al., 2001a; Rüedi-Bettschen et al., 2005) and maternal care 
(Pryce et al., 2001b). Studies by Leventopulos et al. (2007, 2009) have measured the 
GFAP density and serotonin receptor binding in NH and ED groups only. The 
inclusion of the EH group in the present study is important as it controls for the 
handling that takes place during the caging, cleaning and breeding (Levine et al., 
2001; Pryce et al., 2003).     
The use of the sought after stereological quantitative analysis makes the present work 
unbiased as it applies systematic random sampling estimation of the regional brain 
volume, cell number and length (Schmitz and Hof, 2005). To my knowledge, the 
present study is the first one to apply stereology to the analysis of anatomical brain 
changes caused by prenatal exposure to dexamethasone in adult rats.  
In order to assess the astroglial morphology, the present study applied the 
Neurolucida system – a stereology technique to measure the primary process length 
and number. The previous studies have reported astroglial density and number 
responses to ED (Leventopoulos et al., 2007) but the present study is the first one to 
measure the length of the primary processes using stereology.  
In terms of the methodology, peripheral quantitative computed tomography was 
employed in a novel approach to measure total brain volume post-mortem in a high-
precision manner, which is important as overall brain size itself is a variable in 
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neuroanatomy and neurobiology research. In this respect, the present study shows 
that pQCT can be used as a tool for soft tissue (brain) and not only hard (bone) tissue 
volume analysis. This approach is of relevance to volumetric studies on 
neuroplasticity where regional volumes need to be scaled to the total brain volume; 
thanks to this the present study could estimate the relative hippocampal volume, 
similarly to human studies by means of MRI.  
Following on the observations of the consequences of prenatal dexamethasone 
exposure in rats (Study 2), the present study also evaluated in vitro effects of 
dexamethasone in neural stem cells (Study 4).  
7.4 Limitations 
 
The present study suffers from some limitations mainly due to the time restrictions. 
Firstly, there is a lack of behavioural studies with which the observed post-mortem 
changes could have been correlated. Although there are published studies in ED rats, 
which show altered learning and memory based tasks (Pryce at el., 2003; Rüedi-
Betchen et al., 2005) which correlate with the present findings concerning the 
hippocampus, it would have been ideal to match the behaviour with the post mortem 
data of the same experimental animals. Behavioural tests such as Morris water maze, 
forced swim and US preexposure tests could have been performed. 
Secondly, no neuronal analysis was completed in the present study. Previous studies 
have shown a decrease in the neuronal number, neurogenesis and dendritic atrophy in 
relation to the effects of stress and depression (McEwen, 2001, 2005; Duman, 2002, 
2004; Fuchs et al., 2004). Although it had been planned to assess neurone-astroglia 
interactions, that was abandoned for technical reasons and the present project 
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focused mainly on the astroglial cells, as less studied in the litearture. However, it is 
interesting to know if ED and prenatal Dex exposure affect neurones along with 
astroglial cells. Hence stereological analysis of neuronal numbers and dendritic 
length should have been done.    
Lastly, a small sample size was analysed in the present study. Considering the ethical 
regulations and with the attempt to reduce use of animals in research, six animals per 
treatment per experiment were used. Previously published studies and the in-house 
experience were also taken into account while designing the experiment. However, 
despite the small sample size the present study findings still indicated significant 
effects.  
 
7.5 Future directions  
The present thesis findings suggest the need for further experiments which could add 
more details and new understanding to the current observations.  
The present study attempted to analyse neurone-glia interactions using double layer – 
immunohistochemistry; however, the experiments were unsuccessful. It is important 
to understand the colocalisation as astroglial impoverishment was observed in the 
current study. Both neurones and glial cells communicate with each other and control 
various important processes of brain development and homeostasis (Bhat, 2003; 
Gomes et al., 1999; Lim & Alvarez-Buylla 1999). Also glial cells are important for 
neuronal cell surviaval as they provide energy substrates for neurones (Dringen et al., 
1993; Cohen et al 1999). Therefore it is pivotal to know about the neurone-glia 
interaction and hence there is a need for further study. 
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There is also a need to analyse the effects of ED and prenatal Dex treatment on the 
glial cell genesis (gliogenesis). The present study observed loss of glial cell number 
(ED) and primary process length reduction (ED and Dex). It will be interesting to 
know that if these animal models affect the formation of new glial cells. This can be 
evaluated by immunohistochemistry technique by staining 5-bromo 2-deoxyuridine 
(BrdU) and GFAP positive astroglia colocalisation (Gould et al., 1997; Lemaire et 
al., 2000).  
The observed strain differences in the study 1 suggests an involvement of genetic 
mechanisms (McEven et al., 2012) as exposure to stress in early life results in 
‘environmental programming’ (Levine, 1994; Pryce et al., 2005). An implementation 
of the techniques such as DNA methylation assays to assess epigenetic phenomena, 
pyrosequencing, RT-PCR are key to further understand the mechanisms involved in 
the programming of the brain under ED and prenatal Dex exposure. 
Early weaning and maternal deprivation in rats have been shown to reduce BDNF 
levels and suppress adult neurogenesis in the hippocampus (Kikusui et al , 2009; Liu 
et al., 2000; Mirescu et al., 2004). Therefore, further analysis of the mRNA 
expression, stress related proteins, oxytocin and serotonin gene transcription and 
BDNF expression could be evaluated using in situ hybridisation technique. 
Over the recent years the concept of resilience has gained attention in stress related 
research studies (Russo et al., 2012). Neuropeptide Y, a peptide neurotransmitter, is 
considered to be protective against stress (Morgan et al., 2000). Higher levels of 
NPY have shown to reduce psychological distress in response to acute stress 
(Morgan et al., 2002). Therefore, it would be interesting to analyse NPY expression 
in ED rats as it may explain the differences seen between Wistar and Lewis rats.       





The work presented in the present thesis provides a strong support for the general 
hypothesis that genetic and environmental factors contribute to the regional brain 
remodelling and provides further evidence that early life deprivation in rats 
represents a valuable and interesting model for studying interactions between genetic 
and environmental effects.  
The observed impoverishment of the astroglial morphology in the postnatal 
deprivation and prenatal dexamethasone treatment can be treated as a demonstration 
of ‘glial plasticity’, a phenomenon that deserves more research in the context of 
stress related pathologies. It is tempting to speculate that enhancing neuronal 
plasticity and cellular resilience may represent a novel therapeutic approach to the 
treatment of psychiatric conditions.  
Further understanding of the mechanism of action of prenatal corticosteroids in the 
hippocampus may lead to the discovery of specific treatments preventing undesirable 
side effects in childrens in whom prenatal corticosteroids were used as a life saving 
treatment.    
Overall, both early postnatal or prenatal manipulations that increase levels of stress 
and/or glucocorticoids as the chemical mediators of stress, lead to a long-term 
maladaptive brain remodelling with losses in the hippocampal volume, 
impoverishment of hippocampal astroglial morphology and changes in the properties 
of central regulatory receptors in the brain areas involved in the reaction to stress. 
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These effects are consistent with maladaptive brain plasticity that also implicates 
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E. SPSS Statistical Output 












A.  Reagents 
 Anti-glial fibrillary acidic protein (anti-GFAP), Monoclonal, clone G-A-5, mouse ascitic fluid, 




 Anti - S100, developed in rabbit, IgG fraction of antiserum, Company: Sigma, Product no: S-




 Anti - PGP 9.5, Mouse monoclonal neuronal marker, Company: Abcam, Cat no: ab8189, Lot 




 Anti - Beta III tubulin, clone 2G10, mouse monoclonal neuronal specific, Company: Abcam, 




 Anti Rabbit – FITC, developed in goat, Company: Sigma-Aldrich, Cat no: F0382, Lot no: 




 Anti Mouse – Texas red, developed in goat, Company: Sigma-Aldrich, Cat no: T5393, Lot no: 




 Albumin from bovine serum, lyophilized powder, Company: Sigma-Aldrich, Cat no: A4503, 
mol wt ~66 kDa, stored at 2-8°C  
 
 Bacitracin, from bacillus licheniformis, C66H103N17O16S, molecular weight: 1422.69, 
Company: Sigma-Aldrich, Cat no:11702, stored at 2-8°C 
 
 B27 supplement, 10ml, Company: Invitrogen, Cat no: 17504-044, stored at -200C 
 
 Bovine serum albumin, 7.5%, Company: Invitrogen UK, Cat. no: 15260, stored at 2-80C 
 
 Choline chloride, (2-Hydroxyethyl) trimethyl ammonium chloride, (CH3)3N(Cl)CH2CH2OH, 
molecular weight: 139.62, Company: Sigma- Aldrich, Cat no: C7017, stored at cool place. 
 
 Cover slips, Company: Fisher brand, 22mm x 50mm, Product no: FB58661.  
 
 Conical falcon centrifuge tubes, 15ml, BD FaconTM, BD Biosciences 
 





 CytoTox-96 LDH assay, Company: Promega, Southampton, UK, Cat no: G1780, Storage - 
Substrate Mix and Assay Buffer at –20°C and store LDH Positive Control, Lysis Solution (10X) 
and Stop Solution at 4°C. 
 
 Dulbecco’s Modified Eagel Medium: nutrient mixture F12, D-MEM/F12, liquid, 500ml, 




 3,3l – Diaminobenzidine 99%, 5gms, Company: Sigma-Aldrich, Cat. no: D1,238-4 ; Lot no: 




 Dexamethasone, powder, 100mg, molecular weight: 392.46, Company: Sigma – Aldrich UK, 




 DAPI (Vecatshield®), 10 ml, Company: Vector Lab, Cat no. H-1200, concentration of DAPI 1.5 
μg/ml, Stored at 2-8
0
C in the dark. 
 
 DMSO, Dimethyl sulfoxide, Hybri-Max™, sterile-filtered, (CH3)2SO, molecular 
weight: 78.13, Company: Sigma-Aldrich, UK, Cat no: D2650, stored at RT.   
 
 Ethanol 96% v/v, C3H5OH = 46.07, 2.5L, Company: BDH GPR
TM
, Product no: 28719, Lot no: 
L142905. 
 
 EGF Murine, Company: PeproTech, USA, Cat no: 315-09, stored at -200C 
 
 FGF-2 Recombinant Human, Company: PeproTech, Cat no: 100-18B, stored at -200C 
 
 Film developer, D-19 Developer, Kodak Processing chemicals, Cat no: 146 4593, Company: 
Sigma- Aldrich, Inc. Stored in dark. 
 
 Film fixative, Kodak Fixer, Kodak Processing chemicals, Cat no: 197 1746, Company: Sigma-
Aldrich, Inc. Stored in dark. 
 
 Hydrogen peroxide, 30% w/w solution, FW: 34.01, 500ml, Company: Sigma, Cat. no: H-1009, 




 HistomountTM, Histological mounting medium, 100ml, Company: National diagnostics, Cat. 
no: HS-103. 
 






 Hyperfilm, Company: Kodak BioMax MR film, 18x24 cm, Cat no: 873 6936, Carestream 
Health, Inc. Stored in dark. 
 
 ImmEdgeTM pen, Company: Vector laboratories, Cat. no: H-4000. 
 
 L-glutamine (Gibco) liquid, Company: Invitrogen, Cat. No:  25030-034, stored at 2-80C 
 
 Lebovitz’s L-15 medium, Company: Invitrogen, Cat no: 11415-049  
 
 Magnesium chloride, anhydrous, molecular weight: 95.21, Company: Sigma-Aldrich, Cat no: 
M8266, stored at cool place. 
 
 Methanol, CH3OH= 32.04 g/mol, 2.5L, Company: BDH, Product no: 291926G, Lot no: 
K34702469520.  
 
 Normal Horse Serum, 20ml, Company: Vector laboratories, Cat. no: S-2000, stored at 2-80C. 
 
 Oxytocin, lyophilized powder, ~50 IU/mg solid, C43H66N12O12S2, molecular weight: 1007.19, 
Company: Sigma-Aldrich, Cat no: O3251, stored at 2-8°C. 
 
 Oxytocin radioligand - d(CH2)5[Tyr(Me)2, Thr4, Orn8, [
125
I] Tyr9-NH2] – [
125
I]-OVTA, specific 
activity: 2200 Ci/mmol, concentration: 50 μCi/ml, molecular weight ≈ 1277, Company: 




 Oxytocin standards: [125I]-OVTA microscale standards for quantitative autoradiography Cat 




 Optimum cutting tissue (OCT) embedding medium, Company: RALamb Ltd, Eastbourne, UK 
 
 Pargyline hydrochloride, C6H5CH2N(CH3)CH2C≡CH·HCl, Company: Sigma-Aldrich, 
UK,Cat no: P8013, molecular weight: 195.69, stored at −20°C. 
 
 Phosphate buffered saline tablets, 100 tablets, Company: Oxoid, Product no: BR0014G.    
 
 Polysine glass slides, Company: Menzel-GlaserR, 25x75x1mm. 
 
 PBS (Ca2+/Mg2+ free), 100ml, Company: Invitrogen, Cat no: 14200-059, stored at RT 
 
 Poly-D-lysine hydrobromide,  mol wt: 30,000-70,000, D-Lys-(D-Lys)n-D-Lys · xHBr 







 Serotonin radioligand - [3H]WAY100635, tritium radioligand, Company: Amersham 





 Serotonin hydrochloride, powder form, C10H12N2O·HCl, molecular weight 212.68, Company: 
Sigma-Alrich UK, Cat no: H9523, stored at 2-8°C. 
 
 Sodium azide, 25gms, Company: Sigma-Aldrich, Cat. no: S-2002, Lot no: 098K0052. 
 
 Triton X-100, 100ml, Company: Sigma-Aldrich, Cat. no: X-100, Lot no: 058K0073. 
 
 Tris(hydroxymethyl)aminomethane, H2NC(CH2OH)3, molecular weight: 121.4, Company: 
Sigma-Aldrich, Cat no: 154563, stored in cool place, hygroscopic in nature. 
 
 T75 Nunclon flasks, Nuc Roskilde, Denmark, Cat no: 156499. 
 
 0.05% Trypsin/EDTA, 500ml, Company: Invitrogen, Cat no: 25300-062, stored at -5 to -20° C. 
 
 Vectastain Elite ABC kit, Company: Vector laboratories, Cat. no: PK-6102, contains: Anti-
mouse IgG biotinylated Ab (blue label), Normal Horse Serum (Yellow label), Avidin DH- 
















 Phosphate buffered saline (PBS) (pH: 7.4 at RT) 
For 1 litre of PBS: Dissolve 10 PBS tablets  in 1000 ml of distilled water.  
 
 0.1% PBST - rehydrating solution 
Mix 5ml of triton X-100 with 500ml of PBS solution in a flask and place on the stirrer to 
obtain 0.1% PBST. 
 
 0.5% sodium azide 
Weigh 0.1 gm of sodium azide and mix with 20ml of PBS to obtain 0.5% sodium azide. 
 
 1.5% H2O2 - peroxidase inactivating solution 
For 50ml of this solution, mix 10ml of methanol; 0.15ml of 0.3% Triton X-100; 2.5ml of 30% 
H2O2 and then PBS solution was to make up to 50ml. 
 
 Blocking serum solution (BS) 
To prepare 10ml of BS with 10% Normal Horse Serum (NHS), mix the following on a vortex: 
1ml of NHS; 8ml of 0.1% PBST; 1ml of 0.5% sodium azide solution. 
 
 Primary antibody (10Ab) solution 
The respective antibody concentration as mentioned in the methodology chapter was diluted 
using antibody diluent.  
 
 Primary antibody diluent 
For 10ml of diluent – 0.1ml of Normal Horse Serum (NHS) + 8.85ml PBS + 1ml of 0.5% 
sodium azide + 0.05ml of triton X-100 solutions were mixed on vortex. 
 
 Biotinylated secondary antibody (20Ab) solution 
This is a mixture of horse serum and anti-mouse IgG biotinylated Ab. Solution was made from 
4 drops of NHS + 10 ml PBS +1 drop of biotinylated 2
0
 Ab stock. 
 
 Fluorochrome labelled secondary antibody 
The respective concentration of the Anti rabbit-FITC and Anti mouse-Texas red secondary 
antibodies labelled with fluorochrome were diluted using PBS. 
 
 Avidin-Biotin (ABC) complex 
The Avidin-Biotin complex from Vector laboratories comes as a kit that needs reconstitution. 
It has: Anti-mouse IgG biotinylated Ab (blue label), Horse normal serum (Yellow label), 




Mix 10 ml of PBS + 4 drops of reagent A + 4 drops of reagent B. Allow it to stand for 30 
minutes. 
 Diaminobenzidine tetra-hydrochloride (DAB) 
For 10 ml of DAB solution: 9ml of PBS + 1 ml of DAB (already aliquoted). 
 
DAB aliquots: Each 1 ml aliquots were previously prepared as stock solution containing 1mg 





Ready to use hematoxylin solution was used to stain cell nuclei. 
 
 Acid - Alcohol differentiation solution 
1% HCl – 70% ethanol solution was used.  
To make 50ml = 1.18ml of conc HCl + 35ml of 70% ethanol + 13.8ml distilled water.  
 
 Tris – HCl (50mM, pH 7.4) 
Weighted 7.55gm of Tris and dissolved in 100ml distilled water. Adjusted pH to 8 and left 
overnight to settle down. Finally, adjusted pH to 7.4 and diluted to make final volume as 
1.25L. 
 
 Bovine serum albumin (0.1% BSA) 
In order to prepare 1L of 0.1% BSA = 1gm of BSA was added to 1L of distilled water. 
 
 Magnesium chloride (10mM) 
In order to prepare 1L = 0.952gm was added to 1L of distilled water. 
 
 Bacitracin (0.05%) 
In order to prepare 1L of 0.05%  bacitracin = 0.5gm was added to 1L of distilled water. 
 
 Choline chloride (100mM) 
In order to make 1L solution = 13.96gm of choline chloride was dissolved in 1L of distilled 
water. 
 
 [125I] OVTA radioligand  
 
Conversion of fmol 
Specific activity – 2200 Ci/mmol 
2200 Ci/mmol – 1 mmol → 2200 mCi – 1 µmol → 220µCi – 1 nmol →  
2200 nCi – 1 pmol 




x = 1/2200 = 4.54 x 10
-4
 = 0.000454 pmol 
1 pmol – 1000 fmol  
4.54 x 10
-4 
pmol – y?    y = 0.454 fmol 
Therefore, 1 nCi → 0.454 fmol 
 w? nCi → z?    z = 0.454 fmol . w  
 
 [3H]WAY100635 radioligand 
 
80 Ci/mmol = 80 mCi/µmol = 80 µCi/nmol 
80 µCi – 1  nmol 
200 µCi – x? 
x = 2.5 nmol/ml = 2500 nmol/L → 2.5 µM [
3
H]WAY solution. 
Therefore to make 30 ml of 2 nM solution,  
2 nM = 2 nmol → 1L 
 y?  → 30ml  
y= 0.06 nmol in 30 ml or 60 pmol 
This solution: 2.5 nmol/ml  i.e.   2.5 pmol/µl 
     60 pmol → z? 




Conversion to fmol 
Specific activity – 80 Ci/mmol 
80 Ci/mmol – 1 mmol → 80 mCi – 1 µmol → 8µCi – 1 nmol →  
80 nCi – 1 pmol 
1 nCi → x? pmol 
x = 1/80 = 0.0125 pmol 
1 pmol – 1000 fmol  
0.0125
 
pmol – y?    y = 12.5 fmol 
Therefore, 1 nCi → 12.5 fmol 









 Brightfield Microscope, BX51, Olympus with Nicon Coolpix E 4500 video camera, Germany 
 Microscope, Olympus Inverted Model IMT-2 
 Centrifuge, Sigma  
 Cryostat, Model 5040, Bright Instruments Co. Ltd, Huntington, UK 
 Cell counter, Tamaco. 
 Dell Desktop Workstation PWS370 computer, Intel Pentium 4, CPU 2.8 GHz 
 Digital colour video camera, CoolSNAPTM, Photometrics 
 DL10 safelight, cat no: 1552924, Ilford imaging Ltd., UK 
 Fluorescent microscope, BX51, Olympus with Nicon Coolpix E 4500 video camera, 
Germany  
 Heracell 150i CO2 incubator, Thermo Scientific, UK 
 Herasafe KS12 Safety cabinet, ThermoScientific, UK 
 HypercassetteTM, Size 18 x 24 cm, Amersham Biosciences, UK 
 Lightbox, Northern light imaging research, Inc. Canada 
 Magnetic stirrer thermostat hotplate, Gallen Kamp, Harding scientific instruments, UK  
 pH meter 140, Scientific &Medical products Ltd, Corning, UK 
 Vortex, FISONS, WhirlimixerTM, Serial no: NEL11490, UK 








 Avizo 5, version 5, Mercury Computer Systems, Chelmsford, MA, USA. 
 Microsoft Office packages, Word and Excel 2007, Microsoft corporation, USA 
 MCID, Version 7.0, Interfocus imaging research, Linton, England, UK. 
 Neurolucida, Version 9, MicroBrightField, Inc., Germany.  
 SteroInvestigator, Version 9, MicroBrightField, Inc., Germany. 
 SPSS, Version 17.0, Statistical software by SPSS Inc., Illinois, USA. 



























Between Strain comparison 
 













Dorsal Hippocampus volume 
 
HX cell counts 
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Primary Process Length 
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Mean Primary Process Length 
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Basolateral Amygdala volume 
 







GFAP Stained – Astroglia Cell Counts 
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Primary Process Length 
CA3 
 

















































Differentiation – GFAP cells 
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LDH Assay 
 
 
 
